Common use of Additional Definitions Clause in Contracts

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)

Appears in 4 contracts

Sources: Merger Agreement (Skullcandy, Inc.), Merger Agreement (Mill Road Capital II, L.P.), Merger Agreement (Mill Road Capital II, L.P.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approval Annex A Appointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.14 Assumed Option 3.7(e) Board Recommendation Section 2.2(bAssumed RSU 3.7(d) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.18(k) Company Disclosure Letter Article Art. IV Preamble Company License-In Intellectual Property Agreements Section 4.16(g4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.2(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 7.2(c) Confidentiality Agreement Section 10.4 Current Company 8.8 Consent 4.5 Continuing Directors 2.3(a) Conversion RSUs 3.7(d)(ii) Covered Securityholders 4.18(k) D&O Insurance Section 7.8(c7.1(c) Customs Laws Section 4.22(aDeemed Cashout Value 3.7(e)(ii) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) Employment Compensation Arrangements 4.18(k) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.1(a) Inventions Section 1.1 Material Contract Section International Employee Plans 4.18(a) Leased Real Property 4.13(b) Leases 4.13(b) (a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNew Plans 7.2(d) Offer Recitals Offer Price Recitals Offer to Purchase 2.1(a) Offer Documents 2.1(g) Old Plans 7.2(d) Option Consideration 3.7(e) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Proxy Statement 4.28(c) Recommendation Change Notice 6.3(b) Representatives 6.2(b) Requisite Stockholder Approval 4.3 Schedule TO 2.1(g) Schedule 14D-9 2.2(b) Stockholders Recitals Subsidiary Securities 4.7(c) Superior Proposal Notice 10.1(e) Surviving Corporation 3.1 (a) Tax Returns 4.16 (a) Tender and Voting Agreement Recitals Termination Date 10.1(b) Top-Up Notice 2.4(a) Top-Up Option 2.4(a) Top-Up Option Shares 2.4(a) Uncertificated Shares 3.8(c)

Appears in 3 contracts

Sources: Merger Agreement (3PAR Inc.), Merger Agreement (Hewlett Packard Co), Merger Agreement (Hewlett Packard Co)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality A&R Partnership Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Recitals Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Financing Section 6.19(a) BAM Letter Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Recitals Cancelled Company Shares Section 3.7(a)(ii2.07(a)(ii) Capitalization Date Section 3.06(a) Cash Electing Share Section 2.03(d)(1) Cash Election Section 2.03(d)(1) Certificate of Merger Section 3.2 2.02 Certificates Section 3.8(c2.09(c) Changes Section 1.1 Charter Closing Section 3.3 2.03(a) Charter Closing Date Section 3.3 COBRA 2.03(a) Charter Effective Time Section 4.11(d2.03(a) Citigroup Section 3.25 Class B Exchange Recitals Class B Exchange Agreement Section 2.03(b) Class B Exchange Closing Section 2.03(b) Class B Exchange Effective Time Section 2.03(b) Collective Bargaining Agreement Section 3.19(a) Committed Financing Section 4.29 Company Preamble Company Common Stock Benefit Plans Section 3.18(a) Company Board Recitals Company Board Recommendation Section 3.02 Company Board Recommendation Change Section 5.03(c) Company Board Recommendation Notice Section 5.03(f) Company Budget Section 5.01(a) Company Charter Recitals Company Disclosure Letter Article IV III Company License-In Agreements Related Parties Section 4.16(g8.03(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.08 Company Securities Section 4.2(a3.06(c) Company Shares Special Distribution Section 5.01(a) Company Stockholder Meeting Section 3.02 Company Stockholders Recitals Competing Acquisition Transaction Section 8.03(b)(ii) Competing Proposal Section 5.03(b) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 9.04 Consent Section 7.8(c3.05 Continuing Employees Section 6.08(a) Customs Laws Converted Option Section 4.22(a2.07(d)(ii) Debt Financing Dispute Converted Restricted Stock Section 10.9(a2.07(e)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.07(c)(i) EAR Election Deadline Section 4.22(a2.08(b) Effective Time Election Form Section 3.2 2.08(a) Election Form Record Date Section 2.08(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.02 Escrow Account Section 4.15(b2.09(a) Escrow Agent Section 2.09(a) Escrow Agreement Section 2.09(a) Exchange Fund Section 3.8(b2.09(b) Expiration Time Expenses Section 2.1(d)(i8.03(a) Financial Statements Incipio Incipio Merger Agreement Fee Letter Section 4.7(b4.29 Final Offering Section 2.07(g) Recitals Recitals Financing Commitment Section 4.29 Financing Commitment Papers Section 4.29 Form F-4 Section 4.23 Form S-4 Section 3.28 Fraud and Bribery Laws Section 3.21(b) ▇▇▇▇▇▇▇ ▇▇▇▇▇ Section 3.25 Indemnified Persons Parties Section 7.8(a6.07(a) Inventions Mailing Date Section 1.1 2.08(a) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Merger Closing Section 2.03(e) Merger Closing Date. Section 2.03(e) Merger Consideration Section 3.7(a)(i2.07(a)(i) Minimum Condition Merger Effective Time Section 2.1(a)(i2.02 New Plans Section 6.08(b) Multiemployer Plan Non-Electing Shares Section 4.11(c2.08(b) Notice Period Section 5.03(g) Old Plans Section 6.08(b) Operating Partnership Recitals Owned Real Property Section 3.13(a) Parent Preamble Parent Capitalization Date Section 4.06 Parent Common Units Election Section 2.08(b) Parent Common Units Election Share Section 2.08(b) Parent Common Units Exchange Section 2.03(f) Parent Disclosure Letter Article IV Parent Material Contract Section 4.12(a) Parent Related Parties Section 8.03(d) Parent SEC Reports Section 4.08 Parent Securities Section 4.06(c) Parent Subsidiary Securities Section 4.07(c) Parent Unitholder Consent Section 4.04 Parent Unitholder Meeting Section 6.16 Partnership Agreement Amendment and Restatement Recitals Payment Agent Section 2.09(a) Per Restricted Share Cash Consideration Section 2.07(e)(i) Permits Section 3.20 Pre-Closing Dividend Section 2.03(d) Prorated Per Share Cash Dividend Section 2.03(d)(1) Prorated Per Share Stock Dividend Section 2.03(d)(2) Proxy Statement Section 3.28 PTP Qualifying Income Section 8.03(b)(iv)(1) Qualifying Income Section 8.03(c)(i) Qualifying Income Section 8.03(b)(iv)(3) REIT Affiliate Section 8.03(b)(iv)(3) REIT Subsidiary Section 3.17(f) Representatives Section 5.03(a) Requested Transactions Section 6.14 Requested Transactions Closing Section 2.03(c) Requested Transactions Effective Time Section 2.03(c) Requisite Stockholder Approval Section 3.03 Retention Program Section 6.08(d) Rev. Proc. 93-27 Section 3.06(b) Reverse Termination Fee Section 8.03(c) Rights Agreement Recitals Schedule 13E3 Section 4.23 Shelf Registration Statement(s) Section 7.03(e) Short Taxable Year Section 7.02(d) Special Committee Recitals Specified JV Agreements Section 6.19(c) Specified JV Consent Section 6.19(c) Specified JV Party Section 6.19(c) Stock Electing Share Section 2.03(d)(2) Stock Election Section 2.03(d)(2) Subsidiary Interests Section 6.14 Subsidiary Securities Section 3.07(c) Surviving Corporation Section 2.01 Surviving Debt Section 6.19(b) Surviving Debt Consent Section 6.19(b) Surviving Debt Party Section 6.19(b) Tail Period Section 8.03(b)(ii) Tail Policy Section 6.07(b) Tax Protection Agreement Section 3.17(j) Tax Sharing Agreement Section 3.17(j) Termination Date Section 8.01(a)(ii) Termination Fee Section 8.03(b)(i) Uncertificated Shares Section 2.09(c) Voting Agreement Recitals Voting Parties Recitals WARN Section 3.19(c)

Appears in 3 contracts

Sources: Merger Agreement (Brookfield Property Partners L.P.), Merger Agreement (Brookfield Asset Management Inc.), Merger Agreement (GGP Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAmended Offer Documents 2.1(a)(i) Antiboycott Rules Section 4.22(aAnnual Meeting 7.6(b) Board Recommendation Section 2.2(bAssets 4.19 Assumed Option 3.8(a) Cancelled Company Assumed Restricted Stock Unit 3.8(b) Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d3.2 Collective Bargaining Agreements 4.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Products 4.20(a) Company Financial Advisor Section 4.10 Restricted Stock 3.8(c) Company SEC Reports Section 4.7(a4.6(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.6(a) Confidential Materials 7.9(a) Continuing Directors 2.4(b) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(vi) EAR Section 4.22(aEffect 1.1(pp) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b3.3(a) (a) Exchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Foreign Employees 4.15(j) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 4.20(d) Recitals Recitals Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 Independent Directors 2.4(c) Leased Real Property 4.17 Leases 4.17 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.6(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A NetApp Merger Agreement Recitals Notes 7.9(a)

Appears in 3 contracts

Sources: Merger Agreement (Emc Corp), Merger Agreement (Data Domain, Inc.), Merger Agreement (Emc Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.11(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.19 Book-Entry Shares 3.9(c) Board Recommendation Section 2.2(bCapitalization Date 4.4(a) Cancelled Company Shares Section 3.7(a)(ii) Capitalization Representation Annex A Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Claims Annex A Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.17(a) Company Preamble Company Common Stock Recitals Board Recommendation 2.2(a)(iv) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Company License-In Agreements Section 4.16(gRegistered Intellectual Property 4.20(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 7.1(b) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Stockholders 2.1(f)(ii) Company Stockholders’ Meeting 7.3(a) Compensation Committee 4.3(c) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) Continuing Employees 7.11(a) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.16(a) Employment Agreement Recitals ESPP 3.8(c) eScription Transition Condition Annex A Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iFinal Exercise Date 3.8(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 4.16(k) Recitals Recitals Funded International Employee Plan 4.16(b) Government Conditions 7.5(f) Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 International Employee Plans 4.16(a) IP Contracts 4.20(h) Lazard 4.26 Leased Real Property 4.18(b) Leases 4.18(b) Material Contract Section 4.18(a4.11(a) Material Customer 4.23(a) Material Supplier 4.23(b) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)

Appears in 3 contracts

Sources: Merger Agreement (Nuance Communications, Inc.), Merger Agreement (Nuance Communications, Inc.), Merger Agreement (Transcend Services Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdverse Effect on Financing 7.18(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(aBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Cash Offer Price Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8 Effect 1.1(u) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c) Event Notice Period 6.3(e)(i)(2) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Form S-4 2.1(e) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Lease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(iFractional Share Payout 3.7(d) Minimum Condition Section 2.1(a)(i) Merger Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)

Appears in 3 contracts

Sources: Agreement and Plan of Merger (Herc Holdings Inc), Agreement and Plan of Merger (Herc Holdings Inc), Agreement and Plan of Merger (H&E Equipment Services, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.12(c)(i) Board Recommendation Section 2.2(bCFIUS Filing 6.2(c) Cancelled Company Shares Section 3.7(a)(iiChosen Courts 9.12(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.6 Closing Date Section 3.3 COBRA Section 4.11(d2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Benefit Plan Expiration Date 6.11(b) Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(g) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPlans 6.11(c) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(e) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSoftware 3.15(j) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stock-Based Award Consideration 2.11(a) Company D&O Insurance Section 7.8(cTrade Secrets 3.15(i) Customs Laws Section 4.22(aComparable Plans 6.11(c) Debt Financing Dispute Section 10.9(aContributor 3.15(h) DGCL Recitals Copyrights 1.1(eee) Dissenting Company Shares Section 3.7(c)(i2.10(c)(i) EAR Section 4.22(aDissenting Shareholder Statute 2.10(c)(i) Draft CFIUS Filing 6.2(c) DTC Payment 2.12(d) ▇▇▇▇▇ 3.8 Effect 1.1(x) Effective Time Section 2.5 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEvent Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.12(b) Excluded Benefits 6.11(c) Expiration Date 2.1(c) Expiration Time Section 2.1(d)(iAnnex I Extension Deadline 2.1(d)(ii) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Expiration Date 2.1(c) International Company Benefit Plans 3.18(a) Joinder 9.7 Lease 3.13(b) Leased Real Property 3.13(b) Marks 1.1(eee) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Sub Recitals Minimum Condition Section 2.1(a)(iAnnex I New Plans 6.11(d) Multiemployer Plan Section 4.11(cOffer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(f)(i) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i)

Appears in 3 contracts

Sources: Merger Agreement (True Wind Capital, L.P.), Merger Agreement (Zix Corp), Merger Agreement (Open Text Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery/AML Laws 3.19(a) Antiboycott Rules Section 4.22(aBorrower 4.7(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Control Payment 3.15(a)(xii) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 6.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company ESPP Rights 2.7(e) Company Financial Advisor Section 4.10 Advisors 3.21 Company Financial Statements 3.5(b) Company Plans 6.9(c) Company Related Parties 8.4(c) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a3.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Company Termination Fee 8.4(a) Competing Acquisition Transaction 8.4(a)(i) Current Company D&O Insurance Section 7.8(c6.4(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.7(a) Debt Financing Dispute Section 10.9(a4.7(a) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.2 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(e) Recitals Recitals Financing Agreements 6.16(d) Financing Sources 8.5 In-bound License 3.14(b) In-the-money Option 2.7(c) Indemnified Persons Section 7.8(a6.4(a) Indemnified Proceeding 6.4(b) Inventions Section 1.1 Article X Know-How Article X Labor Agreements 3.15(a)(xvii) Labor Organizations 3.16(i) Material Contract Section 4.18(a3.15(a) Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Commencement Date 1.1(a) Offer Conditions Annex A Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Out-bound License 3.14(b) Parent Preamble Payment Agent 2.8(a) Payoff Amount 2.7(f) Payoff Letter 2.7(f) Plans 3.16(a) Principal Stockholders Recitals Real Property Leases 3.13(b) Representatives 5.3 Restraint 7.1(b) Regulatory Authorities 3.17(b) Regulatory Permits 3.17(b) Required Information 6.16(a)(iv) Restricted Benefits 3.19(b) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software Article X Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.4(a)(i) Trademarks Article X Uncertificated Shares 2.8(c) Works of Authorship Article X

Appears in 2 contracts

Sources: Merger Agreement (Horizon Pharma PLC), Merger Agreement (Raptor Pharmaceutical Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEffect on Financing 7.18 Advisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aE▇▇▇▇ 4.8 Effect 1.1(t) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c)6.3(e)(i) Event Notice Period 6.3(e)(i) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Go-Shop Period 6.3(a) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) (a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) No-Shop Period Start Date 6.3(a) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)

Appears in 2 contracts

Sources: Merger Agreement (United Rentals, Inc.), Merger Agreement (United Rentals North America Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBook-Entry Shares 2.8(c)(ii) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(a) Board Recommendation Section 2.2(bCanceled Shares 2.7(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation Notice 5.3(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.13(d) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.5 Company Board Recommendation Change 5.3(a) Company Disclosure Letter Article IV Company License-In Agreements III Term Section 4.16(g) Company License-Out Agreements Section 4.16(h) Reference Company Financial Advisor Section 4.10 3.12 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Termination Fee 8.3(c) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.4 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFDA Permits 3.22(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(f) Recitals Recitals Final Offering Periods 2.7(f) Foreign Antitrust Laws 3.7 Indemnified Persons Section 7.8(a6.8(a) Indemnified Proceeding 6.8(b) Intercompany Indebtedness 1.1 Inventions Section 1.1 Letter of Transmittal 2.8(c)(i) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 3.21 Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.9(c) Multiemployer Plan Section 4.11(cOld Plans 6.9(c) Option Consideration 2.7(d) Parent Preamble Parent Termination Fee 8.3(d) Paying Agent 2.8(a) Payor 2.8(e) Plans 3.13(a) Proxy Statement 6.1(a) Real Property Leases 3.20(b) RSU Consideration 2.7(e) Solvent 4.10 Stockholder Approval 3.6 Stockholders Meeting 6.1(c) Surviving Corporation 2.1 Termination Date 8.1(b)(i)

Appears in 2 contracts

Sources: Merger Agreement (Biogen Inc.), Merger Agreement (Reata Pharmaceuticals Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2023 Bonus Plan 7.9(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bAntitrust Clearance Condition Annex A Balance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Cash Amount Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section Date. 3.3 COBRA Section 4.11(dCollaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.23 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.2(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Covered Entity 4.20(j) CVR Recitals CVR Agreement Recitals D&O Insurance Section 7.8(cIndemnified Party 7.8(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData 1.1 Depository Agent 3.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Existing Payment Period 3.7(h) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDCA 4.20(a) Recitals Recitals Indemnified Persons Section 7.8(aForeign Antitrust Laws 4.6 French Tax Code 10.14 GDPR 1.1 Internet Properties 1.1 Inventions 1.1 Leased Real Property 4.18(b) Inventions Section 1.1 Material Contract Section 4.18(a4.19(a) Maximum Annual Premium Section 7.8(cMedical Device 4.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Milestone Option Amount 3.7(d)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) No Antitrust Proceedings Condition Annex A No Legal Restraint Condition Annex A Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Owned Real Property 4.18(a) Parent Preamble Paying Agent 3.8(a) Proprietary Information 1.1 PSU Consideration 3.7(f) Real Property 4.18(a) Real Property Leases 4.18(b) Regulatory Permits 4.20(i) Remedy Action 7.2(a) Rights Agent Recitals RSU Consideration 3.7(e) Schedule TO 2.1(f)(i) Schedule 14D-9 2.2(a) Social Security Act 4.20(e) Subsidiary Securities 4.2(e) Surviving Corporation. 3.1 Termination Condition Annex A Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c)(ii) Works of Authorship 1.1

Appears in 2 contracts

Sources: Merger Agreement (Johnson & Johnson), Merger Agreement (Johnson & Johnson)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement Adjusted Option Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i3.2(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 2.2 Bank Merger Recitals Bank Merger Surviving Bank Section 3.8(c2.6 Burdensome Condition Section 6.3(c) Changes Cash Consideration Section 1.1 3.1(a)(1) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock 401(k) Plan Section 6.12(b)(1) Company Articles Section 2.5 Company Bank Sub Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.2(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.2(j)(1) Company Securities Indemnified Parties Section 4.2(a6.11(b) Company Shares Meeting Section 6.2(a) Term Section Company Restricted Stock Award Section 3.1(a)(1) Company Shareholder Matters Section 5.2(e) Company Stock Option Section 3.2(a) Company Voting Agreements Recitals Confidentiality Agreement Conversion Project Manager Section 10.4 Current Company D&O Insurance 6.13 Covered Employees Section 7.8(c6.12(b) Customs Laws Determination Date Section 4.22(a8.1(h) Debt Financing Dispute Disclosure Schedule Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 5.1 Effective Time Section 3.2 Enforceability Exceptions 2.2 Environmental Condition Section 4.4 6.15(a) Environmental Permits Survey Section 4.15(b6.15(a) Equity Award Exchange Ratio Section 3.2(a) Exchange Agent Section 3.3(a) Exchange Fund Section 3.8(b3.3(a) Expiration Time Exchange Ratio Section 2.1(d)(i3.1 FDICIA Reporting Requirements Section 5.2(j)(2) Financial Statements Incipio Incipio Merger Agreement Fee Section 4.7(b8.3(a) Fee Triggering Event Section 8.3(a) Final Parent Market Price Section 8.1(h) Final Index Price Section 8.1(h) Index Section 8.1(h) Index Ratio Section 8.1(h) Initial Index Price Section 8.1(h) Initial Parent Market Price Section 8.1(h) Intended Tax Treatment Recitals Recitals Indemnified Persons Interest Rate Instruments Section 7.8(a5.2(aa) Inventions Joint Proxy Statement Section 1.1 6.5(a) Loans Section 5.2(z)(1) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Section 7.8(c5.2(v)(1) Merger Recitals Merger Sub Preamble New Certificates Section 3.3(a) Old Certificates Section 3.3(a) OREO Section 6.14(a) Outside Date Section 8.1(e) Parent Preamble Parent 401(k) Plan Section 6.12(b)(3) Parent Audited Financial Statements Section 5.3(i)(1) Parent Bank Sub Recitals Parent Closing Price Section 3.2(a) Parent Common Stock Issuance Section 5.3(e) Parent Determination Stock Price Section 8.1(g) Parent Meeting Section 6.2(b) Term Section Parent Merger Recitals Parent Merger Surviving Company Section 2.6 Parent SEC Filings Section 5.3(i)(1) Pension Plan Section 5.3(r), Section 5.2(t)(2) Per Common Share Consideration Section 3.7(a)(i3.1(a)(1) Minimum Condition Phase II Survey Section 2.1(a)(i6.15(b) Multiemployer Plan Real Property Section 4.11(c5.2(u)(2) Registration Statement Section 6.5(a) Required Third Party Consents Section 6.3(a) Requisite Regulatory Approvals Section 6.3(a) Scheduled Intellectual Property Section 5.2(p)(1) Subsequent Mergers Recitals Supplemental Disclosure Schedule Section 6.1(c) Survey Section 6.14(a) Surviving Corporation Recitals Tail Coverage Period Section 6.11(a)(2) Tail Policy Section 6.11(a)(1) Takeover Laws Section 5.2(h) Title Commitment Section 6.14(a) Title Company Section 6.14(a) Title Notice Section 6.14(b) Title Review Period Section 6.14(b) Trust or Agency Accounts Section 5.2(y)(1) Trust or Agency Agreements Section 5.2(y)(1) Trust or Agency Records Section 5.2(y)(6) ▇▇▇▇▇▇ Section 7.3(c)

Appears in 2 contracts

Sources: Merger Agreement, Merger Agreement (Byline Bancorp, Inc.)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.7(a) Audit Rights Holder Section 9.7(e) Auditee Section 9.7(e) DEFINITION SECTION Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.2 Celgene Independent Product Master Agreement Challenge Section 14.3(d) Challenging Party Section 14.3(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.4 Combination Product Section 1.41 Commercialization/Commercialize Master Agreement Commercialization Budget Section 6.2(c) Commercialization Costs Section 6.5(c) Commercialization Plan Section 6.2(a) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.3(b)(i) Damages Master Agreement Deemed Buy-In Section 3.3(c) Develop/Development Master Agreement Development Budget Section 3.1(a)(i) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iii)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 DEFINITION SECTION Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.8(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Initial Enforcement Party Section 10.3(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.3(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.3(b)(i) Non-Proposing Party Section 3.3 Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.8(b)(i) Paying Party Section 9.8(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.3(a) Program Assets Section 12.4(a) DEFINITION SECTION DEFINITION SECTION Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Proposing Party Section 3.3 Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Expenses Exhibit D Regulatory Interactions Section 5.1(b) Report Exhibit D Requesting Party Section 11.3(b)(iii) Royalty Rate Section 9.4(a) Royalty Term Section Reference Acceptable Confidentiality 9.4(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.41 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Step-In Enforcement Party Section 10.3(d) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.5(b) Acquisition Proposal Term Section 6.2(e)(i14.1 Third Party Contractors Section 8.2(a)(ii) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1 Vividion Opt-Out Notice Section 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.3(b)

Appears in 2 contracts

Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i409A Authorities 4.11(f) Action 4.9 Affiliate Transaction 4.24 Agents 4.20(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Appointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Arrangements 7.17 Book Entry Shares Section 3.7(a)(ii3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Bylaws 4.1(b) Company Charter 4.1(b) Company Compensation Committee 7.17 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEscrow Agreement 4.18(l) Company License-Out Agreements Section 4.16(hInsurance Policies 4.16 Company International Plan 4.11(g) Company Financial Advisor Section 4.10 Plans 4.11(a) Company Registered IP 4.18(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(aDocuments 4.6(a) Company Shares Recitals Company Stockholder Approval 4.4(a) Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidential Customer Information 4.18(m) Confidentiality Agreement Section 10.4 Current Company 7.9 Continuing Director 2.3(a) Covered Securityholders 7.17 D&O Insurance Section 7.8(c7.13(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployment Compensation Arrangement 7.17 ESPP 7.11(g) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(b) Recitals Recitals FAR 4.20(c) Final Exercise Date 7.11(g) Indebtedness 6.2(h) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Independent Directors 2.3(b) Initial Termination Date 9.1(b) Leased Real Property 4.17(a) Material Contract Section 4.18(a4.15(a) Maximum Annual Premium Section 7.8(c7.13(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 4.25 Nonqualified Deferred Compensation Plan Section 4.11(c4.11(f) Offer Recitals Offer Documents 2.1(f)

Appears in 2 contracts

Sources: Merger Agreement (Hewlett Packard Co), Merger Agreement (ArcSight Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Accel Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRecitals Accel Breakup Fee 1.1(ss) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(e)(ii) Antiboycott Rules Section 4.22(aAssets 3.14 Bylaws 2.5(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letter 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(c) Company License-Out Agreements Section 4.16(hProducts 3.16(b) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.16(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStock-Based Award Consideration 2.7(d) Company Shares Recitals Stockholder Meeting 6.4 Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuing Discussion Period 5.3(c) Dissenting Company Shares 2.7(c)(i) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a) 6.6 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aEffect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) ESPP 2.7(g) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinal Offering 2.7.(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 In-Licenses 3.16(c) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Lease 3.15(b) Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Newco Preamble Newco Expenses 8.3 Newco Representatives 5.3(f) No-Shop Period Start Date 5.3(a) Notice Period 5.3(f) Option Consideration Section 3.7(a)(i2.7(e) Minimum Condition Section 2.1(a)(iOther Required Company Filing or Other Required Company Filings 3.27(a) Multiemployer Plan Section 4.11(c)Other Required Newco Filing or Other Required Newco Filings 4.6(b) Out-Licenses 3.16(c) Owned Company Shares 2.7(a)(iii) Payment Agent 2.8(a) Proxy Statement 3.27(a) Recent SEC Reports Article III Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.15(c) Subsidiary Securities 3.8(c) Surviving Corporation 2.1 (a) Termination Date 8.1

Appears in 2 contracts

Sources: Merger Agreement (Sumtotal Systems Inc), Merger Agreement (Vista Equity Partners Fund III LP)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.4(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Common Stock Recitals Company Compensation Committee 4.17(m) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gFinancial Advisors 4.25 Company IP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.10(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.8(a) Company Shares Recitals Competing Acquisition Transaction 9.3(b)(iii) Competing Party 9.3(b)(iii) Confidentiality Agreement Section 10.4 Consent 4.5 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(m) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGrant Date 4.6(e) Recitals Recitals Indemnified Persons Section 7.8(a7.9(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) LKQ Preamble Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.4(c) New Plans 7.10(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.10(c) Option Consideration 3.7(d) Outside Date 9.1(b) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Representatives 6.2(b) Restraint 8.1(b) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Stockholder List Date 2.2(c) Subsidiary Securities 4.7(c) Support Agreement Recitals Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Fee 9.3(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)

Appears in 2 contracts

Sources: Merger Agreement (LKQ Corp), Merger Agreement (Coast Distribution System Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(c)(ii) Antiboycott Rules Section 4.22(aAlternative Financing 6.5(b) Board Recommendation Section 2.2(bAnti-Corruption Laws 3.26(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.12 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.11(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gOption Consideration 2.9(a) Company License-Out Agreements Section 4.16(hPBRSU Consideration 2.9(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e) Company RSU Consideration 2.9(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Agreements 9.6 Consent 3.6 Copyrights 1.1(bbb) D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) Definitive Financing Agreements 6.5(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) ▇▇▇▇▇ 1.3(q) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.15 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFairness Opinions 3.3(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.11(a) Fee Letters 6.5(a) Financing 4.11(a) Guarantee Recitals Holdings Recitals Holdings Subsidiary Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(bbb) Maximum Annual Premium Section 7.8(c6.9(c) Maximum Company Liability Amount 8.3(e) Maximum Parent Liability Amount 8.3(a) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plan 6.10(c) Minimum Condition Section 2.1(a)(iNon-Recourse Party 9.18 Other Required Company Filing 6.3(b) Multiemployer Plan Section Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(ii) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter Article IV Parent Related Parties 8.3(a) Parties Preamble Party Preamble Patents 1.1(bbb) Payment Agent 2.10(a) Payoff Letters 6.19 Per Share Price 2.7(a)(iv) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Repaid Indebtedness 6.19 Required Amount 4.11(c) Requisite Stockholder Approval 3.4 Reverse Termination Fee 8.3(a) Rollover Agreements Recitals Rollover Shares 2.7(a)(ii) Rollover Stockholders Recitals SaaS 3.16(f) Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Subsidiary Owned Share 2.7(a)(iii) Support Agreement Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Written 1.3(r)

Appears in 2 contracts

Sources: Merger Agreement (R1 RCM Inc. /DE), Merger Agreement (R1 RCM Inc. /DE)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.8 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(4) Affiliate Master Agreement Agreement Preamble Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.5(a) Bankruptcy Code Section 8.8 Business Day Master Agreement CCB Program Master Agreement Celgene Preamble Celgene Independent Product Master Agreement Celgene Indemnified Parties Section 13.2(a) Celgene Manufacturing Responsibilities Section 4.1(a) Challenge Section 14.3(d) Challenging Party Section 14.3(d) Clinically Develop Section 8.6(a) Combination Product Section 1.34 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) DEFINITION SECTION Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Compound Master Agreement Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement Cure Period Section 14.3(b)(i) Deal Target Master Agreement Deal Target Program Master Agreement Develop/Development Master Agreement Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 Distinct Product Master Agreement Distinct Product Catch-Up Payments Section 9.1(a)(iv) Earlier Patent Section 10.8 Electronic Delivery Section 15.14 Enabling Manufacturing Section 8.6(a) Execution Date Preamble E3 Ligase Program Master Agreement FDA Master Agreement First Program Master Agreement force majeure event Section 15.5 Functional Phenotypic Assay Similarity Criteria Master Agreement Implementation Date Master Agreement IND Master Agreement Indication Master Agreement Indirect Taxes Section 9.6(a) Invalidity Claim Section 10.4(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.2(c) Licensed Product Data Section 14.4(c) Licensed Program Introduction Manufacture/Manufacturing Master Agreement Master Agreement Introduction Material Breach Section 14.3(b)(i) Opt-In Right Master Agreement Party/Parties Preamble Patent Master Agreement Payee Party Section 9.6(a) Paying Party Section 9.6(a) Person Master Agreement DEFINITION SECTION Permitted Indication Section 8.6(b)(vii) Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Product Trademarks Section 6.2(a) Program Assets Section 12.4 Program Compound Master Agreement Prosecution/Prosecute Master Agreement Publication Master Agreement Publication Purpose Section 11.4(a) Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.2 Requesting Party Section 11.3(b)(iii) Royalty Term Section Reference Acceptable Confidentiality 9.2(b) SEC Section 11.3(b)(i) Separate Program Master Agreement Separate Program Product Section 6.2(e)(iii8.6(b)(vii) Acquisition Proposal Selling Party Section 6.2(e)(i1.34 Target Master Agreement Term Section 14.1 Third Party Master Agreement Third Party Contractors Section 8.2(b) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4(a) Vividion Preamble Adverse Recommendation Change Vividion Cereblon Program Master Agreement Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseVividion Opt-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Notice Master Agreement

Appears in 2 contracts

Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts ‎Section 2.8(d)(i) Alternative Acquisition Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i‎Section 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Vesting Period ‎Section 2.7(c)(ii) Antiboycott Rules Section 4.22(aApproval ‎Section 3.5 Assignee ‎Section 10.3 Assumed Consideration ‎Section 2.7(c)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date ‎Section 3.6(a) Certificate of Merger Section 3.2 ‎Section 2.3 Certificates Section 3.8(c‎Section 2.8(c) Change ‎Section 1.1 Changes Section ‎Section 1.1 Charter Documents ‎Section 3.1 Closing Section 3.3 ‎Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(d‎Section 2.2 Code ‎Section 2.8(f) Collective Bargaining Agreement ‎Section 3.18(a) Companies Registrar ‎Section 2.3 Company Preamble Company Common Stock Recitals Board Recommendation ‎Section 5.3(a) Company Board Recommendation Change ‎Section 5.3(b) Company Disclosure Letter Article IV ‎Article III Company License-In Agreements Section 4.16(gProducts ‎Section 3.15(b) Company License-Out Agreements Reports ‎Section 3.8 Term Section 4.16(hReference Company Securities ‎Section 3.6(d) Company Financial Advisor Section 4.10 Shareholder Approval ‎Section 3.2 Company SEC Reports Section 4.7(aShareholders Meeting ‎Section 7.3(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company ‎Section 7.8 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Due Diligence Review ‎Section 4.13 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b‎Section 2.3 Employee Plans ‎Section 3.17(a) Exchange Fund ‎Section 2.8(b) FCPA Section 3.8(b3.20(b) Expiration Time Section 2.1(d)(iFDA ‎Section 3.20(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b‎Section 3.9(a) Recitals Funded International Employee Plan ‎Section 3.17(i) Good Clinical Practices ‎Section 3.20(e) Good Laboratory Practices ‎Section 3.20(f) ICL Recitals Indemnified Persons Section 7.8(a‎Section 6.1(a) Information Agent ‎Section 2.8(a) Interim Option Tax Ruling ‎Section 7.9(a) Israeli Employees ‎Section 3.18(d) ITA ‎Section 2.8(f) Inventions Section ‎Section 1.1 Joint Venture Interests ‎Section 3.7(f) Leased Real Property ‎Section 3.13(b) Leases ‎Section 3.13(b) Letter of Transmittal ‎Section 2.8(c) Material Contract Section 4.18(a‎Section 3.12(a) Material Employee Plans ‎Section 3.17(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c‎Section 6.1(c)

Appears in 2 contracts

Sources: Merger Agreement (Lumenis LTD), Merger Agreement (Lumenis LTD)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this Jounce Lead Co-Co Agreement set forth opposite each of the capitalized terms indicated below: Adverse Study Effect 2.3.2(c)(4) Allocable Overhead Exhibit D Allowable Expenses Exhibit D Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Co-Co Candidates Recitals; 2.2.3; Exhibit B Co-Co Diagnostic Products 2.2(a) Co-Co Enforcement Proceeding 6.5.2(d) Co-Co Materials Receiving Party 2.7.1 Co-Co Products Recitals Co-Co Step-In Proceeding 6.5.2(d) Co-Co Target 2.1.2; Exhibit B Co-Co Transferring Party 2.7.1 Commercialization Report 3.1.3 Competitive Infringement 6.5.1 Cost of Goods Sold or COGS Exhibit D Cure Period 8.3.1 [***] [***] Development Cost Report 2.3.6(c) Development Cost Share 2.3.4 Distribution Costs Exhibit D Full Amount 8.7.2 Gross Profit Exhibit D ▇▇▇▇▇-▇▇▇▇▇▇ Act 6.5.2(a) CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Indemnification Claim 7.3 Indemnitee 7.3 Indemnitor 7.3 [***] [***] Information Request 3.1.5(d) JCC 4.3.1 Jounce Preamble Jounce Co-Co Additional Study 2.3.2(c) Jounce Co-Co Additional Study Approval 2.3.2(c)(3) Jounce Co-Co Material Transfer Agreement 2.7.1 Jounce Co-Co Material Transfer Agreement Effective Date Exhibit E Jounce Co-Co Materials 2.7.1 Jounce Co-Co Product Patents 6.5.2(a) Jounce Co-Co Program Exhibit A Jounce Co-Co Purpose 2.7.1 Jounce Co-Co Selling Party 1.11 Jounce Co-Co Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 8.1 Jounce Independent Product 2.9 Jounce Lead Co-Co Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseJounce Opt-Out Agreements Section 4.16(hNotice 4.4.1 Jounce Opt-Out Date 4.4.2 [***] [***] Jounce Lead Effective Date Preamble Jounce Reversion Products 8.7.1 Lump Sum 2.3.2(c)(3) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aManufacturing Costs Exhibit D Marketing Costs Exhibit D Master Collaboration Agreement Recitals MSKCC Patents 6.3.3 Non-Proposing Party 2.3.2(c)(1) Company Securities Section 4.2(aOperating Profits or Losses Exhibit D Other Actives 1.15 Other Operating Income/Expenses Exhibit D Party or Parties Preamble Payee Party 5.7.3 Paying Party 5.7.3 Pharmacovigilance Agreement 2.4.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cPharmacovigilance Expenses Exhibit D Product Recall Expenses Exhibit D Profit & Loss Share 5.6 Program Assets 2.9 Proposing Party 2.3.2(c) Customs Laws Section 4.22(aRecording Party Exhibit D Regulatory Expenses Exhibit D Report Exhibit D ROW Development Costs 2.3.4 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Safety and CMC Data 2.4.3(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety Reason 8.2.2 Sales Costs Exhibit D Sublicense Revenues Exhibit D U.S. Administration Liabilities 7.5 U.S. Commercialization Costs 3.1.6 U.S. Commercialization Report 3.2.3 Worldwide Development Costs 2.3.4

Appears in 2 contracts

Sources: Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.), Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.)

Additional Definitions. The For the purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto meaning specified in the respective sections of this Agreement Section set forth opposite each of the capitalized terms belowto such term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Aggregate Merger Consideration 3.1 Alternative Acquisition Agreement Section 6.2(c)(ii7.2(d)(i)(D) Antiboycott Rules Section 4.22(aCompany Agreement Amendment 2.4 Applicable Date 5.5(a) Board Recommendation Section 2.2(bBankruptcy and Equity Exception 5.3(a) Cancelled Company Shares Section 3.7(a)(ii) Book-Entry Share 3.2 Certificate 3.2 Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Change of Recommendation 7.2(d)(i)(D) Changes Section 1.1 Chosen Courts 10.4(b) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Approvals 5.4(a) Company Board Recitals Company Disclosure Letter Article IV ARTICLE V Company License-In Agreements Section 4.16(gMaterial Contracts 5.12(a) Company License-Out Agreements Section 4.16(hRecommendation Recitals Company Reports 5.5(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) DLLCA Recitals EECI Preamble Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Eligible Shares 3.1 Encumber 5.11 Encumbrance 5.11 Exchange Agent 4.1 Exchange Fund Section 3.8(b4.1 Exchange Ratio 4.1 Indemnified Parties 7.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cLetter of Transmittal 4.2(a) Merger Recitals Merger Consideration Section 3.7(a)(i3.1 Merger Sub Preamble Non-DTC Book-Entry Share 4.2(b) Minimum Condition Section 2.1(a)(iOriginal Date 7.4(b) Multiemployer Plan Section 4.11(cOutside Date 9.2(a) Parent Preamble Parent Approvals 6.4 Parent Board Recitals Parent Capital Stock 6.2(a) Parent Common Stock Recitals Parent Disclosure Letter ARTICLE VI Parent Material Contract 6.12(a) Parent Reports 6.5(a) Party/Parties Preamble Preference Shares 6.2(a) Proxy/Prospectus 7.3(a) Public Shareholders Recitals Registration Statement 7.3(a) Requisite Company Vote 5.3(a) Special Committee Recitals Surviving Entity 2.1 Tail Period 7.10(b) Transaction Litigation 7.13 Transactions Recitals Voting Shares 5.2(a)

Appears in 2 contracts

Sources: Merger Agreement (Enbridge Energy Management L L C), Merger Agreement (Enbridge Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAcquisition Transaction 1.1(c) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Charter Amendment 6.20 Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.20(a) Company Preamble Company Common Stock 401(k) Plan 6.11(b) Company Board Recitals Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gPSU Consideration 2.8(b) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(ii) Company Financial Advisor Section 4.10 Restricted Stock Consideration 2.8(d) Company RSU Consideration 2.8(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aSpecial Committee Recitals Company Stockholder Meeting 6.4(a) Comparable Plans 6.11(c) Confidentiality Agreement 9.4 Consent 3.6 Continuation Period 6.11(c) Converted Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 2.7(a)(iv) Copyrights 1.1(oo) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) Effect 1.1(l) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Employee Plans 3.19(a) Exchange Fund Section 3.8(bEquity Commitment Letter 4.10(a) Expiration Time Section 2.1(d)(iEquity Financing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bERISA Affiliate 3.19(b) Recitals Recitals Fee Letter 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Investor 4.10(a) Lease 3.15 Leased Real Property 3.15 Legal Restraint 7.1(c) Marks 1.1(oo) Material Contract Section 4.18(a) Suppliers 3.14 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(i)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOwned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter 4.12 Parent Liability Cap 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(oo) Paying Agent 2.9(a) Payment Fund 2.9(b) Permits 3.21 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Amount 4.10(c) Requisite Stockholder Approval 3.4 Sublease 3.15 Surviving Corporation Article II Termination Date 8.1(c) Uncertificated Shares 2.9(c)

Appears in 2 contracts

Sources: Merger Agreement (Liberty Tax, Inc.), Merger Agreement (Vitamin Shoppe, Inc.)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.4 Additional Study Approval Section 3.4(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.9(a) Audit Rights Holder Section 9.9(e) Auditee Section 9.9(e) Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.1(b) Celgene Independent Product Master Agreement Challenge Section 14.2(d) Challenging Party Section 14.2(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.5 DEFINITION SECTION Combination Product Section 1.39 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGs Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.2(b)(i) Damages Master Agreement Deemed Buy-In Section 3.4(c) Develop/Development Master Agreement Development Budget Section 3.2(a)(i) Development Cost Share Section 9.1(a) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iv)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.10(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement DEFINITION SECTION Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.4(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.2(b)(i) Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.10(b)(i) Paying Party Section 9.10(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.6(a) Program Assets Section 12.4(a) Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.2(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.1(b) Regulatory Expenses Exhibit D Report Exhibit D Requesting Party Section 11.3(b)(iii) ROW Development Costs Section 9.1(a) DEFINITION SECTION Royalty Term Section Reference Acceptable Confidentiality 9.3(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.39 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.7(b) Acquisition Proposal Term Section 6.2(e)(i14.1(a) Acquisition Sub Third Party Contractors Section 8.2(a)(ii) Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) U.S. Commercialization Budget Section 6.2(c) U.S. Commercialization Costs Section 6.5(c) U.S. Commercialization Plan Section 6.2(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Vividion Opt-Out Notice Section 6.2(c)(ii2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA 2.3(b) Worldwide Development Costs Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c9.1(a)

Appears in 2 contracts

Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Ancillary Scheme Documentation Section Reference Acceptable Confidentiality Agreement 4.1(a) Anti-Takeover Laws Section 6.2(e)(iii5.30 Bidco Preamble Burdensome Condition Section 8.2(a) Acquisition Proposal Closing Section 6.2(e)(i2.2 Closing Date Section 2.2 Company Preamble Company 401(k) Acquisition Sub Preamble Adverse Plan Section 8.8(c) Company Board Recitals Company Board Recommendation Section 5.5 Company Board Recommendation Change Section 6.2(c)(i7.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Equity Award Consideration Section 4.16(g3.2(a)(iii) Company License-Out Agreements Option Consideration Section 4.16(h3.2(a)(i) Company Financial Advisor Permits ‎Section 5.24‎(e) Company PRSU Consideration Section 4.10 3.2(a)(iv) Company Related Parties Section 6.12 Company RSU Consideration Section 3.2(a)(iii) Company SEC Reports Section 4.7(a5.9(a) Company Securities Section 4.2(a5.2(d) Company Shares Recitals Confidentiality Agreement Section 10.4 11.6 Consideration Section 3.1(a) Court Documentation ‎Section 4.1‎(g) Current Company Employee ‎Section 8.8‎(a) D&O Insurance Section 7.8(c8.7(c) Customs Laws EBT Cash Amounts Section 4.22(a3.2(b) Debt Financing Dispute EBT Settled Company Equity Awards Section 10.9(a3.2(a)(i) DGCL Recitals Dissenting Company Shares EBT Trustee Section 3.7(c)(i) EAR Section 4.22(a3.2(a)(i) Effective Time Section 3.2 2.2 End Date Section 10.1(b)(i) Enforceability Exceptions Section 4.4 Environmental Permits 5.4 Equity Securities Section 4.15(b5.2(d) Exchange Fund Forms of Proxy Section 3.8(b4.1(a) Expiration Time In the Money Company Option Section 2.1(d)(i3.2(a)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a8.7(b) Inventions Indemnified Proceeding Section 1.1 8.7(b) Interim Time Section 3.2(a)(i) Leased Real Property ‎Section 5.22‎(b) Match Right Notice Section 7.3(b) Material Contract ‎Section 5.23‎(a) Other Required SEC Filing Section 4.18(a4.1(a) Maximum Annual Premium Parent Preamble Parent 401(k) Plan Section 7.8(c8.8(c) Merger Parent Board Recitals Merger Parent Related Parties Section 6.12 Parties Preamble Paying Agent Section 3.1(b) Payment Fund Section 3.1(b) Per ADS Consideration Section 3.7(a)(i3.1(a) Minimum Condition Proxy Statement Section 2.1(a)(i4.1(a) Multiemployer Plan Real Property Leases ‎Section 5.22‎(b) Remedial Action Section 4.11(c)8.2(a) Scheme Document Annex Section 4.1(a) Transaction Recitals Transaction Documentation ‎Section 4.1‎(d) Transfer Taxes Section 10.3(b) Voting and Support Agreement Recitals

Appears in 2 contracts

Sources: Transaction Agreement (Verona Pharma PLC), Transaction Agreement (Verona Pharma PLC)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAssumed Company Option 3.8(a) Antiboycott Rules Section 4.22(aAssumed Company Restricted Stock 3.8(c) Board Recommendation Section 2.2(bAssumed Company RSU 3.8(d) Cancelled Assumed Company Stock Awards 3.8(d) Amended Offer Documents 2.1(a)(i) Assets 4.14 Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Restricted Stock 3.8(c) Company Financial Advisor Section 4.10 Rights 4.16 Company SEC Reports Section 4.7(a4.6 Company Securities 4.4(c) Company Securities Section 4.2(aSeverance Arrangements 7.11(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.5(a) Continuing Directors 2.4(b) Continuing Employee 3.8(a) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(iv) EAR Section 4.22(aEffect 1.1(kk) (a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bExchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Indemnified Parties 7.12(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIndependent Directors 2.4(c) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.5(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A Non-Continuing Employee 3.8(b)

Appears in 2 contracts

Sources: Merger Agreement (Ramtron International Corp), Merger Agreement (Cypress Semiconductor Corp /De/)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Corruption Law 3.18(b) Antiboycott Rules Section 4.22(aAntitrust Laws 7.2(a) Board Recommendation Section 2.2(bAssumed Option 2.7(d) Assumed Unit 2.7(d)(ii) Barclays 3.26 Book-Entry Shares 2.8(b)(i) Cancelled Company Shares Section 3.7(a)(ii2.7(b)(iv) Cash Consideration 2.7(b)(i) Certificate 2.8(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock Recitals 2001 Plan 3.4(a) Company 2007 Director Plan 3.4(a) Company 2007 Plan 3.4(a) Company 2012 Inducement Plan 3.4(a) Company Board Recommendation 6.4(a) Company Board Recommendation Change 6.4(b) Company Capitalization Representations 8.2(a)(ii) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gExpense Reimbursement 9.3(c)(vi) Company License-Out Agreements Section 4.16(hFundamental Representations 8.2(a)(i) Company Financial Advisor Section 4.10 In Licenses 3.12(e) Company IP Licenses 3.12(f) Company Material Contract 3.13(a) Company Non-U.S. Employee Plans 3.15(i) Company Out Licenses 3.12(f) Company Permits 3.19 Company Qualified Plan 3.15(e) Company Real Property Leases 3.10 Company Registered Intellectual Property Rights 3.12(a) Company SEC Reports Section 4.7(a3.6 Company Stock Awards 3.4(c) Company Securities Section 4.2(aStock Option 2.7(d)(i) Company Shares Recitals Stock Plans 3.4(b) Company Stockholder Meeting 7.4(a) Company Subsidiary Documents 3.1(b) Company Terminating Plans 7.7(a) Company Voting Proposal 3.2(b) Confidentiality Agreement Section 10.4 Current Company 7.5(h) D&O Insurance Section 7.8(cPolicy 7.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) DLLCA Recitals ▇▇▇▇-▇▇▇▇▇ Act 3.6 EAR Section 4.22(a3.18(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cECCNs 3.18(c)(ii)

Appears in 2 contracts

Sources: Merger Agreement (Entropic Communications Inc), Merger Agreement (Maxlinear Inc)

Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Acquired Assets 2.3 Additional Withholding Taxes 5.9.2 Agreed Claims 9.5.6 Agreement Preamble Alternative Acquisition Assignment Consent 2.7.1 Assumed Liabilities 2.5 Buyer Preamble Buyer Change 5.9.2 Buyer Indemnified Parties 9.3 CDA Effective Date CDA definition [***] Merger Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 3.5.1 Claim Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 9.5.1 Claims 9.2 Clinical Trial Agreements 2.8.2 Closing Section 3.3 2.1 Closing Cash Consideration 5.1 Closing Date Section 3.3 COBRA Section 4.11(d) Company 2.1 Commercial Milestone Event 5.4 Commercial Milestone Payment 5.4 Confidential Information 7.2.1 Cooperation Period 2.7.1 Deductible 9.4.1 Excluded Assets 2.4 Excluded Liabilities 2.6 Factors Net Sales Definition FIRPTA Certificate 5.9.5 IFRS Net Sales Definition IND Transfer 2.9 Indemnifying Party 9.5.1 Indication 5.3 Licensed Patent 7.2.6 Losses 9.2 MHRA Regulatory Authority Definition Non-Assignable Asset 2.7.1 Ongoing Clinical Trials 2.8.1 Party/Parties Preamble Company Common Stock Recitals Company Purchase Price Allocation 5.9.7 Regulatory Milestone Event 5.3 Regulatory Milestone Payment 5.3 Report 3.3.1 Royalty Term 5.2.2 Seller Preamble Seller Disclosure Letter Article IV Company LicenseSchedule 6.1 Seller Indemnified Parties 9.2 Selling Party Net Sales Definition Term 8.1 Third-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Party Claim 9.5.1 Transfer Taxes 5.9.3 Transferred Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Reimbursement Amount 5.1

Appears in 2 contracts

Sources: Asset Purchase Agreement (Kronos Bio, Inc.), Asset Purchase Agreement (Kronos Bio, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti Bribery Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bArticles of Merger 2.2 Assets 3.14 Assumed Restricted Stock Unit Award 2.7(d)(ii) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Cash Consideration 2.7(a)(i) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letter 4.28 Company Preamble Company Annual Report Article III Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.17(a) Company License-Out Agreements Section 4.16(hERISA Affiliate 3.17(a) Company ESPP Rights 2.7(f) Company Financial Advisor Section 4.10 3.25 Company International Employee Plans 3.17(a) Company Material Contract 3.12(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Plans 6.12(a) Company Related Parties 8.3(b)(v) Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSource Code 3.15(o) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 3.3 Company Stockholder Meeting 6.4(a) Company Subsidiary Securities 3.7(c) Consent 3.5 Contaminants 3.15(n) Copyrights 1.1 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.11(b) DGCL Recitals 2.1 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aECCN 3.20(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iexport 3.20(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.27 Final Exercise Date 2.7(f) Recitals Recitals Financing 4.28(a) Financing Documents 4.28(a) Financing Failure Termination Fee 8.3(c)(iii) Form S-4 3.28 FSE List 3.20(i) Fractional Share Cash Amounts 2.11 FY2019 Plans 6.12(c) Government Officials 3.20(d) Grant Date 3.6(e) Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Termination Date 8.1(b)(i) Joint Proxy Statement/Prospectus 3.28 Leased Real Property 3.13(b) Leases 3.13(b) Lenders 4.28 Maximum Annual Premium Section 7.8(c6.11(b) MBCA Recitals Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.12(b) Multiemployer Old Plans 6.12(b) Owned Real Property 3.13(a) Parent Preamble Parent Annual Report Article IV Parent Board Recommendation Recitals Parent Board Recommendation Change 6.6(a) Parent Capitalization Date 4.6(a) Parent Common Stock Recitals Parent Common Stock Issuance Recitals Parent Disclosure Letter Article IV Parent Financial Advisor 4.24 Parent Grant Date 4.6(e) Parent Related Parties 8.3(c)(iii) Parent SEC Reports 4.8 Parent Securities 4.6(c) Parent Stockholder Approval 4.3 Parent Stockholder Meeting 6.4(c) Parent Subsidiary Securities 4.7(c) Patents 1.1 Permits 3.19 Regulatory Filings 6.2(a) Repatriation Notice 6.20 Replacement Bonus Plan Section 4.11(c6.12(c) Representatives 5.3(a) Restricted Stock Unit Consideration 2.7(d)(i) Reverse Termination Fee 8.3(c)(i) SDN List 3.20(i)

Appears in 2 contracts

Sources: Merger Agreement (Cohu Inc), Merger Agreement (Xcerra Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(n) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Change of Recommendation Notice 7.5(b) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Confidentiality Agreement Section 10.4 Consent 4.5 Continuing Directors 2.3(a) Copyright Rights 1.1 Covered Securityholders 4.17(n) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8(a) Effective Time Section 3.2 Employee Plan / Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Institutions 4.15(h) International Employee Plans 4.17(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c)

Appears in 2 contracts

Sources: Merger Agreement (Otsuka Holdings Co., Ltd.), Merger Agreement (Astex Pharmaceuticals, Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(b) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.12(f) Company Financial Advisor Section 4.10 Advisors 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholder Approval 3.5 Company Stockholders’ Meeting 6.12(b) Company Termination Fee 8.3(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aTail Policy 6.7(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.3 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.19(a)(xix) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(cNew Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Paying Agent 2.8(a) Proxy Statement 3.6 PSU Consideration 2.7(f) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) RSU Consideration 2.7(e) Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Uncertificated Shares 2.8(c)(ii)

Appears in 2 contracts

Sources: Merger Agreement (Intra-Cellular Therapies, Inc.), Merger Agreement (Intra-Cellular Therapies, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDebt Financing 5.6(b)(ii) Antiboycott Rules Section 4.22(aBreach Cure Period 7.1(g) Board Recommendation Section 2.2(bBreach Termination Date 7.1(g) Cancelled Company Shares Section 3.7(a)(iiCertificate of Incorporation 1.5(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chancery Court 8.10 Closing Section 3.3 1.3 Closing Date Section 3.3 COBRA Section 4.11(d1.3 Collective Bargaining Agreement 2.18(a) Communications Act 2.6 Company Preamble Company Common Stock Recitals Board Recommendation 2.3 Company Board Recommendation Change 4.3(a) Company Disclosure Letter Schedule Article IV II Company License-In Agreements Section 4.16(gParties 7.3(e)(i) Company License-Out Agreements Section 4.16(hPermits 2.20 Company Restricted Share 1.7(d)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a2.9 Company Securities 2.7(c) Company Securities Section 4.2(aStockholder Meeting 5.4(a) Company Shares Recitals Systems 2.16(c) Confidentiality Agreement Section 10.4 Current Company 8.4 Consent 2.6 Continuation Period 5.11(b) Continuing Plans 5.11(a) D&O Insurance Section 7.8(c5.10(c) Customs Laws Section 4.22(aDebt Commitment Letter 3.10(b) Debt Financing Dispute Section 10.9(a3.10(b) Delaware Secretary of State 1.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b1.2 Employee Plans 2.18(a) Employment Laws 2.19(b) Equity Financing 3.10(b) Equity Financing Letter 3.10(b) Equity Financing Sources 3.10(b) ERISA Affiliate 2.18(b) Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iFCC 2.6 FCC Approvals 2.6 Federal Communications Laws 2.26(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 3.10(b) Financing 3.10(b) Financing Letters 3.10(b) Franchise 2.6 Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a5.10(a) Inventions Section 1.1 Leased Real Property 2.15(b) Leases 2.15(b) LFA 2.6 LFA Approvals 2.6 Material Contract Section 4.18(a2.13(a) Maximum Annual Premium Section 7.8(c5.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letter 5.6(b)(ii) New Plans 5.11(c) Notice Period 3.4(d)(i) Old Plans 5.11(c) Option Consideration Section 3.7(a)(i1.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c2.30 Owned Company Shares 1.7(a)(ii) Parent Preamble Parent Expenses 7.3(b)(ii) Parent Material Adverse Effect 3.1 Parent Parties 7.3(e)(ii) Payment Agent 1.8(a) Per Share Price 1.7(a)(i) Proxy Statement 2.30 Record Date 5.4(b) Required Information 5.6(b)(v)(A) Requisite Stockholder Approval 2.4 Rights 2.31 Rights Agreement 2.31 Rule 13a-15 2.10(b) Second Request 5.2(c) State Communications Laws 2.26(a) State PUC 2.6 State PUC Approvals 2.6 Subscribers 2.32 Subsidiary Securities 2.7(c) Surviving Corporation 1.1 Tax Returns 2.17(a) Termination Date 7.1(c) Transaction Committee Recitals Transaction Litigation 5.16 Uncertificated Shares 1.8(c) Warrant Consideration 1.7(d)(iii)

Appears in 2 contracts

Sources: Merger Agreement (Valley Telephone Co., LLC), Merger Agreement (Knology Inc)

Additional Definitions. The In addition, each of the following capitalized terms shall have the respective meanings ascribed thereto meaning described in the respective sections corresponding section in the body of this Agreement set forth opposite each of or in the capitalized terms Financial Appendix referenced below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiIntroduction All Other Costs Exhibit 4.2E Asia-Pacific License 2.4(a) Acquisition Proposal Section 6.2(e)(iAsia-Pacific Licensee 2.4(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAuditing Party 7.17(a) BioMarin CF Improvements 11.1(c) BioMarin CF Indemnitees 16.2 Capitalized Asset Financial Appendix Co-Chair 3.3 Collaboration Agreement Preamble Alternative Acquisition Financial Appendix Completion Notice 7.7 Confidential Information 10.1 Contingent Right 2.4(f) Controlled Affiliate 1.2 Cost Effective Price 9.1(a) Data Monitoring Board 7.6(a) Definitive Agreement Section 6.2(c)(ii2.4(c) Antiboycott Rules Section 4.22(aDevelopment Costs Financial Appendix Development Transition Period 14.4(a)(i) Board Recommendation Section 2.2(bDispute 17.2 Distribution Costs Financial Appendix Effective Date Introduction Eliminated Party 14.4(a)(i) Cancelled Company Shares Section 3.7(a)(iiEnforcement Action 11.3(b)(i) Certificate Equity Election Notice 7.5 Fault of Merger Section 3.2 Certificates Section 3.8(cBioMarin CF 16.4(b)(ii) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dFault of La Jolla 16.4(b)(i) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseField-In Agreements Section 4.16(gBased FTEs 6.2(a)(i) Company LicenseFirst Commercial Sale Financial Appendix FTE Costs Financial Appendix Force Majeure Event 18.1 Forecast Exhibit 9.1A Futile Determination 7.6(b) GAAP Financial Appendix GMP 5.4 Gross Sales Financial Appendix IFRS Financial Appendix Indemnitee 16.3 Indemnitor 16.3 Infringement 11.3(a) Infringement Actions 11.4 Initial Operating Plan/Budget 4.2(b) Initial Product 4.3(a) Inspected Party 5.3 Interest Rate 7.14(b) IP Management Costs Financial Appendix JAMS 17.3(a) Joint Promotion Plan 6.2(c) Joint Steering Committee or JSC 3.1(a) JHU License Exhibit 1.15 La Jolla Improvements 11.1(c) La Jolla Indemnitees 16.1 Launch-1st Year Period Exhibit 4.2E Liabilities 16.1 Manufacturing Costs Financial Appendix Manufacturing Process Development 4.2(e)(ii) Marketing Costs Financial Appendix Maximum Regional Spend Exhibit 4.2E Multiple Product Sales Financial Appendix Negotiation Period 2.4(c) New Technology 11.6(c) Net Sales Financial Appendix Non-Out Agreements Section 4.16(hFutile Determination 7.6(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aObjecting Party 17.2 Ongoing Trials 14.4(a)(i) Company Securities Section Operating Forecast 4.2(a) Company Shares Recitals Confidentiality Operating Plan/Budget 4.2(a) Other Operating Expense Financial Appendix Other Operating Income Financial Appendix Out-of-Pocket Expenses Financial Appendix Paying Party Financial Appendix Phase IV Studies Exhibit 4.2E Prior Agreement Section 10.6 Producing Party 9.4(a) Product Liability Claim 16.5(a) Product Promotional Materials 12.1 Profit/Loss Financial Appendix Promotional/Sales/Marketing or PSM Exhibit 4.2E Proposed Territory 2.4(a) Prosecution and Maintenance or Prosecute and Maintain 11.2(c) Publication 10.4 Current Company D&O Insurance Section 7.8(cPurchased Interests 14.2.2(a) Customs Laws Section 4.22(aPurchase Notice 14.2.2(b) Debt Financing Dispute Section 10.9(aPurchase Price 14.2.2(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iPurchase Right 14.2.2(a) EAR Section 4.22(aP-Value Achievement 7.6(c) Effective Time Section Quarterly Measurement Exhibit 4.2E Q4, Q5 and Q6 Exhibit 9.1A Recall Costs 16.4(b) Region Exhibit 4.2E Remaining Party 14.4(a)(i) Renal Events Committee 7.6(d) Report Table Financial Appendix Responding Party 7.17(a) ROT Exhibit 4.2E Royalty Notice 6.3 R&D/LCM Exhibit 4.2E Sale Price 14.2.1 Sale Right 14.2.1 Sales Costs Financial Appendix Sales Force Deployment Option 6.2(a) Shared Costs Financial Appendix SEC Financial Appendix Secured Note 14.2.1 SLE Background Sold Interests 14.2.1 Third Party Claim 16.1 Wind-down Period 14.4(a)(ii) Working Group 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2nd Year of Sales Exhibit 4.2E 128 Flare Topline Data 7.6(e)

Appears in 2 contracts

Sources: Development and Commercialization Agreement (Biomarin Pharmaceutical Inc), Development and Commercialization Agreement (La Jolla Pharmaceutical Co)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approvals 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCARES Act 3.18(h) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.9(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Commitment Letters 4.10(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.3(u) Company License-Out Agreements Section 4.16(hIntellectual Property 3.17(b) Company Financial Advisor Section 4.10 Option 2.8(c)(i) Company Privacy Policy 3.17(m) Company PSU 2.8(b)(i) Company Recommendation 3.3(a) Company Recommendation Change 5.4(c)(i) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.8(d) Company Securities Section 4.2(a3.7(b) Company Shares Special Committee Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aContinuing Employees 6.11(b) Converted Cash Award 2.8(a)(ii) Copyrights 1.1(hhh) Covenant Exceptions 5.1(a) Debt Commitment Letter 4.10(a) Debt Fee Letter 6.6(b)(ii) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Elephant Recitals Enforcement Expenses 8.3(e) Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Arrangements 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Founder Recitals Guarantees Recitals Guarantors Recitals Indemnified Party Proceeding 6.10(b) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) IP Contracts 3.17(d) KKR Recitals Labor Agreements 3.20(a) Lease 3.15(b) Leased Real Property 3.15(b) Marks 1.1(hhh) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval 6.19 New Plans 6.11(a) Notice Period 5.4(d)(ii)(2) Old Plans 6.11(a) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Divesture Obligations 6.2(b) Party or Parties Preamble Patents 1.1(hhh) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Promissory Note 6.22 Proxy Statement 6.3(a) Reimbursement Obligations 6.6(h) Reinvestment Shareholders Recitals Required Amount 4.10(a) Required Permits 3.20(c) Restraint 7.1(b) Rollover Shares Recitals Statutory Stockholder Approval 3.4(a) Support Agreements Recitals Surviving Corporation Recitals Tail Policy 6.10(b) Technical Deficiencies 3.17(l) Termination Date 8.1(b) Trade Controls 3.22(b) Trade Secrets 1.1(hhh) Transaction Matters 9.12(a) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU 2.8(b)(i) Unvested Company RSU 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU 2.8(b)(i) Multiemployer Plan Section 4.11(c)Vested Company PSU Consideration 2.8(b)(i) Vested Company RSU 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Vista Recitals

Appears in 2 contracts

Sources: Merger Agreement (KnowBe4, Inc.), Merger Agreement (Vepf Vii SPV I, L.P.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aASU 1.1(zz) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPrivacy Policy 3.16(h) Company License-Out Agreements Section 4.16(hPlans 6.11(b) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aComparable Plans 6.11(b) Converted Stock-Based Award 2.8(a)(ii) Copyrights 1.1(aaa) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDPA 4.13(a) DTC Payment 2.9(d) Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letters 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Lookback Date Article III Marks 1.1(aaa) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(c) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(e) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(aaa) Payment Agent 2.9(a) Payoff Letter 6.18 Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) SEC Reports Article III Reimbursement Obligations 6.6(f) Required Financing Information 6.6(a)(v) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tail Policy 6.10(c)

Appears in 2 contracts

Sources: Merger Agreement (Forescout Technologies, Inc), Merger Agreement (Forescout Technologies, Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 7.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 4.21 Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.19(a) Company Preamble Company Common Stock Recitals Acquisition Transaction 9.4(b) Company Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Preamble Company License-In IP Agreements Section 4.16(g4.22(e) Company License-Out Agreements Section 4.16(hProducts 4.22(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRestricted Stock 3.7(e) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(c) Recitals Recitals Foreign Employees 4.18(l) Funded International Employee Plan 4.18(b) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Initial Termination Date 9.1(c) International Employee Plans 4.18(a) Leased Real Property 4.20(b) Leases 4.20(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNet Cash Position 4.7(h)

Appears in 2 contracts

Sources: Merger Agreement (Spectralink Corp), Merger Agreement (Polycom Inc)

Additional Definitions. The For purposes of this Agreement, the following capitalized terms terms, when used in this Agreement, shall have the respective meanings ascribed thereto assigned to them in the respective sections of this Agreement set forth opposite each of the capitalized terms belowidentified Section: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Merger Consideration 3.1(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAntitrust Condition 8.1(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.3 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Code 3.2(g) Collective Bargaining Agreement 4.9 Company Preamble Company Closing Price 3.3(a)(ii) Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gContracts 4.12(a) Company License-Out Agreements Section 4.16(hIndemnitees 6.7(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aLeases 4.4(b) Company Securities Section 4.2(aMultiemployer Plans 4.10(a)(ii) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 4.2(a)(ii) Company D&O Insurance Section 7.8(cStockholders Meeting 6.4(a) Customs Laws Section 4.22(aCompany Tenant Lease 4.4(b) Company Title IV Plan 4.10(d) Consent Solicitation 6.11(a) Continuing Employees 6.14(a) Debt Financing Dispute Section 10.9(aTender Offer 6.11(a) DGCL Recitals Dissenting Company 2.1 Discharge 6.11(b) Dissent Shares Section 3.7(c)(i3.1(d) EAR Section 4.22(aDissenters’ Rights Statute 3.1(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 ERISA 1.1 Exchange Agent 3.2(a) Exchange Fund Section 3.8(bExtension Termination Fee 8.2(f) Expiration Time Section 2.1(d)(iFinancing 6.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitments 5.17 Form S-4 6.10(a) Recitals Recitals Indemnified Persons Section 7.8(aIndenture 6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aIRS 4.10(a)(iii) Maximum Annual Premium Section 7.8(cJoint Proxy Statement 6.10(a) Merger Recitals Merger Sub Preamble MGCL 4.20 Nine-Month Termination Fee 8.2(d) Notice of Adverse Change 6.3(c) One-Year Termination Fee 8.2(e) Option Exchange Ratio 3.3(a)(iii) Outside Date 8.1(b)(i) Owned Real Property 4.4(a) Parent Preamble Parent Multiemployer Plans 5.10(b) Parent Stockholder Approval 5.2(a) Parent Stockholders Meeting 6.4(b) Parent Title IV Plan 5.10(c) PBGC 4.10(d) Per Share Cash Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPer Share Merger Consideration 3.1(c) Multiemployer Plan Section 4.11(cPer Share Stock Consideration 3.1(c) Permanent Restraint 8.1(b)(iv) Pre-Amendment Option 3.3(a)(iii) Real Property 4.4(c) Required Information 6.5(b)(v) Restraints 7.1(c) Share Issuance 5.2(a) Stock Option 3.3(a)(i) Surviving Corporation 2.1 Voting Debt 4.3(a)

Appears in 2 contracts

Sources: Merger Agreement (Great Atlantic & Pacific Tea Co Inc), Merger Agreement (Pathmark Stores Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Balance Sheet Date 1.1 Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.2(b) Company Financial Advisor Section 4.10 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholders’ Meeting 6.12(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 9.4 Current Company D&O Insurance Section 7.8(c6.8(b) Customs Laws Section 4.22(aD&O Tail Insurance 6.8(b) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Effects 1.1 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FFDCA 1.1 GDPR 1.1 Indemnified Persons Section 7.8(a6.7(a) Internet Properties 1.1 Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a3.19(a)(xix) Maximum Annual Premium Section 7.8(cAmount 6.7(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(c)New Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Parent Disclosure Letter 1.1 Paying Agent 2.8(a) Predecessor Registrant 3.7(a) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) Reorganization Date 3.7(c) RSU Consideration 2.7(e) Specified Governmental Authority 7.2 Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Termination Fee 8.3(b) Trade Secret 1.1 Trademarks 1.1 Uncertificated Shares 2.8(c) Works of Authorship 1.1

Appears in 2 contracts

Sources: Merger Agreement (Ambrx Biopharma, Inc.), Merger Agreement (Ambrx Biopharma, Inc.)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this PD-1 License Agreement set forth opposite each of the capitalized terms indicated below: Additional Study 2.3.2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Additional Study Approval 2.3.2(c) Celgene Preamble Celgene Corp. Preamble Celgene PD-1 Patents 4.5.1 Celgene RIVOT Preamble Collaboration Combination Products 2.2.1 Combination Products 2.2.1 Competitive Infringement 4.5.1 Cure Period 6.3 [***] [***] Development Costs 2.3.5 Development Cost Report 2.3.5(b) Development Cost Share 2.3.5 Included Collaboration Candidates 2.1.3 Indemnification Claim 5.3 Indemnitee 5.3 Indemnitor 5.3 Indirect Taxes 3.2.3(b) Jounce Preamble Jounce Independent Product 4.5.2(b) Jounce License Material Transfer Agreement 2.7.1 Jounce License Material Transfer Agreement Effective Date Exhibit B Jounce Licensed Materials 2.7.1 Jounce Licensed Product Patents 4.5.2(a) Jounce Licensed Purpose 2.7.1 [***] [***] Jounce Reversion Products 6.7.1 JWG 2.3.1(a) Licensed Candidate 2.1.3; Exhibit A Licensed Diagnostic Products 2.2.1 Licensed Enforcement Proceeding 4.5.2(b) Licensed Materials Receiving Party 2.7.1 Licensed Products Recitals Licensed Program Assets 2.9 Licensed Step-In Proceeding 4.5.2(b) Licensed Target 2.1.2 License Transferring Party 2.7.1 Lump Sum 2.3.2(c) Master Collaboration Agreement Recitals Monotherapy Products 2.2.1 Non-Proposing Party 2.3.2 Party or Parties Preamble CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Payee Party 3.2.3 Paying Party 3.2.3 PD-1 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.1 PD-1 License Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiPD-1 Effective Date Preamble Proposing Party 2.3.2(b) Antiboycott Rules Section 4.22(aRegulatory Interactions 2.4.2 Revenue Split Product Exhibit E Third Party Agreements 3.2.1(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety and CMC Data 2.4.4 Safety Reason 6.2.2

Appears in 2 contracts

Sources: Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.), Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term 35 U.S.C. § 102(c) Patent Section Reference Acceptable Confidentiality 10.7 [**] Section 8.6(b)(iii) Accounting Standards Exhibit D Acquirer Program Section 8.6(b)(v)(D) Additional Revenue Exhibit D Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Advertising and Market Research Expenses Exhibit D Affiliate Master Agreement Agios Preamble Agios Clinical-Scale Manufacturing Responsibilities Section 6.2(e)(iii4.1(a) Acquisition Proposal Agios Commercial-Scale Manufacturing Responsibilities Section 6.2(e)(i4.1(a) Acquisition Sub Agios Indemnified Parties Section 13.1(a) Agios Opt-Out Notice Section 2.3(a) Agios Opt-Out Date Section 2.3(b) Agios Pharmaceuticals Preamble Adverse Recommendation Change Agios Program Assets Section 6.2(c)(i) 12.4 Agreement Preamble Alternative Acquisition Annual Net Sales Exhibit D Antitrust Law Master Agreement Audit Team Section 6.2(c)(ii9.8(a) Antiboycott Rules Audit Rights Holder Section 4.22(a9.8(e) Board Recommendation Auditee Section 2.2(b9.8(e) Cancelled Company Shares Bankruptcy Code Section 3.7(a)(ii8.8 Business Day Master Agreement Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Celgene Indemnified Parties Section 13.2(a) Certificate of Merger Celgene Clinical-Scale Manufacturing Responsibilities Section 3.2 Certificates 4.1(c) Celgene Commercial-Scale Manufacturing Responsibilities Section 3.8(c4.1(c) Changes Celgene Manufacturing Responsibilities Section 1.1 Closing 4.1(c) Challenge Section 3.3 Closing Date 14.3(d) Challenging Party Section 3.3 COBRA Section 4.11(d14.3(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseCo-Co Buy-In Agreements Section 4.16(g3.4 Combination Product Exhibit D Commercialization/Commercialize Master Agreement Commercialization Expenses Exhibit D Commercialization Budget Section 6.2(a)(i) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Commercialization Plan Section 4.11(c)6.2(a)(i) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement CPI Exhibit D Cure Period Section 14.3(b)(i) Damages Master Agreement

Appears in 1 contract

Sources: Master Research and Collaboration Agreement (Agios Pharmaceuticals Inc)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections Section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Abandoned Patents Section Reference Acceptable 7.2(a) Action Section 7.3(b) Agents Section 8.1 Biosense Section 1.5 Commercialization Plan Section 4.2 Confidential Information Section 8.2 Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal 8.2 Courts Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change 13.1 Development Milestone Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement 6.2 Development Milestone Payment Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger 6.2 Development Plan Section 3.2 Certificates Effective Date Preamble Incumbent Board Section 3.8(c1.8 Indemnified Party Section 10.3(a) Changes Indemnifying Party Section 1.1 Closing 10.3(a) Infringement Claim Section 3.3 Closing Date 7.3(a) Joint Intellectual Property Section 3.3 COBRA 7.1(c) Joint Inventions Section 4.11(d7.1(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article Joint Patent Rights Section 7.2(b) MSs Section 6.2 Ocuphire Section 10.2(e) Other API Section 1.8 Paragraph IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Claim Section 7.8(a) Periodic Report Section 6.7 Product Liability Claim Section 10.1(b) Processa Preamble Processa Common Stock Section 6.1(a) Processa Excluded Affiliates Section 1.46 Processa Parties Section 10.2 Processa Pre-Existing Affiliates Section 1.46 Processa Sole Inventions Section 1.1 Material Contract 7.1(b) Product Liability Claims Section 4.18(a10.1(b) Maximum Annual Premium Royalty Term Section 7.8(c6.5(b) Merger Recitals Merger Consideration Ocuphire Preamble Ocuphire Parties Section 3.7(a)(i10.1 Ocuphire Sole Inventions Section 7.1(b) Minimum Condition Sales Milestone Section 2.1(a)(i6.4 Sales Milestone Payment Section 6.4 SEC Section 6.1(b) Multiemployer Plan Sole Inventions Section 4.11(c)7.1(b) Sublicense Payment Section 6.6(a) Sublicensee Intellectual Property Section 2.1(b) Taxes Section 6.9 Term Section 11.1 Third-Party Claims Section 10.1 Third-Party Patent Licenses Section 6.5(c) Upfront Fee Section 6.1(a) Upfront Shares Section 6.1(a) VWAP Section 6.2

Appears in 1 contract

Sources: License Agreement (Processa Pharmaceuticals, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Jurisdiction Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.21 Agreement Preamble Alternative Acquisition Agreement Anti-Bribery Laws Section 6.2(c)(ii3.25 Assumed Option Section 6.11(b) Antiboycott Rules Assumed RSU Section 4.22(a) Board Recommendation Section 2.2(b6.11(a) Cancelled Company Shares Option Section 3.7(a)(ii6.11(b)(ii) Capitalization Reference Date Section 3.04(a) Certificate of Merger Section 3.2 2.02(a) Certificates Section 3.8(c2.06(a) Changes Clarification Request Section 1.1 6.01(b) Closing Section 3.3 2.03 Closing Date Section 3.3 COBRA 2.03 Collective Bargaining Agreements Section 4.11(d3.19(a) Company Preamble Company Balance Sheet Section 3.09 Company Board Recitals Company Board Recommendation Section 6.02(a) Company Board Recommendation Change Section 6.02(b) Company Capitalization Representation Section 7.02(a)(iii) Company Common Stock Recitals Company Disclosure Letter Article IV ARTICLE III Company License-In Inbound License Section 3.21(c) Company IP Agreements Section 4.16(g3.21(c) Term Section Reference Company Leased Real Property Section 3.20(b) Company License-Out Agreements Outbound License Section 4.16(h3.21(c) Company Financial Advisor Owned Real Property Section 4.10 3.20(a) Company Real Property Leases Section 3.20(b) Company Registered IP Section 3.21(a) Company Regulatory Agency Section 3.26(a) Company Regulatory Permits Section 3.26(a) Company SEC Reports Section 4.7(a3.06(a) Company Securities Section 4.2(a3.04(c) Company Shares Stockholders’ Meeting Section 6.03(a) Company Specified Representations Section 7.02(a)(ii) Company Support Agreement Recitals Company Termination Fee Amount Section 8.03(b) Confidentiality Agreement Section 10.4 Current Company 6.09 Consent Section 3.05(b) Copyrights Section 1.01 D&O Insurance Section 7.8(c6.13(b) Customs Laws Delaware Secretary of State Section 4.22(a2.02(a) Debt Financing Dispute DOJ Section 10.9(a6.05(a) DGCL Recitals Dissenting Company Shares Dollars or $ Section 3.7(c)(i1.03(d) EAR Domain Names Section 4.22(a) 1.01 Effect Section 1.01 Effective Time Section 3.2 2.02(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.03(a) EPA Section 4.15(b3.26(a) EU Section 1.01 Exchange Agent Section 2.06(a) Term Section Reference Exchange Fund Section 3.8(b2.06(b) Expiration Time Excluded Shares Section 2.1(d)(i2.05(a)(i) Financial Statements Incipio Incipio Merger Agreement Export and Import Approvals Section 4.7(b3.22 Export Controls Section 3.22 FDA Section 3.26(a) Recitals Recitals FDCA Section 3.26(a) FIFRA Section 3.26(a) FQPA Section 3.26(a) FTC Section 6.05(a) Form F-4 Section 6.04(a) Fractional Share Cash Amount Section 2.05(c) Import Restrictions Section 3.22 Indemnified Persons Parties Section 7.8(a6.13(a) Inventions Issuance Section 1.1 6.04 Labor Organization Section 3.19(a) Linklaters Section 6.04(e) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Sub Preamble MoFo Section 6.04(e) Notice Period Section 6.02(d)(ii) Option Consideration Section 3.7(a)(i6.11(b)(ii) Minimum Condition Parent Preamble Parent Board Recitals Parent Capitalization Date Section 2.1(a)(i4.03(a) Multiemployer Plan Parent Capitalization Representation Section 4.11(c7.03(a)(iii) Term Section Reference Parent Disclosure Letter ARTICLE IV Parent Regulatory Agency Section 4.16(a) Parent Regulatory Permits Section 4.16(a) Parent SEC Reports Section 4.05(a) Parent Securities Section 4.03(d) Parent Subsidiary Securities Section 4.01(e) Parent Specified Representations Section 7.03(a)(ii) Permits Section 3.13 Patents Section 1.01 Proxy Statement/Prospectus Section 6.04(a) Requisite Stockholder Approval Section 3.03(c) Restrictive Contracts Section 3.11(a)(vi) R&W Policy Section 6.14 Significant Customer Section 3.15(a) Significant Supplier Section 3.15(b) Specified Jurisdictions Section 7.01(b) Share Consideration Section 2.05(a)(i) Subsidiary Securities Section 3.02(d) Surviving Company Section 2.01 Tail Policy Section 6.13(b) Takeover Law Section 3.29(b) Targeted Amount Section 6.21 Tax Incentive Section 3.16(l) Termination Date Section 8.01(c) Trademarks Section 1.01 Trade Secrets Section 1.01 Triggering Event Section 8.01(e)(ii) Uncertificated Shares Section 2.06(a) USDA Section 3.26(a)

Appears in 1 contract

Sources: Merger Agreement (Marrone Bio Innovations Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Consideration 2.8(b) Antiboycott Rules Section 4.22(aAnti Bribery Laws 3.20(c) Board Recommendation Section 2.2(b) Articles of Merger 2.2 Annual Report Article III Assets 3.14 Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Certificate of Merger Section 3.2 Capitalization Date 3.6(a) Certificates Section 3.8(c2.8(c) Changes Section 1.1 CFIUS 6.2(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letters 4.11(a) Company Preamble Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hESPP Rights 2.7(e) Company Financial Advisor Section 4.10 3.25 Company Plans 6.11(b) Company Related Parties 8.3(b)(v) Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSource Code 3.15(o) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 6.4(a) Consent 3.5 Contaminants 3.15(n) Copyrights 1.1 D&O Insurance Section 7.8(c6.10(b) Customs Laws Section 4.22(aDDTC 3.20(i) Debt Commitment Letter 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aECCN 3.20(i) Effective Time Section 3.2 2.2 Employee Plans 3.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExcluded Party 5.2(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bTable of Contents Exon-▇▇▇▇▇▇ 3.5(d) (i) Recitals Final Exercise Date 2.7(e) Financing 4.11(a) Financing Documents 4.11(a) FSE List 3.20(i) Go-Shop Period 5.2(h) Government Officials 3.20(d) Grant Date 3.6(e) Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Initial Termination Date 8.1(b)(i) International Employee Plans 3.17(a) ITAR 3.20(i) Joinder Recitals Joint Notice 3.5(d) Leased Real Property 3.13(b) Leases 3.13(b) Material Contract Section 4.18(a3.12(a) Material Customer 3.30(a) Material Supplier 3.30(b) Maximum Annual Premium Section 7.8(c6.10(b) MBCA Recitals Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Recitals New Plans 6.11(c) Minimum Condition Section 2.1(a)(iNo-Shop Period Start Date 5.2(a) Multiemployer Plan Section 4.11(cOld Plans 6.11(c) Owned Real Property 3.13(a) Parent Preamble Parent Related Parties 8.3(c)(v) Patents 1.1 Payment Agent 2.8(a) Permits 3.19 PRC Overseas Investment Approvals 4.4(f) Proxy Statement 3.28 Regulatory Filings 6.2(a) Related Parties 3.24 Representatives 5.2(a) Requisite Stockholder Approval 3.3 Restricted Stock Unit Consideration 2.7(d)(i) Reverse Termination Fee 8.3(c)(i) SAFE Share Incentive Rules and Regulations 3.20(k) (i) Second Termination Date 8.1(b)(i) Sino IC Recitals Solvent 4.10 Sponsor Preamble SSI List 3.20(i) Standard Form PIIAs 3.15(b) Table of Contents Subsidiary Securities 3.7(c) Surviving Corporation 2.1 Takeover Laws 3.27 Tax Returns 3.16(a) Taiwan Approvals 3.5(e) Termination Date 8.1(b)(i) Termination Fee 8.3(b)(i) Trademarks 1.1 Trade Secrets 1.1 Uncertificated Shares 2.8(c) Unvested Restricted Stock Unit 2.7(d)(ii) Unvested Restricted Stock Unit Consideration 2.7(d)(ii) Vested Restricted Stock Unit 2.7(d)(i)

Appears in 1 contract

Sources: Merger Agreement (Xcerra Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(iii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(iii) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(rr) Covered Severance Plan Employees 6.11(b) Cut-Off Date 5.3(b) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDSPP Participation Schedule 3.73.7(b) DTC 2.10(d) Effect 1.1(q) Effective Time Section 2.2 Electronic Delivery 9.13 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iGo-Shop Period 5.3(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(j) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(rr) Material Contract Section 4.18(aCustomer 1.1(vv)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble No-Shop Period Start Date 5.3(a) Minimum Condition Section 2.1(a)(iNotice Period 5.3(e)(ii)(3) Multiemployer Plan Section 4.11(cOther Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(rr) Payment Agent 2.10(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Surviving Corporation Article II (a) Termination Date 8.1(c) Uncertificated Shares 2.10(c)

Appears in 1 contract

Sources: Merger Agreement (Nutraceutical International Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Agreement Date Preamble Alternate Debt Financing 6.5(c) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Payments 4.12(a) Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 1.1 Company Liability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 0 Consent 3.6 Copyrights 1.1 D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letter Recitals Debt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a4.12(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1 Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter Recitals Equity Financing 4.12(a) ERISA Affiliate 3.18(a) ESPP 2.8(e) Event Notice Period 5.3(e)(i)(1) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFee Letter Recitals Financing 4.12(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Letters Recitals Go-Shop Period 5.3(a) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section Interim Period 5.1 International Employee Plans 3.18(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1 Material Contract Section 4.18(aRevision 5.3(e)(ii)(3) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i4.12(a) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Debt Commitment Letters 6.5(c) Multiemployer Plan Section 4.11(cNew Plans 6.11(d) No-Shop Period Start Date 5.3(a) Old Plans 6.11(d) Option Consideration 2.8(b)(i) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Reimbursement Obligations 6.6(f) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)

Appears in 1 contract

Sources: Merger Agreement (STAMPS.COM Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii“Aggregate Consideration” 4.10(b) Acquisition Proposal Section 6.2(e)(i“Agreement” Preamble “Alternative Financing Commitment Letter” 6.12(b) Acquisition Sub Preamble Adverse “Alternative Financing” 6.12(b) “Ancillary Documents” 9.13 “Antitrust Consents” 7.1(c) “Book-Entry Shares” 2.7(h)(iii) “Canceled Company Shares” 2.7(a)(ii) “Capitalization Date” 3.2(a) “Cautionary Note Regarding Forward-Looking Statements” Article III “Certificate of Merger” 2.2 “Certificates” 2.7(h)(ii) “Change of Recommendation Change Section 6.2(c)(iNotice” 5.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii“Closing Date” 2.3 “Closing” 2.3 “COBRA” 3.11(d) Antiboycott Rules Section 4.22(a) “Company Board Recommendation Section 2.2(bChange” 5.3(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Board Recommendation” Recitals “Company Preamble Company Common Stock Board” Recitals Company Disclosure Letter Letter” Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) III “Company Financial Advisor Section 4.10 Advisors” 3.10 “Company SEC Reports Section 4.7(aReports” 3.7(a) Company Securities Section 4.2(aSecurities” 3.2(c) Company Shares Source Code” 3.16(f) “Company Stockholder Damages” 8.2 “Company Stockholder Meeting” 5.4(c) “Company Termination Fee” 8.3(b) “Company” Preamble “Confidentiality Agreement” 9.4 “D&O Insurance” 6.7(c) “Debt Financing” 4.10(a) “Definitive Financing Agreements” 6.12(a) “DGCL” Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iShares” 2.7(c)(i) EAR Section 4.22(a“Effective Time” 2.2 “Enforceability Exceptions” 3.4 “Equity Commitment Letter” Recitals “Equity Financing” 4.10(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b“Exchange Fund” 2.7(g) Exchange Fund Section 3.8(b“Financing Letters” 4.10(a) Expiration Time Section 2.1(d)(i“Financing” 4.10(a) Financial Statements Incipio Incipio “Foreign Antitrust Laws” 3.6 “Indemnified Persons” 6.7(a) “Indemnified Proceeding” 6.7(b) “Investors” Recitals “Company IT Systems” 3.16(h) “Letter of Transmittal” 2.7(h)(ii) “Limited Guarantee” 4.10(f) “Material Contract” 3.18(a)(xi) “Merger Agreement Section 4.7(bConsideration” 2.7(a)(i) “Merger Sub” Preamble “Merger” Recitals Recitals Indemnified Persons Section 7.8(a“Multiemployer Plan” 3.11(c) Inventions Section 1.1 Material Contract Section 4.18(a“Option Consideration” 2.7(d) Maximum Annual Premium Section 7.8(c“Owned Real Property” 3.17(a) Merger Recitals Merger Consideration Section 3.7(a)(i“Parent 401(k) Minimum Condition Section 2.1(a)(iPlan” 6.8(c) Multiemployer Plan Section 4.11(c“Parent Termination Fee” 8.3(c) “Parent” Preamble “Paying Agent” 2.7(f) “Payoff Letter” 6.11(d) “Plans” 3.11(a) “Proxy Date” 5.4(c) “Proxy Statement” 5.4(a) “Real Property Leases” 3.17(b) “Remedy Actions” 6.2(a) “Required Amount” 4.10(b) “Risk Factors” Article III “Service Provider” 3.11(e) “Solvent” 4.8 “Surviving Corporation” 2.1 “Termination Date” 8.1(b)(i)

Appears in 1 contract

Sources: Merger Agreement (Nextgen Healthcare, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii$ 1.3(e) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEntity Recitals Advisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.5(a) Antiboycott Rules Section 4.22(aBylaws 2.3(b) Board Recommendation Section 2.2(bCapitalization Date 3.7(a) Cancelled Company Shares Section 3.7(a)(iiCash Consideration Recitals CCC 4.35(a) Certificate of Merger Section 3.2 Certificates Section 3.8(cCFPOA 4.35(a) Changes Section 1.1 Charter 2.3(a) Chosen Courts 9.10 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.5(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.18(a) Company License-Out Agreements Section 4.16(hIP Contracts 3.16(c) Company Financial Advisor Section 4.10 Lease 3.14(a) Company Leased Real Property 3.14(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Company Transaction Documents 3.2 Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDerivative Security 2.1(b)(ii) DGCL 2.3(a) Electronic Delivery 9.14 Enforceability Limitations 3.2 Financing Recitals Dissenting Company Shares Section 3.7(c)(iHoldings Recitals Holdings Employee Plans 4.29(a) EAR Section 4.22(aHoldings IP Contracts 4.27(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bHoldings Lease 4.25(a) Exchange Fund Section 3.8(bHoldings Leased Real Property 4.25(a) Expiration Time Section 2.1(d)(iHoldings Securities 4.20(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aIndigo Recitals Information Statement 6.3(a) Intervening Event 5.5(d)(i) Maximum Annual Premium Section 7.8(c6.9(c) Merger Net Working Capital Shortfall 6.25(a) Net Working Capital Statement 6.25(a) Notice Period 5.5(d)(ii)(C) Other Party 8.3(e) Parent Preamble Parent Disclosure Letter Article IV Parent Material Customer 4.38(a) Parent Material Supplier 4.38(b) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)(i) Parent Termination Fee Event 8.3(c)(i) Party Preamble Payor 8.3(e) Permits 3.20 Proxy Statement 6.3(a) Purchased Shares 2.1(b)(i) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.5(a) Requisite Stockholder Approvals 3.4 SEC Clearance Date 6.3(d) Share Amount 2.1(b)(iv) SpinCo Recitals Merger Consideration Section 3.7(a)(iSpin-Off Recitals Spin-Off Registration Statement 6.18(a) Minimum Condition Section 2.1(a)(iStockholders’ Agreement Recitals Tangible Company Assets 3.14(b) Multiemployer Plan Section 4.11(c)Tangible Holdings Assets 4.25(b) Tax Returns 3.17(a) Termination Date 8.1(c) Transactions Recitals V7 Recitals Voting Agreement Recitals Voting Matters Recitals WARN Act 3.19(c) WAS Recitals

Appears in 1 contract

Sources: Business Combination Agreement (Cogint, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto to such terms in the respective sections following Sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement. Call Option Notice Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii10.2(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Call Right Closing Date Section 3.3 COBRA 10.2(b) Capital Contribution Default Section 4.11(d4.1(d) Capital Note Section 4.1(d)(ii) CB Acceptance Notice Section 10.6(b) CB Member Section 10.6(a) CB Notice Period Section 10.6(a) CB Offer Section 10.6(a) CB Offer Notice Section 10.6(a) CB Units Section 10.6(a) Certificate Section 2.2 Class A Managers Section 5.1(b)(i)(A) Class A Member Call Option Section 10.2(a) Class B Default Section 10.4 Class B Managers Section 5.1(b)(i)(B) Committee(s) Section 5.5 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Sale Notice Section 4.16(g10.7(c) Company LicenseTax Liability Section 7.11(e) Confidential Information Section 2.10 Drag-Out Agreements Along Sale Section 4.16(h10.1(a) Company Financial Advisor Dragged Members Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a9.1(a) Effective Time Date Preamble Exercising Member Section 3.2 Enforceability Exceptions 6.1(d)(iv) Indemnitee Section 4.4 Environmental Permits 11.3(a) Initial Class A Contribution Section 4.15(b4.1(a) Exchange Fund Initial Class B Contribution Section 3.8(b4.1(b) Expiration Time Offer Election Period Section 2.1(d)(i10.6(a) Financial Statements Incipio Incipio Merger Agreement Offered Units Section 4.7(b5.1(c) Recitals Recitals Indemnified Persons Offering Member Section 7.8(a6.1(c) Inventions Offering Member Notice Section 1.1 Material Contract 6.1(c)(i) Officer(s) Section 4.18(a5.6 Option Units Section 10.2(a) Maximum Annual Premium Partnership Representative Section 7.8(c7.11(a) Merger Recitals Merger Consideration Pass-Thru Member Section 3.7(a)(i7.11(d) Minimum Condition Permitted Transfer Section 2.1(a)(i6.1(a) Multiemployer Plan Permitted Transferee Section 4.11(c6.1(b) Proposed Purchaser Section 6.1(d)(i) Purchase Offer Section 10.7(a) Purchasing Member Section 6.1(c)(iv) ROFO Section 6.1(c) ROFO Acceptance Notice Section 6.1 (c)(iv) ROFO Notice Period Section 6.1(c)(ii) ROFR Section 6.1(d) ROFR Acceptance Notice Section 6.1(d)(iv) ROFR Notice Period Section 6.1(d)(ii) Sale Election Notice Section 10.7(a) Sale Election Period Section 10.7(a) Sale Process Section 10.7(a) Sale Right Section 10.7(a) Subject Units Section 6.1(d) Subsequent Capital Contribution Section 4.1(d) Tax Distributions Section 7.10 Tax Matters Member Section 7.11(a) Tax Matters Partner Section 7.11(a) Tax Proceeding Section 7.11(c)(ii) Transfer Notice Section 6.1(d)(i) Transferring Member Section 7.1(d) Waived ROFO Transfer Period Section 6.1(c)(v) Waived ROFR Transfer Period Section 6.1(d)(v)

Appears in 1 contract

Sources: Limited Liability Company Agreement (Cinemark Holdings, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Termination Fee 6.17(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Anti-Corruption Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bAssets 3.14 Commitment Letter 4.10(a) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 claim 4.11 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 CMB Escrow Agent Recitals CMB Escrow Agreement Recitals CMB Escrow Amount 6.17(c) Collective Bargaining Agreement 3.18(a) Company Preamble Company Board Recommendation Recitals Company Board Recommendation Change 6.5(b) Company Common Stock Recitals Company Escrow Agent Recitals Company Escrow Agreement Recitals Company Escrow Amount 6.17(a) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gRelated Parties 8.3(b)(iv) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(e) Company Securities Section 4.2(aStockholder Meeting 6.4(b) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.5 Continuing Obligations 2.7(d)(ii) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDB Escrow Amount 6.17(b) Debt debt 4.11 Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Employee Plans 3.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Equity Award or Equity Awards 3.6(b)(v) ▇▇▇▇ ▇▇▇▇▇▇▇ Reference ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing Agreements 6.15(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGovernment Officials 3.20(d) Recitals Recitals Grant Date 3.6(d) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.17(a) Intervening Event Notice 6.5(c)(ii)(C) JoinderITAR Recitals3.20(h) Leased Real Property 3.13(b) Leases 3.13(b) Lender 4.10(a) Major Customer 3.27(a) Major Supplier 3.27(a) (a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals New Plans 6.11(c) Minimum Condition Section 2.1(a)(iOld Plans 6.11(c) Multiemployer Plan Section 4.11(cOwned Real Property 3.13(a) Parent Preamble Payment Agent 2.8(a) Permits 3.19 Proxy Statement 3.30 Representatives 5.2(b) Requisite Stockholder Approval 3.3 Restricted Stock Unit Consideration 2.7(f)(i) Solvent 4.11 Subsidiary Securities 3.7(c) Superior Proposal Amendment Notice 6.5(c)(i)(C) Superior Proposal Notice 6.5(c)(i)(C) Surviving Corporation 2.1 (a) Termination Date 8.1(b)(i) Termination Fee 8.3(b)(i) Uncertificated Shares 2.8(c) Unvested Company Option 2.7(d)(ii) Unvested Company SAR 2.7(e)(ii) Unvested Option Consideration 2.7(d)(ii) Unvested Restricted Stock Unit 2.7(f)(ii)

Appears in 1 contract

Sources: Merger Agreement (Cypress Semiconductor Corp /De/)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: 11 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiPreamble Agreement of Merger 2.2 Antitrust Restraint 6.5(d) Acquisition Proposal Section 6.2(e)(iAssets 3.21 Assumed Option 6.11(b) Acquisition Sub California Secretary of State 2.2 Cancelled Option 6.11(a) Capitalization Representation 7.2(a) Certificates 2.8(c) Change 1.1 Changes 1.1 China RoHS 1.1 Closing 2.3 Closing Date 2.3 Collective Bargaining Agreements 3.19(a) Combined Software 1.1 Company Preamble Adverse Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change Section 6.2(c)(i6.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.22(f) Company License-Out Agreements Section 4.16(hRegistered IP 3.22(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 6.1(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Copyrights 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(aDemand Notice 2.7(c)(i) Debt Financing Dispute Section 10.9(aDissenting Shares 2.7(c)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iDomain Names 1.1 EAR 3.23(a) EAR Section 4.22(aECCNs 3.23(b) Effective Time 2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Term Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Reference EU RoHS Directive 1.1 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExport Controls 3.23(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFIN 48 3.16(n) Recitals Recitals Foreign Employees 3.18(l) Funded International Employee Plan 3.18(b) Import Restrictions 3.23(a) Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 International Employee Plans 3.18(a) ITAR 3.23(a) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble NQDCP 5.2(g) OFAC 3.23(a) Option Consideration 6.11(a) Owned Real Property 3.20(a) Parent Preamble Patents 1.1 Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Shareholder Approval 3.3(c) Retirement Plan Termination Date 6.12(a) Retirement Plans 6.12(a) SEC Reports 3.6 Shares Recitals Significant Customer 3.30(a) Significant Supplier 3.30(b) Specified Representations 7.2(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Laws 3.29 Tax Incentive 3.16(k) Termination Date 8.1(c) Term Section 3.7(a)(iReference Termination Fee Amount 8.3(b)(i) Minimum Condition Section 2.1(a)(iThird Party Leases 3.20(b) Multiemployer Plan Section 4.11(c)Trade Secrets 1.1 Trademarks 1.1 Triggering Event 8.1(e)(ii) Voting Agreement Recitals Voting Agreements Recitals Warranties 3.22(s) WEEE Directive 1.1

Appears in 1 contract

Sources: Merger Agreement (Microchip Technology Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Acquired Company; Acquired Companies RECITALS Aggregate Share Purchase Price Section Reference Acceptable Confidentiality 2.02(c) Agreement PREAMBLE Alternative Acquisition Agreement Section 6.2(e)(iii5.08(c)(ii) Acquisition Proposal Arbitration Notice Section 6.2(e)(i8.13(a) Acquisition Sub Preamble ATA BVI PREAMBLE ATA Learning PREAMBLE ATA Learning Share Purchase Price Section 2.02(c) ATA Learning Shares Section 2.01 ATA Learning SPA RECITALS ATA Online RECITALS ATA Online Share Purchase Price Section 2.02(b) ATA Online Shares Section 2.01 Bankruptcy and Equity Exception Section 4.08(b) Beijing AIC Section 2.04(a)(i) Business RECITALS Buyer; Buyers PREAMBLE Buyer 1 PREAMBLE Buyer 2 PREAMBLE Buyer 3 PREAMBLE Buyer 4 PREAMBLE Buyer 5 PREAMBLE Buyer 6 PREAMBLE Buyer 7 PREAMBLE Contracting Parties Section 8.16(a) Debt Commitment Letters Section 4.08(a) Debt Financing Section 4.08(a) Debt Financing Agreement Section 5.06(a) Deposit RECITALS Deposit Account Section 5.01 Deposit Date Section 3.07(b) Dispute Section 8.13(a) Dividend and Distribution Section 5.10 Dividend and Distribution Amount Section 5.10 Equity Commitment Letter Section 4.08(a) Equity Financing Section 4.08(a) First Closing Section 2.03(a) First Closing Date Section 2.03(a) Financing Section 4.08(a) Financing Documents Section 4.08(a) Foreign Exchange Approvals Section 5.10 Guarantor PREAMBLE HKIAC Section 8.13(b) HKIAC Rules Section 8.13(b) Long-stop Date Section 7.01(b) Non-Party Affiliates Section 8.16(a) Party; Parties PREAMBLE Pledge of Sponsor Acquired Shares Section 5.11 PRC; China PREAMBLE Proposing Person Section 5.08(b)(ii) Second Closing Section 2.03(b) Second Closing Date Section 2.03(b) Seller PREAMBLE Seller Board RECITALS Seller Adverse Recommendation Change Section 6.2(c)(i5.08(c)(i) Agreement Preamble Alternative Acquisition Agreement Seller Termination Fee Section 6.2(c)(ii7.03 Special Committee RECITALS Superior Proposal Notice Period Section 5.08(d)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Third Closing Section 3.3 2.03(c) Third Closing Date Section 3.3 COBRA Section 4.11(d2.03(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Xing Wei RECITALS Zhongxiao RECITALS Zhongxiao Shares Section 3.7(c)(i2.01 Zhongxiao Share Purchase Price Section 2.02(a) EAR Zhongxiao SPA RECITALS 31.5% ATA Online Shares Section 4.22(a2.01(b) Effective Time 7.5% ATA Online Shares Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.01(a)(ii)

Appears in 1 contract

Sources: Share Purchase Agreement (ATA Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Board Recommendation Notice 7.5(e) Company Common Stock Recitals Company Compensation Committee 4.17(m) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(a) Company Financial Advisor Section 4.10 Product 4.20(b) Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Continuing Directors 2.3(a) Covered Securityholders 4.17(m) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(m) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExpenses 9.4(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFraud and Bribery Laws 4.20(c) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Inventions Section 1.1 IT Systems 4.15(h) Leased Real Property 4.13(b) Leases 4.13(b) Major Stockholder Recital Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cNew Plans 7.11(b) Non-Cancelled Company Shares 3.7(a)(ii) Notice of Superior Proposal 7.5(e) Notice Period 7.5(e)

Appears in 1 contract

Sources: Merger Agreement (Vitacost.com, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.9(f) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBook-Entry Shares 3.8(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Certificate of Merger Section 3.2 Certificates Section 3.8(cChange of Recommendation Notice 6.3(b) Changes Section 1.1 Closing Section 3.3 Closing Amount Recitals Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 4.3 Company Board Recommendation Change 6.3(a) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.6(a) Company Securities Section 4.2(a) Company Shares Recitals Company Stock Award Milestone Payment Amount 3.7(d)(iv) Company Termination Fee 9.3(c) Confidentiality Agreement Section 10.4 Current Company CVR Recitals D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Effects 1.1 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.3 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 3.7(e) Recitals Recitals Final Offering Periods 3.7(e) Foreign Antitrust Laws 4.5 Indemnified Persons Section 7.8(a) Inventions Section 1.1 Indemnified Proceeding 7.8(b) Letter of Transmittal 3.8(c)(ii) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 4.19 Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer New Plans 7.9(b) Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(b) Option Closing Consideration 3.7(d) Parent Preamble Parent 401(k) Plan 7.9(f) Patent Rights Section 4.11(c1.1 Paying Agent 3.8(a) Payor 3.8(e) PEO 4.11(a) PEO 401(k) Plan 7.9(f) Plans 4.11(a) PSU Closing Consideration 3.7(d)(iii) Real Property Leases 4.16(a)(b) RSU Closing Consideration 3.7(d)(ii) Schedule 14D-9 2.2(a) Schedule TO 2.1(f)(i) Spinoff 401(k) Plan 7.9(f) Surviving Corporation 3.1 Takeover Laws 4.25 Tender and Support Agreements Recitals Termination Date 9.1(b)(i) Transfer Taxes 9.3(b)

Appears in 1 contract

Sources: Merger Agreement (Icosavax, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Acquired Company; Acquired Companies RECITALS Aggregate Share Purchase Price Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.02(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.08(c)(ii) Antiboycott Rules Arbitration Notice Section 4.22(a8.13(a) Board Recommendation ATA BVI Preamble ATA Learning Preamble ATA Learning Share Purchase Price Section 2.2(b2.02(c) Cancelled Company ATA Learning Shares Section 3.7(a)(ii2.01 ATA Learning SPA RECITALS ATA Online RECITALS ATA Online Share Purchase Price Section 2.02(b) Certificate of Merger ATA Online Shares Section 3.2 Certificates 2.01 Bankruptcy and Equity Exception Section 3.8(c4.08(b) Changes Beijing AIC Section 1.1 2.04(a)(i) Business RECITALS Buyer; Buyers Preamble Buyer 1 Preamble Buyer 2 Preamble Buyer 3 Preamble Buyer 4 Preamble Buyer 5 Preamble Buyer 6 Preamble Buyer 7 Preamble Contracting Parties Section 8.16(a) Debt Commitment Letters Section 4.08(a) Debt Financing Section 4.08(a) Debt Financing Agreement Section 5.06(a) Deposit RECITALS Deposit Account Section 5.01 Deposit Date Section 3.07(b) Dispute Section 8.13(a) Dividend and Distribution Section 5.10 Dividend and Distribution Amount Section 5.10 Equity Commitment Letter Section 4.08(a) Equity Financing Section 4.08(a) First Closing Section 3.3 2.03(a) First Closing Date Section 3.3 COBRA 2.03(a) Financing Section 4.11(d4.08(a) Company Financing Documents Section 4.08(a) Foreign Exchange Approvals Section 5.10 Guarantor Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseHKIAC Section 8.13(b) HKIAC Rules Section 8.13(b) Long-In Agreements stop Date Section 4.16(g7.01(b) Company LicenseNon-Out Agreements Party Affiliates Section 4.16(h8.16(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Party; Parties Preamble Pledge of Sponsor Acquired Shares Section 3.7(c)(i5.11 PRC; China Preamble Proposing Person Section 5.08(b)(ii) EAR Second Closing Section 4.22(a2.03(b) Effective Time Second Closing Date Section 3.2 Enforceability Exceptions 2.03(b) Seller Preamble Seller Board RECITALS Seller Adverse Recommendation Change Section 4.4 Environmental Permits 5.08(c)(i) Seller Termination Fee Section 4.15(b7.03 Special Committee RECITALS Superior Proposal Notice Period Section 5.08(d)(ii) Exchange Fund Third Closing Section 3.8(b2.03(c) Expiration Time Third Closing Date Section 2.1(d)(i2.03(c) Financial Statements Incipio Incipio Merger Agreement Xing Wei RECITALS Zhongxiao RECITALS Zhongxiao Shares Section 4.7(b2.01 Zhongxiao Share Purchase Price Section 2.02(a) Recitals Recitals Indemnified Persons Zhongxiao SPA RECITALS 31.5% ATA Online Shares Section 7.8(a2.01(b) Inventions 7.5% ATA Online Shares Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.01(a)(ii)

Appears in 1 contract

Sources: Share Purchase Agreement (Ma Kevin Xiaofeng)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.8(d)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Approval Section 4.22(a) Board Recommendation 3.5 Assignee Section 2.2(b) Cancelled Company 10.3 Book-Entry Shares Section 3.7(a)(ii2.8(c)(ii) Buyer Recitals Capitalization Date Section 3.6(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 102 PSUs Section 2.8(d)(i) Company 1▇▇ ▇▇▇▇ Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Section 7.3(a) Company Board Recommendation Change Section 5.3(b) Company Designated Directors Section 6.5 Company Disclosure Letter Article IV III Company License-In Agreements Plans Section 4.16(g6.2(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Shares Recitals Section 2.7(a) Confidentiality Agreement Section 10.4 Current Company 7.8 consolidated financial statements Section 3.9(a) Copyrights Section 1.1 D&O Insurance Section 7.8(c6.1(c) Customs Laws Designs Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits Section 4.15(b3.16(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) Financial Statements Incipio Incipio Merger Agreement FDA Section 4.7(b3.19(c) Recitals IAA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) Intervening Event Recommendation Change Notice Section 5.3(d) Inventions Section 1.1 Israeli Employee Section 3.17(d) Israeli Employees Section 3.17(d) IT Systems Section 3.14(i) ITA Section 2.8(f) Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.12 Material Employee Plans Section 3.16(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a) Minimum Condition Merger Proposal Section 2.1(a)(i7.4(a) Multiemployer Merger Sub Preamble Notice Date Section 7.3(a) OECD Convention Section 3.19(b) Option Consideration Section 2.7(c) Options Tax Ruling Section 7.9(a) Outside Date Section 9.1(c) Parent Preamble Parent Plans Section 6.2(c) Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.18(a) Prohibited Payment Section 3.19(b) Proxy Statement Section 7.3(a) PSUs Consideration Section 2.7(d) Recommendation Change Notice Section 5.3(d) Registered Intellectual Property Section 3.14(a) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(c) RSUs Consideration Section 2.7(d)(i) Section 102 Plan Section 4.11(c)3.16(g) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Tax Returns Section 3.15(a) Termination Fee Section 9.3(b)(i) Trade Control Laws Section 3.19(d) Trade Secrets Section 1.1 Trademarks Section 1.1 Transition Period SEC Report Section 7.10(b) Uncertificated Shares Section 2.8(c)(ii) Withholding Drop Date Section 2.8(f) Withholding Tax Ruling Section 7.9(b) Works of Authorship Section 1.1

Appears in 1 contract

Sources: Merger Agreement (SodaStream International Ltd.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.1(e) Acquisition Sub Preamble Adverse Recommendation Change Term Section 6.2(c)(i) Reference Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Arrangements 7.10 Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Catch-Up Opportunity 3.7(e) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section Change 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Commitment Letters 5.10(a) Company Preamble Company Common Stock Board Committee 2.2(a) Company Board Recommendation Recitals Company Board Recommendation Change 7.3(b) Company Compensation Committee 7.10(a) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(d) Company Shares Recitals Comparable Plans 7.9(b) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Insight Confidentiality Agreement Section Agreements 10.4 Current Company Consent 4.5 Copyright Rights 1.1 Covered Securityholders 7.10(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Expenses 9.4(a) ▇▇▇▇▇▇▇ Confidentiality Agreement 10.4 Employee Plans 4.17(a) Employment Compensation Arrangement 7.10(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 Equity Award 4.6(b) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Expenses 9.4(a) Financing 5.10(a) Fraud and Bribery Laws 4.20(c) Term Section 2.1(d)(iReference Grant Date 4.6(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGuarantors Recitals Inbound IP Contract 4.15(b) Recitals Recitals Indemnified Persons Section 7.8(a) Insight Confidentiality Agreement 10.4 International Employee Plans 4.17(a) Intervening Event Notice 7.3(c)(ii) Inventions Section 1.1 IT Systems 4.15(j) Leased Real Property 4.13(b) Leases 4.13(b) Limited Guaranty Recitals Major Stockholders Recitals Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)

Appears in 1 contract

Sources: Merger Agreement (E2open Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 6.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffected Employee 6.12(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAlternate Debt Financing 6.15(c) Antiboycott Rules Section 4.22(aAssumed Option 2.7(d)(iv) Board Recommendation Section 2.2(bAssumed RSU 2.7(d)(i) Assumed SAR 2.7(d)(iv) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Representations 7.2(a) Capitalization Time 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.7(a)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Date Indebtedness 6.15(e)(i)f) Collective Bargaining Agreements 3.20(a) Company Preamble Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In IP Agreements Section 4.16(g3.22(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRegistered IP 3.22(a) Company Securities Section 4.2(a3.4(d) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c6.10 Consent 3.5(b) Customs Laws Section 4.22(aDebt Commitment Letters 4.8(a) Debt Financing Dispute Section 10.9(a4.8(a) DGCL Recitals Debt Financing Conditions 4.8(b) Debt Financing Sources 4.8(a) Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.13(b) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Escrowed Compensatory Payments 2.8(c) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExport Controls 3.23(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.15(e)(i) Recitals Recitals Financing Sources 6.15(e)(i) Import Restrictions 3.23(a) Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 Intervening Event 6.2(c)(ii) Labor Organization 3.20(a) Leased Real Property 3.21(b) Leases 3.21(b) Loan Documents 6.17 Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Preamble New Debt Commitment Letters 6.15(c) Minimum Condition Section 2.1(a)(iNoteholders 6.18(c) Multiemployer Plan Section 4.11(cNotes Consents 6.18(a) Notes Offer to Purchase 6.18(a) Notes Tender Offer 6.18(a) Notes Tender Offer Documents 6.18(c) Notice Period 6.2(c)(i) Optional Redemption 6.18(e) Optional Redemption Notice 6.18(e) Owned Real Property 3.21(a) Parent Preamble Parent Expenses 8.3(b)(iv) Parent Specified Representations 7.3(a) Payment Agent 2.8(a) Permits 3.14 Pre-Closing Director 6.15(e)(ii) Proxy Statement 3.8 PSU Consideration 2.7(d)(iii) Real Property 3.21(b) Required Financial Information 6.15(e) Requisite Stockholder Approval 3.3(c) Senior Notes 6.18(a) Significant Customer 3.16(a) Significant Supplier 3.16(b) Special Shares 2.7(e) Specified Representations 7.2(a) Subsidiary Securities 3.2(d) Supplemental Indenture 6.18(d) Surviving Corporation 2.1 Tail Policy 6.13(b) Tax Incentive 3.17(k) Termination Date 8.1(d) Termination Fee Amount 8.3(b)(i) TIA 6.18(b) Transition Period 6.12(b) Uncertificated Shares 2.7(a)(i) Unvested Restricted Stock 2.7(d)(v)

Appears in 1 contract

Sources: Merger Agreement (Microsemi Corp)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bBenefits Period 6.11(b) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.9(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRelevant Persons 3.22(b) Company Financial Advisor Section 4.10 PSU 2.8(b)(i) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Converted Cash Award 2.8(a)(ii) Copyrights 1.1(ooo) Covenant Exceptions 5.1(a) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(aPurchase Period 2.8(f) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(bb) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter Recitals Equity Financing Recitals Event Notice Period 5.4(d)(i)(2) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.6(a) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.19(j) Investor 4.9(a) IP Contracts 3.16(d) Labor Agreements 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(ooo) Material Contract Section 4.18(aCustomers 1.1(vvv)(x) Maximum Annual Premium Section 7.8(cMaterial Vendors 1.1(vvv)(x) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval 6.19 New Plans 6.11(c) Non-Cooperation Notice 6.6(b) Notice Period 5.4(d)(ii)(3) OFAC 1.1(jjjj) Old Plans 6.11(c) Original Equity Commitment Letter Recitals Original Agreement Preamble Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Party Preamble Patents 1.1(ooo) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Processing 3.17(a) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(f) Required Permits 3.21 Requisite Stockholder Approval 3.4 Security Breach 3.17(b) Specified Foreign Direct Investment Law 6.2(a) Surviving Corporation 2.1 Tail Policy 6.10(c) Termination Date 8.1(c) Trade Controls 3.22(b) Trade Secrets 1.1(ooo) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU 2.8(b)(ii) Unvested Company RSU 2.8(a)(ii) UPE 6.2(a) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU 2.8(b)(i) Multiemployer Plan Section 4.11(cVested Company PSU Consideration 2.8(b)(i) Vested Company RSU 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) WARN Act 3.20(b)

Appears in 1 contract

Sources: Agreement and Plan of Merger (Everbridge, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble 90% Top-Up Option 1.4 90% Top-Up Option Shares 1.4 90% Top-Up Exercise Notice 1.4 90% Top-Up Notice Date 1.4 90% Top-Up Closing 1.4 90% Top-Up Notice Receipt 1.4 Adverse Recommendation Change Section 6.2(c)(i) Regulatory Condition Annex A Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 1.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.20 Capitalization Representation Annex A Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Change in Control Agreement 6.13(d) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Company Preamble Company Common Stock Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Schedule Article III Preamble Company IP Agreements 3.21(f) Company Representative 6.1(b) Company Rights Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Rights Plan Recitals Company Securities Section 4.2(a3.4(c) Company Shares Recitals Company Stockholders 1.1(f) Company Stockholders’ Meeting 6.3(a) Compensation Committee 3.3(d) Computershare Recitals Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Continuing Directors 1.3(a) Covered Securityholders 4.9 D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aDistribution Date 3.3(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExclusivity Agreement 6.10 Export Controls 3.22 FIN 48 3.15(o) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(b) Recitals Recitals Import Restrictions 3.22 Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.19(b) Leases 3.19(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Consideration Section 3.7(a)(i2.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c1.1(a)(i)

Appears in 1 contract

Sources: Merger Agreement (Autodesk Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 280G Analysis 6.21 Accounting Firm 5.4(b) Advisor 3.26 Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(e) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.3(a) Capitalization Date 3.5(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) claim 4.13 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.2(b) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLicenses 3.13(e) Company License-Out Agreements Section 4.16(hIP License 3.13(f) Company Financial Advisor Section 4.10 Out Licenses 3.13(f) Company Real Property Lease 3.11(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.7 Company Subsidiary Documents 3.4 Company Termination Fee 8.3(b)(i) Company Securities Section 4.2(aCovered Persons 6.10(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cCOVID-19 1.1(x)(vi) Customs Laws Section 4.22(aCOVID-19 Measures 1.1(x)(xi) debt 4.13 Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) Effect 1.1(x) Effective Time Section 3.2 2.2 Electronic Delivery 9.13 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(d) Enforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Equity Financing Source 4.11(a) ESPP 2.9 Event Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFairness Opinion 3.26 Financing 4.11(c) Financing Conditions 4.11(d) Financing Letters 4.11(c) Guarantee Recitals Guarantor(s) Recitals Recitals Indemnified Persons Section 7.8(aInterim Period 5.1 Labor Agreement 3.14(a)(vii) Inventions Section 1.1 Legacy ERP System 3.13(l) Major Customer 3.14(a)(ix) Major Supplier 3.14(a)(x) Material Contract Section 4.18(a3.14(a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.11(a)(i) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Damages 8.3(f)(i)(A)(y) Parent Expense Reimbursement 8.3(b)(iv) Parent Related Parties 8.3(f)(ii) Party Preamble Payment Agent 2.10(a) Per Share Price 2.7(a)(ii) Permits 3.20 Prohibited Financing Modifications 6.5(b)(iii) Proposal Notice Period 5.3(d)(ii)(3) Prospective Purchaser 5.3(b) Proxy Statement 6.3(a) PSU Consideration 2.8(c) Qualified Plan Section 3.16(d) Related Parties 3.27 Required Amounts 4.11(f) Requisite Stockholder Approval 3.2(c) Restricted Stock Consideration 2.8(d) RSU Consideration 2.8(b) Sale/Leaseback Financing 4.11(c) Sale/Leaseback Purchase Agreement 4.11(c) Sale/Leaseback Transaction 6.24 SAP ERP System 3.13(l) Scheduled Amended Tax Return 5.4 Solvent 4.13 Surviving Corporation 2.1 Takeover Statute 3.24 Termination Date 8.1(c) Third Party Purchaser 6.24 Transaction Legal Proceedings 9.10(a) Uncertificated Shares 2.10(c)

Appears in 1 contract

Sources: Merger Agreement (Tessco Technologies Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.5(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(l) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Competing Acquisition Transaction 9.4(b)(i) Confidentiality Agreement Section 10.4 Consent 4.5 Copyleft Licenses 4.15(i) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(l) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bHealthcare Laws 4.20(a) Recitals Recitals Healthcare Permits 4.20(d) Indemnified Persons Section 7.8(a7.10(a) Inventions Section 1.1 Institutions 4.15(h) Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.11(c) Open Source Licenses 4.15(i) Option Consideration 3.7(d) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Personal Information 4.15(j) Privacy Policies 4.15(j) Representatives 6.2(b) Restraint 8.1(b) RSU Consideration 3.7(e) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Subsidiary Securities 4.7(c) Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Date 9.1(b) Termination Fee 9.4(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)

Appears in 1 contract

Sources: Merger Agreement (Avanir Pharmaceuticals, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term 2020 Indenture Section Reference Acceptable Confidentiality Agreement 6.12(a) 2020 Notes Section 6.2(e)(iii6.12(a) Acquisition Proposal 2021 Indenture Section 6.2(e)(i6.12(a) Acquisition Sub Preamble 2021 Notes Section 6.12(a) Adverse Recommendation Change Section 6.2(c)(i5.03(d)(i) Agreement Preamble Alternative Acquisition Agreement Anti-Bribery and Anti-Corruption Laws Section 6.2(c)(ii4.26 Available Cash Amount Section 2.02(k) Antiboycott Rules Bankruptcy and Equity Exception Section 4.22(a3.02 Book-Entry Shares Section 2.01(c) Board Recommendation Section 2.2(b) Cancelled BR Guarantor Recitals Canceled Company Shares Section 3.7(a)(ii2.01(b) Capital Stock Section 4.03(a) Capitalization Date Section 4.03(a) Certificate Section 2.01(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 1.02 Closing Section 3.3 1.03 Closing Date Section 3.3 COBRA Section 4.11(d) 1.03 Company Preamble Company Common Stock Recitals Benefit Plan Section 4.10(a) Company Board Recommendation Section 4.04 Company Disclosure Documents Section 4.07 Company Disclosure Letter Article ARTICLE IV Company License-In Agreements Financial Advisors Section 4.16(g4.23 Company Owned Property Section 4.17(a) Company License-Out Agreements Related Parties Section 4.16(h8.03(f) Company Financial Advisor SEC Documents Section 4.10 Company SEC Reports Section 4.7(a4.06(a) Company Securities Section 4.2(a4.03(a) Company Shares Recitals Stockholder Approval Section 4.04 Company Stockholder Meeting Section 4.04 Company Termination Fee Section 8.03(b) Confidentiality Agreement Agreements Section 10.4 Current Company D&O Insurance 6.02 Copyrights Section 7.8(c) Customs Laws 10.01 Debt Commitment Letters Section 4.22(a3.09(a) Debt Financing Dispute Section 10.9(a3.09(a) DGCL Recitals Discharge Section 6.12(c) Dissenting Company Shares Section 3.7(c)(i2.03(a) EAR DTC Section 4.22(a2.02(j) DTC Payment Section 2.02(j) Effective Time Section 3.2 Enforceability Exceptions 1.02 End Date Section 4.4 8.01(b)(i) Environmental Permits Law Section 4.15(b4.13 Equity Commitment Letter Section 3.09(a) Equity Financing Section 3.09(a) Exchange Fund Section 3.8(b2.02(b) Expiration Time Excluded Contract Section 2.1(d)(i4.14(b) Financial Statements Incipio Incipio Merger Agreement Filed Company Contract Section 4.7(b4.14(a) Filed Company SEC Documents ARTICLE IV Financing Section 3.09(a) Financing Commitments Section 3.09(a) GAAP Section 4.06(c) Governmental Approvals Section 6.18(a) Grant Date Section 4.03(c) Guarantee Recitals Guarantor Recitals Indemnified Persons Guarantors Recitals Indentures Section 7.8(a6.12(a) Inventions Inquiry Section 1.1 5.03(a)(i) International Benefit Plan Section 4.10(a) Investors Recitals IRS Section 4.10(b) Key Vendor Contracts Section 4.16(a) Key Vendors Section 4.16(a) Lease Section 4.17(a) Leased Real Property Section 4.17(a) Legal Restraints Section 7.01(c) Letter of Transmittal Section 2.02(c) Material Contract Section 4.18(a4.14(b) Maximum Annual Premium Amount Section 7.8(c6.05(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.01(c) Minimum Condition Merger Sub Preamble Merger Sub Common Stock Section 2.1(a)(i2.01(a) Multiemployer Plan Non-Recourse Company Party Section 4.11(c9.10 Notes Section 6.12(a) Notice Period Section 5.03(d)(ii) Optional Redemption Section 6.12(b) Optional Redemption Notices Section 6.12(b) Parent Preamble Parent Disclosure Letter Article III Parent Related Parties Section 8.03(f) Parent Termination Fee Section 8.03(c) Patents Section 10.01 Paying Agent Section 2.02(a) Personal Information Section 4.20(a) Preferred Stock Section 4.03(a) Primary Debt Commitment Letter Section 3.09(a) Privacy Obligations Section 4.20(a) Proxy Statement Section 6.01(a) Real Property Section 4.17(a) Registered Intellectual Property Rights Section 4.18(a) Rental Contract Section 4.15(a) Representatives Section 5.03(a) Secondary Debt Commitment Letter Section 3.09(a) Solvent Section 3.10 Surviving Company Section 1.01 Systems Section 4.21(b) Trademarks Section 10.01 VRTO Guarantor Recitals WARN Act Section 4.19(d)

Appears in 1 contract

Sources: Merger Agreement (Rent a Center Inc De)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 2.2 Assets 3.14 Capitalization Date 3.7(a) Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(b)(ii) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 6.12(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuing Plans 6.12(a) D&O Insurance Section 7.8(c6.11(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.10(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a4.10(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.18(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.18(h)(ii) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 In-Licenses 3.16(b)(i) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Leases 3.15(b) Maryland Department of Assessments and Taxation 2.2 Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(vi) Maximum Annual Premium Section 7.8(c6.11(c) Merger Recitals Merger Sub Preamble MGCL Recitals New Debt Commitment Letter 6.7(b) New Plans 6.12(c) Newco Preamble No-Shop Period Start Date 5.3(a) Old Plans 6.12(c) Option Consideration Section 3.7(a)(i2.7(e)(i) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c)3.27(a) Other Required Newco Filing(s) 4.6(b) Out-Licenses 3.16(b)(ii) Owned Company Shares 2.7(a)(iii) Payment Agent 2.8(a) Per Share Price 2.7(a)(ii) Proxy Statement 3.27(a) Representatives 5.3(a) Requisite Stockholder Approval 3.4 Subleased Real Property 3.15(d) Subleases 3.15(d) Subsidiary Securities 3.8(c) Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Uncertificated Shares 2.8(c) Voting Agreement Recitals

Appears in 1 contract

Sources: Merger Agreement (Entrust Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(c) Board Recommendation Section 2.2(bAlternative Debt Financing Commitment 6.5(c) Cancelled Company Shares Section 3.7(a)(iiAuthor 3.15(c) Buyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Awards 3.7(b) Company Financial Advisor Section 4.10 3.26 Company IT System Interruption 3.15(g) Company Option Consideration 2.8(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a) 3.9 Company Securities Section 4.2(a3.7(c) Company Shares Recitals Confidentiality Agreement Section 10.4 9.4 Consent 3.6 Continuation Period 6.11(a) Copyrights 1.1(uu) Current Company D&O Insurance Section 7.8(c6.10(c) Customs Data Protection Laws Section 4.22(a1.1(jj) Debt Commitment Letter 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) Debt Financing Commitment 4.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDollars 1.3(e) DTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(v) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(jj) Equity Award Consideration 2.8(b) Equity Commitment Letters Recitals Equity Investors Recitals Equity Financing 4.11(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iDate 2.15(c) Financial Statements Incipio Incipio Merger Extension Deadline 2.15(d)(iv) Fee Funding Agreement Section 4.7(bRecitals Financing 4.11(a) Recitals Recitals Financing Commitments 4.11(a) GDPR 1.1(jj) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Expiration Date 2.15(c) Insured Persons 6.10(c) Intervening Event 5.3(d)(i) Lease 3.14(b) Leased Real Property 3.14(b) Malicious Code 3.15(h) Marks 1.1(uu) Maximum Annual Premium Section 7.8(cAmount 6.10(c) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval Recitals New Plan 6.11(b) No-Shop Period Start Date 5.3(a) Notice Period 5.3(d)(ii)(2) Offer Recitals Offer Acceptance Consideration Section 3.7(a)(i2.16(a)(ii) Minimum Condition Section 2.1(a)(iOffer Acceptance Time 2.16(a)(ii) Multiemployer Plan Section 4.11(cOffer Commencement Date 2.15(f)(i) Offer Conditions 2.15(b)(i) Offer Documents 2.15(f)(i) Offer Price Recitals Offer to Purchase 2.15(f)(i) Original Agreement Recitals Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)

Appears in 1 contract

Sources: Agreement and Plan of Merger (Squarespace, Inc.)

Additional Definitions. The In addition to those terms defined in Section 1.01, the following capitalized terms shall have the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Period 3.06(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Division 7.05(b) Antiboycott Rules Section 4.22(aArbitrator 3.06(d) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Balance Sheet Date 4.07 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.03 Closing Section 3.3 2.02 Closing Date Section 3.3 COBRA Section 4.11(d2.02 Closing Indebtedness 3.06(a) Closing Net Working Capital 3.06(a) Closing Payments 3.03 Company Preamble Company Common Stock 401(k) Plan 7.08 Company Benefit Plans 4.18(b) Company Closing Deliverables 3.04(b) Company Shareholder Agreement Recitals Company Disclosure Letter Article IV Shareholder Consent Recitals Company License-In Agreements Section 4.16(gStock Option 3.01(c) Company License-Out Agreements Section 4.16(hTransaction Expense Direction Notice 6.03 Continuing Employees 6.04(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Copyrights 1.01 Current Company D&O Insurance Section 7.8(c) Customs Laws Section Representation 10.14 Customer 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDisputed Items 3.06(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 2.03 Environmental Laws 4.19(a) Environmental Permits Section 4.15(b4.19(c) Exchange Fund Section 3.8(bERISA Affiliate 4.18(g) Expiration Time Section 2.1(d)(iEstimated Closing Cash Amount 3.02 Estimated Closing Indebtedness 3.02 Estimated Closing Net Working Capital 3.02 Estimated Company Transaction Expenses 3.02 FTC 7.05(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bHazardous Material 4.19(a) Recitals Recitals Indemnified Persons Section 7.8(aHSR Act 4.05(a) Inventions Section 1.1 Insurance Policies 4.21 Law 4.05(b) Leased Real Property 4.10 Table of Contents Leases 4.10 Licensed Intellectual Property 4.11(b) Marks 1.01 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.12(a) Merger Recitals Merger Consideration Sub Preamble Notice of Objection 3.06(c) Outside Date 9.01(c) Owned Intellectual Property 4.11(a) Parent Preamble Continuing Employees 6.04(b) Parent Closing Deliverables 3.04(a) Parent DC Plan 7.08 Patents 1.01 Post-Closing Representation 10.14 Post-Closing Statement 3.06(a) Pre-Closing Statement 3.02 Registered Intellectual Property 4.11(a) Section 3.7(a)(i280G Waived Payments 6.05(a) Minimum Condition Section 2.1(a)(iShareholder Group 10.14 Shareholders’ Representative Preamble Surviving Corporation 2.01 Transfer Taxes 7.02(a) Multiemployer Plan Section 4.11(c)Waiving Parties 10.14

Appears in 1 contract

Sources: Merger Agreement (Innophos Holdings, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCertificates 2.10(c)(i) Cancelled Company Shares Section 3.7(a)(iiCFIUS Mitigation 6.2(b) Certificate of Merger Section 3.2 Certificates Section 3.8(cCFIUS Notice 6.2(a) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gOption Consideration 2.8(c) Company License-Out Agreements Section 4.16(hPlans 6.10(b) Company Financial Advisor Section 4.10 Relevant Persons 3.22(b) Company RSU Consideration 2.8(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cWarrant Consideration 2.9 Comparable Plans 6.10(b) Customs Laws Section 4.22(aCopyrights 1.1(lll) Debt Financing Dispute Section 10.9(aCovenant Exceptions 5.1(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.10(d) Effect 1.1(aa) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Compensation and Benefits 6.10(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFormer Government Employee 3.13(c)(v) Recitals Recitals Guaranteed Obligations 9.17(a) Guarantor Preamble Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 International Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(a) Labor Entities 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(lll) Material Contract Section 4.18(aCustomers 1.1(sss)(x) Material Vendors 1.1(sss)(x) Maximum Annual Premium Section 7.8(c6.9(c) Merger Recitals Merger Sub Preamble New Plans 6.10(c) Notice Period 5.4(d)(ii)(3) OFAC 1.1(eeee) Old Plans 6.10(c) Other Required Company Filing 6.4(e) Other Required Parent Filing 6.4(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Party Preamble Patents 1.1(lll) Payment Agent 2.10(a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Proxy Statement 6.4(a) Required Permits 3.21 Requisite Stockholder Approval 3.4 Restraint 7.1(c) RSU Acceleration 2.8(a) Security Breach 3.17(b) Surviving Corporation 2.1 Tail Policy 6.9(c) Termination Date 8.1(c) Termination Payment 8.3(e) Trade Controls 3.22(b) Trade Secrets 1.1(lll) Uncertificated Shares 2.10(c)(ii) Unvested Company RSU Consideration Section 3.7(a)(i2.8(a)(ii) Minimum Condition Section 2.1(a)(iUS Continuing Employee 2.8(a)(ii) Multiemployer Plan Section 4.11(c)Vested Cash Portion 2.8(a)(iv) Vested Company RSU 2.8(b) Vested Company RSU Consideration 2.8(b) Voting Agreement Recitals

Appears in 1 contract

Sources: Merger Agreement (Transphorm, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.14 Certificates 2.8(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Change of Control Payments 3.29 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Commitment Letters 4.9 Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Disclosure Letter Article IV Art. III Company License-In Agreements Section 4.16(gProducts 3.15(a) Company License-Out Agreements Section 4.16(hSecurities 3.7(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Stockholder Meeting 5.4 Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) 7.7 Consent 3.4 Debt Financing Dispute Section 10.9(a) Commitment Letter 4.9 Delaware Secretary of State 2.2 DGCL Recitals Preamble Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.2 Equity Commitment Letter 4.9 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFASB 3.9(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFIN48 3.9(d) Recitals Recitals In-Licenses 3.15(d) Indemnified Liabilities 6.1(a) Indemnified Persons Section 7.8(a6.1(a) Inventions Section 1.1 Insurance Policies 3.23 Interim Period 5.1(a) Leased Real Property 3.13(b) Leases 3.13(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals 2.1 Merger Consideration Sub Preamble Parent Preamble Out-Licenses 3.15(e) Parent Disclosure Letter Art. IV Paying Agent 2.8(a) Permits 3.19 Proxy Statement 7.3 Requisite Stockholder Approval 3.2 Rights Agreement 3.30 Redeemed Series B Shares 5.4 Term Section 3.7(a)(iReference Repurchase Notice Date 5.4 Rights Agreement Amendment 3.30 Section 409A 3.17(b) Minimum Condition Section 2.1(a)(iSeries B Preferred Approval 3.2 Subsidiary Securities 3.6(c) Multiemployer Plan Section 4.11(c)Surviving Corporation 2.1 Termination Date 9.1(b) Termination Employee Plans 6.2(a) Voting Agreement Preamble

Appears in 1 contract

Sources: Merger Agreement (SoftBrands, Inc.)

Additional Definitions. The For purposes of this Agreement, each of the following capitalized terms shall have the respective meanings ascribed thereto meaning specified in the respective sections of this Agreement Section set forth opposite each of the capitalized terms belowto such term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii280G Stockholder Vote 7.5(e) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Closing Consideration 3.2(f) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBalance Sheet Cash Statement 7.15 Balance Sheet Date 6.1(e)(i) Antiboycott Rules Section 4.22(aBurdensome Condition 7.2(d)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 4.2 CARES Act Program 6.1(z) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Charges 11.5(a) Changes Section 1.1 Charter 4.1 Chosen Courts 11.8(a) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Closing Payment Fund 5.8(a) Company Preamble Company Common Stock Recitals 401(k) Plan 7.5(c) Company Benefit Plans 6.1(h)(i) Company Disclosure Letter Article IV 6.1 Company License-In Agreements Section 4.16(gIndemnified Parties 7.6(a) Company License-Out Agreements Section 4.16(hIntellectual Property 6.1(q)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aMaterial Contract 6.1(k)(i) Company Securities Section 4.2(aPrepared Returns 10.1(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Real Property 6.1(l)(ii) Company D&O Insurance Section 7.8(cReal Property Leases 6.1(l)(ii) Customs Laws Section 4.22(aCompany Restricted Share Payment 5.5(b) Debt Financing Dispute Section 10.9(aCompeting Business 6.1(u) Confidential Communications 11.6(c) Continuing Employee 7.5(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i5.4(a) EAR Section 4.22(aDissenting Stockholders 5.4(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Employment Agreements Recitals ERISA 6.1(h)(i) Exchange Fund Section 3.8(bERISA Affiliate 6.1(h)(iii) Expiration Time Section 2.1(d)(iERISA Plan 6.1(h)(ii) Escrow Agreement 5.7(a) Escrow Funds 5.7(a) Escrow Period 5.7(a) Estimated Closing Statement 5.2 Estimated Merger Consideration Adjustment Amount 5.2 Excluded Shares 5.4(a) Final Closing Statement 5.3(a) Final Merger Consideration Adjustment Amount 5.3(f) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b6.1(e)(i) Recitals Recitals Indemnified Persons Section 7.8(aFLSA 6.1(i)(v) Inventions Section 1.1 Government Antitrust Entity 7.2(d)(i) Guaranteed Obligations 11.18(a) Holdback Distribution Amount 11.5(a) HSR Clearance 8.1(b) Information Statement 7.8 Latest Balance Sheet 6.1(e)(i) Letter of Transmittal 5.8(b) Material Contract Section 4.18(aCustomer 6.1(t)(i) Maximum Annual Premium Section 7.8(cMaterial Vendor 6.1(t)(ii) Merger Recitals Merger Consideration Section 3.7(a)(iAdjustment Amount 5.1(a) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Month-End Net Working Capital 7.15 Multiemployer Plans 6.1(h)(ii) Multiemployer Net Working Capital Statement 7.15 Non-Competition Agreements Recitals Non-Party Affiliate 11.11 Objection Notice 5.3(b) Outside Date 9.1(b) Owned Intellectual Property 6.1(q)(i) Parachute Payment 7.5(d) Parent Preamble Parent 401(k) Plan Section 4.11(c7.5(c) Parent Termination Fee 9.3(a) Parent Parties 11.6(a) Paying Agent 5.8(a) Paying Agent Agreement 5.8(a) Payoff Letters 5.10 Related Party 6.1(u) Representative Losses 11.5(f) Restrictive Covenant Agreements Recitals Seller Parties 9.3(b) S▇▇▇▇▇▇ 11.6(b) Stockholder Representative Preamble Surviving Corporation 2.1 Tail Policies 7.6(c) Takeover Statute 6.1(n) Tangible Property 6.1(m)(i) Uruguayan Reorganization 7.13 Ultimate Parent Entity Preamble Voting Stockholders Recitals Written Consent Delivery Period 7.2(e)

Appears in 1 contract

Sources: Agreement and Plan of Merger (KAR Auction Services, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Acquired Company Returns 3.15(a) Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAlternate Debt Financing 6.5(d) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(iiCertification 3.4(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.20 Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hOptions 2.8(b) Company Financial Advisor Section 4.10 Plans 6.11(b) Company SEC Reports Section 4.7(a3.4(a) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cComparable Plans 6.11(b) Customs Laws Section 4.22(aCovenant Exceptions 5.1(a) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Debt Financing Sources 4.10(a) Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(z) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Enforcement Expenses 8.3(e) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFee Letters 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 3.7(a) Leased Real Property 3.7(a) Major Customer 3.11(a) Major Supplier 3.11(b) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Misconduct Claim 3.16(f) New Debt Commitment Letters 6.5(d) New Plans 6.11(c) Non-Cooperation Notice 6.6(a)(vi) Notice Period 5.4(d)(ii)(3) Old Plans 6.11(c) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Party Preamble Patents 1.1(www) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) Qatalyst Partners 3.24 Reimbursement Obligations 6.6(f) Requisite Stockholder Approval 3.22 Restraint 7.1(c) Sanctioned Jurisdictions 3.13(d) Section 409A 3.16(l) Specified Foreign Direct Investment Laws 6.2(a) Standards Organization 3.8(c) Surviving Corporation 2.1 Tail Policy 6.10(b) Takeover Statute 3.21 Termination Date 8.1(c) Trade Secrets 1.1(www) Uncertificated Shares 2.9(c)(ii) Underwater Option 2.8(c)(i) Unfair Labor Practice 3.16(b) Unvested Company RSU 2.8(a) UPE 6.2(a) Vested Company Option 2.8(b) Vested Company Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iVested Company RSU 2.8(a) Multiemployer Plan Section 4.11(c)Vested Company RSU Consideration 2.8(a) Voting Agreements Recitals

Appears in 1 contract

Sources: Merger Agreement (Momentive Global Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCertificates 2.10(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hOption 2.8(c)(i) Company Financial Advisor Section 4.10 PSU Award 2.8(b)(i) Company Relevant Persons 3.22(b) Company RSU Award 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.5(a) Company Shares Voting Agreements Recitals Confidentiality Agreement Section 10.4 Company Warrant Consideration 2.9 Copyrights 1.1(jjj) Covenant Exceptions 5.1(a) Current Company D&O Insurance Section 7.8(cPurchase Period 2.8(f) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.10(d) Effect 1.1(w) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFinal Purchase 2.8(f) Financial Statements Incipio Incipio Merger Financing Reimbursement Obligations 6.7(f) Go-Shop Period 5.4(a) Guarantee Recitals Guarantors Recitals Haveli Voting Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 International Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(b) Labor Entities 3.20(b) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(jjj) Material Contract Section 4.18(aCustomers 1.1(qqq)(ix) Material Vendors 1.1(qqq)(ix) Maximum Annual Premium Section 7.8(c6.11(c) Merger Recitals Merger Sub Preamble New Plans 6.12(c) No-Shop Period Start Date 5.4(b) Non-Cooperation Notice 6.7(b) Notice Period 5.4(e)(ii)(3) OFAC 1.1(eeee) Old Plans 6.12(c) Other Required Company Filing 6.4(e) Other Required Parent Filing 6.4(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Party Preamble Patents 1.1(jjj) (a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Processing 3.17 Proxy Statement 6.4(a) Required Amount 4.11(c) Required Permits 3.21 Requisite Stockholder Approval 3.4 Restraint 7.1(c) Security Breach 3.17(b) Solvent 4.11(d) Specified Date 8.1(c) Surviving Corporation 2.1 Tail Policy 6.11(c) Termination Date 8.1(c) Trade Secrets 1.1(jjj) Uncertificated Shares 2.10(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU Award 2.8(b)(ii) Unvested Company RSU Award 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU Award 2.8(b)(i) Multiemployer Plan Section 4.11(cVested Company PSU Consideration 2.8(b)(i) Vested Company RSU Award 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Voting Agreements Recitals WARN Act 3.21(e)

Appears in 1 contract

Sources: Merger Agreement (Couchbase, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Anti-Corruption Laws Section Reference Acceptable 3.19(b) Articles of Merger Section 1.1 ▇▇▇▇▇ Option Section 4.5(a)(iv) Book-Entry Shares Section 2.3(c) Canaccord Section 4.2(b) Certificates Section 2.3(c) Closing Date Section 2.1 Code Recitals Common Stock Consideration Section 1.4(b)(i) Confidentiality Agreement Section 6.2(e)(iii7.5(h) Acquisition Proposal Continuing Employee Section 6.2(e)(i7.7(a) Acquisition Sub Preamble Adverse Recommendation Change Continuing Employees Section 6.2(c)(i7.7(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Policy Section 7.8(c) Customs Laws DGCL Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) 3.23 EAR Section 4.22(a3.19(c)(i) ECCNs Section 3.19(c)(ii) Effective Time Section 3.2 Enforceability Exceptions 1.1 Employment Agreements Recitals Exchange Agent Section 4.4 Environmental Permits Section 4.15(b2.3(a) Exchange Fund Section 3.8(b2.3(b)(i) Expiration Time Exchange Ratio Section 2.1(d)(i1.4(b)(i) Financial Statements Incipio Incipio Merger Agreement Export Controls Section 4.7(b3.19(c)(i) Recitals Recitals FCPA Section 3.19(b) Import Restrictions Section 3.19(c)(i) Indemnified Persons Parties Section 7.8(a) Inventions ITAR Section 1.1 Material Contract 3.19(c)(i) Joint Proxy Statement/Prospectus Section 4.18(a7.3(a) Malicious Code Section 3.13(m) Maximum Annual Premium Section 7.8(c) MBCA Recitals Merger Recitals Merger Consideration Shareholder Meetings Section 3.7(a)(i7.4(a) Minimum Condition Merger Sub Preamble OFAC Section 2.1(a)(i3.19(c)(i) Multiemployer Plan Qumu Preamble Qumu Board Section 4.11(c3.2(b) Qumu Board Recommendation Section 7.4(e) Qumu Board Recommendation Change Section 7.4(f) Qumu Capitalization Representations Section 2.2(b)(ii)(B) Qumu Designee Section 8.1(a) Qumu Disclosure Letter Article III Qumu Fundamental Representations Section 2.2(b)(ii)(A)

Appears in 1 contract

Sources: Loan and Security Agreement (Synacor, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.13(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppraisal Rights Provisions 2.12(a) Antiboycott Rules Section 4.22(aAssets 3.21 Cash Consideration 2.7(a)(1) Board Recommendation Section 2.2(bCertificates 2.8(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gIntellectual Property 3.22(a) Company License-Out Agreements Section 4.16(hProduct 3.22(a) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.22(b) Company Restricted Stock 2.7(d) Company Rights Plan Recitals Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Special Representations 7.3(a) Company Stockholder Approval 3.3(c) Company Stockholders’ Meeting 6.3 Company Triggering Event 8.1(f)(ii) Confidentiality Agreement Section 10.4 Current Company 6.10 Copyrights 3.22(a)(2) D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(aDelaware Secretary of State 2.2 Dissenting Shares 2.12(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aStockholders 2.12(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Eligible Company Stock Option 2.7(a)(5) Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Agent 2.8(a) Exchange Fund 2.8(b) Exclusivity Agreement 6.1(b) First Certificate of Merger 2.2 First Merger 2.1(a) Term Section 3.8(bReference First Merger Surviving Entity 2.1(a) Expiration Time Section 2.1(d)(iForm S-4 6.6(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 3.22(k) Recitals Recitals Incentives 3.16(m) Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 Intellectual Property Rights 3.22(a) International Employee Plans 3.18(a) IP Licenses 3.22(l) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Communication 6.11(b) Merger Consideration 2.7(a) Merger Sub 1 Preamble Merger Sub 2 Preamble Modified Stock Option 6.12(a)(2) Modified RSU 6.12(a)(2) Open Source License 3.22(a)(4) Open Source Materials 3.22(a)(4) Option Exchange Ratio 2.7(a)(5) Out-Licenses 3.22(l) Parent Preamble Parent Disclosure Schedule Article IV Parent Intellectual Property 4.13(a) Parent Registered Intellectual Property 4.13(b) Parent SEC Reports 4.5 Parent Securities 4.3(c) Parent Special Representations 7.2(a) Patents 3.22(a)(2) Permits 3.13 Proxy Statement 3.8 Registered Intellectual Property 3.22(a)(6) Rollover RSU 6.12(b) Rollover Stock Option 6.12(b) Second Certificate of Merger 2.1(b) Second Merger 2.1(b) Second Merger Surviving Entity 2.1(b) Source Code 3.22(a)(7) Subsidiary Securities 3.2(c) Surviving Entity 2.1(b) Tax Opinions 6.19 Term Section 3.7(a)(iReference Technology 3.22(a)(1) Minimum Condition Section 2.1(a)(iTermination Fee Amount 8.3(b)(1) Multiemployer Plan Section 4.11(cTrade Secrets 3.22(a)(2) Trademarks 3.22(a)(2) Uncertificated Shares 2.8(a)

Appears in 1 contract

Sources: Merger Agreement (Transwitch Corp /De)

Additional Definitions. The following capitalized Each of the terms shall have set forth below has the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement provision set forth opposite each of such term in the capitalized terms belowfollowing table: Term Accounting Firm Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii1.3(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Additional HM Purchaser Recitals Agreement Preamble Alternative Acquisition Agreement Expiration Date Section 6.2(c)(ii9.1(c) Antiboycott Rules Books and Records Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 6.5 Closing Section 3.3 2.1 Closing Date Section 3.3 COBRA 2.1 Closing Debt Amount Section 4.11(d1.2(a)(i)(B) Company Confidential Information Section 6.4(a) Disputed Item Section 1.3(b) Eagle Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Eagle Parties Preamble Effective Time Section 3.2 Enforceability Exceptions 2.5 Estimated Partnership Cash Section 4.4 Environmental Permits 1.2(a)(i)(A) Estimated Working Capital Section 4.15(b1.2(a)(i)(C) Exchange Fund Final Adjustment Amount Section 3.8(b1.3(a) Final CFO Certificate Section 1.3(a) Final Payment Section 1.3(e) HM Preamble HM Parties Preamble HMSC Put Option Recitals Initial Adjustment Amount Section 1.2(b) Initial Adjustment Statement Section 1.2(a)(i) Initial Purchase Price Section 1.2(b) Losses Section 10.2 Negotiation Period Section 1.3(c) Objection Date Section 1.3(b) Objection Notice Section 1.3(b) Other Tax Proceeding Section 6.7(f) Parent Companies Preamble Parties Preamble Partnership Recitals Partnership Agreement Recitals Purchase Price Section 1.3(g) Purchasers Preamble Purchaser Indemnified Parties Section 10.2 Purchaser Party Release Section 2.3(d) Put Option Agreement Recitals Record Retention Period Section 6.5 -34- Seller[s] Preamble Seller Indemnified Parties Section 10.3 Seller Party Release Section 2.2(c) Subject Partnership Interests Recitals Survival Expiration Time Date Section 2.1(d)(i10.1 Surviving Indemnification Rights Section 6.2 Tax Proceeding Section 6.7(e) Financial Statements Incipio Incipio Merger Agreement Third-Party Claims Section 4.7(b) 10.4 TLCC Partners Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)TLCC Put Option Recitals

Appears in 1 contract

Sources: Put Option Agreement (Eagle Materials Inc)

Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement set forth opposite each section of the capitalized terms Agreement indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAAA 2.5(b)(iii) Actual 2008 Revenues 2.6(a)(ii) Acquisition Proposal Section 6.2(e)(i6.3(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffiliated Indebtedness 4.30(a)(iii) Agreement Preamble Alternative Acquisition Recitals Arbitrator 2.5(b)(iii) Assignment of Inventions Agreement Section 6.2(c)(ii6.1(o) Antiboycott Rules Section 4.22(aCash Escrow 2.4(a)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 Closing Date Working Capital 2.5(b)(i) COBRA Section 4.11(dCoverage 4.25(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gTax Returns 4.14(a) Company LicenseRecitals Consulting Agreement 6.1(l) Employment Agreement 6.1(k) Escrow Agent Escrow Agreement Escrow Agent’s Wire Transfer Instructions 2.4(a)(ii) Escrow Agreement 2.4(c) Escrow Shares 2.4(a)(ii) Estimated 2008 Revenues 2.6(a)(i) Final Post-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iClosing Revenue Report 2.6(a)(iii) Financial Statements Incipio Incipio Merger 4.9 Leases 4.21(e) License Agreements 4.22(g) Material Contract(s) 4.12(a) Non-Competition and Non-Solicitation Agreement Section 4.7(b6.1(j) Non-Disclosure Agreement 8.2 Post-Closing Revenue Report 2.6(a)(ii) Products 4.31 Purchase Price 2.2 Purchaser Recitals Recitals Purchaser’s Accountants 2.6(a)(ii) Purchaser Indemnified Persons Section 7.8(a7.3 Reference Balance Sheet Date 4.9 Reference Working Capital 2.5(a) Inventions Section 1.1 Material Contract Section 4.18(aRelease(s) Maximum Annual Premium Section 7.8(c2.4(b)(ii) Merger Revenue Dispute Notice Period 2.6(a)(iii) Revenue Disputed Matters 2.6(a)(iv) Revenue Dispute Resolution Period 2.6(a)(iii) Revenue Notice of Disagreement 2.6(a)(iii) Revenue-Related Adjustment 2.6(a)(v)(A) Revenue-Related Adjustment Reduction 2.6(a)(v)(A) SEC 5.6 Seller and Sellers Recitals Merger Consideration Section 3.7(a)(iSellers’ Accountant 2.5(b)(ii) Minimum Condition Section 2.1(a)(iSellers’ Indemnified Persons 7.4 Sellers’ Representative 2.7(a) Multiemployer Plan Section 4.11(cSeller Wire Transfer Instructions 2.4(a)(i) Share(s)s Recitals Survival Date 7.1(b) Upfront Payment 8.14 Tangible Personal Property 4.23(a) Third Party Claim 7.7 Working Capital Dispute Notice Period 2.5(b)(ii) Working Capital Dispute Resolution Period 2.5(b)(ii) Working Capital Disputed Matters 2.5(b)(iii) Working Capital Notice of Disagreement 2.5(b)(ii)

Appears in 1 contract

Sources: Stock Purchase and Sale Agreement (Orchid Cellmark Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2020 Bonus Plan 7.9(d) Acquisition Proposal Section 6.2(e)(i2020 Bonuses 7.9(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i401(k) Plan 7.9(e) 401(k) Plan Termination Date 7.9(e) Accepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bBalance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) CARES Act 1.1 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d4.12(d) Collaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 3.7(g) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 4.2(b) Company Financial Advisor Section 4.10 Advisors 4.11 Company Program Requirements 4.20(d) Company Programs 4.20(d) Company Regulatory Agency 4.20(b) Company Regulatory Permits 4.20(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section Tail Policy 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 Effects 1.1 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFFCRA 1.1 FFDCA 1.1 Final Exercise Date 3.7(g) Recitals Recitals Final Offering Period 3.7(g) Foreign Antitrust Laws 1.1 Indemnified Persons Section 7.8(a) Indemnified Proceeding 7.8(b) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.19(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Parent Preamble Parent 401(k) Plans 7.9(e) Participant 4.12(e) Paying Agent 3.8(a) Plans 4.12(a) Proprietary Information 1.1 Real Property Leases 4.18(b) Remedy Actions 7.2(a) Retention Agreements Recitals RSU Consideration 3.7(e) Schedule 14D-9 2.2(a) Schedule TO 2.1(f)(i) Subsidiary Securities 4.2(e) Surviving Corporation 3.1 Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1

Appears in 1 contract

Sources: Merger Agreement (Momenta Pharmaceuticals Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvance Notice Period 5.2(d)(i)(1) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(a) Antiboycott Rules Section 4.22(aAlternative Financing 6.20(b) Board Recommendation Section 2.2(bBuyer Parties Preamble Bylaws 1.6(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 1.3 Certificates Section 3.8(c2.3(c) Changes Section 1.1 Charter 1.6(a) Closing Section 3.3 1.4 Closing Date Section 3.3 COBRA Section 4.11(d) 1.4 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(c) Company Board Recommendation Change 5.2(c)(i) Company Confidential Information 3.17(e) Company Data 3.17(l) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gFinancial Statements 3.5(c) Company License-Out Agreements Section 4.16(hMaterial Contracts 3.16(b) Company Financial Advisor Section 4.10 Preferred Stock 3.2(a) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.6 Continuation Period 6.19(a) Covered Employees 6.19(a) D&O Insurance Section 7.8(cTail Policies 6.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData Security Incident 3.17(l) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.1(c)(i) EAR Section 4.22(aDTC 2.3(d) DTC Payment 2.3(d) Effective Time Section 3.2 1.3 Electronic Delivery 9.15 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Exchange Fund Section 3.8(b2.3(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Guarantee 9.16 Guarantor Preamble Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 Material Contract Section 4.18(aInsurance Policies 3.20 Interim Period 5.1 Intervening Event 5.2(d)(i) Maximum Annual Premium Section 7.8(cLabor Agreement 3.12(a) Lease Agreement 3.16(a)(xi) Leased Real Property 3.14(b) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble Merger Transactions Recitals New Litigation Claim 6.12 Note Recitals Notice Period Expiration 5.2(d)(i)(2) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(c) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(d) Owned Company Share 2.1(a)(iii)

Appears in 1 contract

Sources: Agreement and Plan of Merger (Hall of Fame Resort & Entertainment Co)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiPreamble Agreement of Merger 2.2 Antitrust Restraint 6.5(d) Acquisition Proposal Section 6.2(e)(iAssets 3.21 Assumed Option 6.11(b) Acquisition Sub California Secretary of State 2.2 Cancelled Option 6.11(a) Capitalization Representation 7.2(a) Certificates 2.8(c) Change 1.1 Changes 1.1 China RoHS 1.1 Closing 2.3 Closing Date 2.3 Collective Bargaining Agreements 3.19(a) Combined Software 1.1 Company Preamble Adverse Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change Section 6.2(c)(i6.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.22(f) Company License-Out Agreements Section 4.16(hRegistered IP 3.22(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 6.1(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Copyrights 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(aDemand Notice 2.7(c)(i) Debt Financing Dispute Section 10.9(aDissenting Shares 2.7(c)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iDomain Names 1.1 EAR 3.23(a) EAR Section 4.22(aECCNs 3.23(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) EU RoHS Directive 1.1 Exchange Fund 2.8(b) Export Controls 3.23(a) FIN 48 3.16(n) Term Section 3.8(bReference Foreign Employees 3.18(l) Expiration Time Section 2.1(d)(iFunded International Employee Plan 3.18(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bImport Restrictions 3.23(a) Recitals Recitals Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 International Employee Plans 3.18(a) ITAR 3.23(a) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble NQDCP 5.2(g) OFAC 3.23(a) Option Consideration 6.11(a) Owned Real Property 3.20(a) Parent Preamble Patents 1.1 Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Shareholder Approval 3.3(c) Retirement Plan Termination Date 6.12(a) Retirement Plans 6.12(a) SEC Reports 3.6 Shares Recitals Significant Customer 3.30(a) Significant Supplier 3.30(b) Specified Representations 7.2(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Laws 3.29 Tax Incentive 3.16(k) Termination Date 8.1(c) Termination Fee Amount 8.3(b)(i) Third Party Leases 3.20(b) Trade Secrets 1.1 Trademarks 1.1 Triggering Event 8.1(e)(ii) USML 3.23(b) Term Section 3.7(a)(iReference Voting Agreement Recitals Voting Agreements Recitals Warranties 3.22(s) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)WEEE Directive 1.1

Appears in 1 contract

Sources: Merger Agreement (Supertex Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Action 10.9 Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Financing 6.2(c) Board Recommendation Section 2.2(bAlternative Financing Documents 6.2(c) Cancelled Available Company Shares Section 3.7(a)(iiCash Financing 6.2(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.8(c) Change 1.1 Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Recitals Benefit Plans 3.14(a) Company Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aShareholders Meeting 7.3(d) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 3.6 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.10(a) Debt Financing 4.10(a) Dispute Section 10.9(a10.9 Dissenting Shareholder 2.7(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFacility Agreement 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 1.1 Fee Letter 4.10(a) Recitals Financing 4.10(a) Financing Commitments 4.10(a) HKIAC 10.9 HKIAC Rules 10.9 Holdco Recitals Indemnified Persons Section 7.8(a6.1(a) Inventions Section 1.1 Leased Real Property 3.15(b) Limited Guarantee Recitals Material Contract Section 4.18(aContracts 3.12(a) Maximum Annual Premium Section 7.8(c6.1(c) Measurement Date 3.7(a) Merger Recitals Merger Sub Preamble Negotiation Period 5.3(c) Operating Subsidiary 1.1 Outside Date 9.1(b) Parent Preamble Paying Agent 2.8(a) Per ADS Merger Consideration Section 3.7(a)(i2.7(a)(ii) Minimum Condition Section 2.1(a)(iPer Share Merger Consideration 2.7(a)(ii) Multiemployer Permits 3.15 Plan Section 4.11(cof Merger Recitals Proxy Statement 7.3(a) Real Property Leases 3.15(b) Recommendation Change Notice 5.3(c) Registrar of Companies 2.3 Rollover Shareholders Recitals Rollover Shares Recitals Shareholder Approval 3.4 Schedule 13E-3 3.6 Special Committee Recitals Sponsor 4.10(a) Subsidiary Securities 3.8(c) Support Agreement Recitals Surviving Corporation 2.1 Takeover Statute 3.23 Tax Returns 3.16(b) Trade Secrets 1.1 Uncertificated Shares 2.8(c)

Appears in 1 contract

Sources: Merger Agreement (Liu Tianwen)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii6.2(f)(iii) Acquisition Proposal Section 6.2(e)(i6.2(f)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.2(d)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.2(d)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Option Consideration 3.7(d) Parent Preamble Patent Rights 1.1 Payment Agent 3.8(a) Plans 4.11(a) Real Property Leases 4.17(b) Restraint 8.1(b) Restricted Territories 4.22(a)(i) RSU Consideration 3.7(e) Sanctions Laws 4.22(a) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Solicitation Period End-Date 6.2(a) Subsidiary Securities 4.2(b) Superior Proposal 6.2(f)(ii) Surviving Corporation 3.1 Termination Date 9.1(b) Termination Fee 1.1 Trade Compliance Laws 4.22(a) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1

Appears in 1 contract

Sources: Merger Agreement (Skullcandy, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble AI 1.1(mmmmm) Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hOption 2.8(b)(i) Company Financial Advisor Section 4.10 Plans 6.11(b) Company Relevant Persons 3.22(b) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cConverted Cash Award 2.8(a)(ii) Customs Laws Section 4.22(aCopyrights 1.1(yyy) Debt Financing Dispute Section 10.9(aCovenant Exceptions 5.1(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(hh) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(d) Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Equity Financing Sources 4.10(a) Event Notice Period 5.4(d)(i)(2) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFirst Extended Termination Date 8.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantees Recitals Guarantors Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 IP Contracts 3.16(e) Labor Agreements 3.20(a) Labor Entities 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(yyy) Material Contract Section 4.18(aCustomers 1.1(hhhh)(xiii) Material Vendors 1.1(hhhh)(xiii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble Misconduct Claim 3.20(d) Minimum Condition Section 2.1(a)(iNon-US Continuing Employees 6.11(b) Multiemployer Plan Section 4.11(cNotice Period 5.4(d)(ii)(3) Notified Party 6.2(c) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(e)(i) Party Preamble Patents 1.1(yyy) Payment Agent 2.9(a) PCI DSS 1.1(xxx) Per Share Price 2.7(a)(iii) Privacy and Data Security Requirements 3.17(a) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(f) Required Governmental Authorizations 3.21 Requisite Stockholder Approval 3.4 Restraint 7.1(c) Surviving Corporation 2.1 Tail Policy 6.10(c) Takeover Statute 3.3(c)

Appears in 1 contract

Sources: Merger Agreement (Alteryx, Inc.)

Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article I shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term . Adjustment Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 2.10 Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(d)(iii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Book Entry Shares Section 3.7(a)(ii2.7(a) Cash Consideration Section 2.6(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.6(b) Changes Section 1.1 Closing Section 3.3 2.4 Closing Date Section 3.3 COBRA Section 4.11(d) 2.4 Code Recitals Company Preamble Company Common Stock Recitals 401(k) Plan Section 5.12 Company Disclosure Letter Article IV Company License-In Agreements Adverse Recommendation Change Section 4.16(g5.2(d) Company License-Out Agreements Data Section 4.16(h3.14(b) Company Financial Advisor Statements Section 4.10 3.6(b) Company Intellectual Property Section 3.13(a) Company IT Systems Section 3.14(a) Company Material Contract Section 3.17(a) Company Multiemployer Plan Section 3.15(k) Company Plans Section 3.15(a) Company RSU Section 2.8(c) Company SEC Reports Documents Section 4.7(a3.6(a) Company Securities Stockholder Approval Section 4.2(a3.4(a) Company Shares Recitals Stockholders’ Meeting Section 3.19 Confidentiality Agreement Section 10.4 Current Company 5.2(b)(i) Copyrights Section 3.13(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a5.8(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.6(d) EAR Divestitures Section 4.22(a5.6(c) Effective Time Section 3.2 Enforceability Exceptions 2.3 ERISA Affiliate Section 4.4 Environmental Permits 3.15(a) Exchange Agent Section 4.15(b2.7(a) Exchange Fund Section 3.8(b2.7(a) Expiration Time Expenses Section 2.1(d)(i7.3(c) Financial Statements Incipio Incipio Merger Agreement Films in Progress Section 4.7(b3.22(a) ▇▇.▇▇▇ Common Stock Section 4.2(a) Indemnified Parties Section 5.8(a) Intellectual Property Section 3.13(a) IP Contracts Section 3.13(a) Leased Property Section 3.11(b) LLC Act Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.6(b) Minimum Condition Merger LLC Preamble Merger Sub Preamble Non-Owned Intellectual Property Section 2.1(a)(i3.13(a) Multiemployer Plan Outside Date Section 4.11(c7.1(b)(i) Owned Intellectual Property Section 3.13(a) Parent Preamble Parent SEC Documents Section 4.5(a) Real Property Leases Section 3.11(b) Reinstated Recommendation Section 5.3(b) Stock Consideration Section 2.6(b) Surviving Company Section 5.18 Surviving Corporation Section 2.1 Termination Fee Section 7.3(a) Trade Secrets Section 3.13(a) Upstream Merger Recitals Voting Agreement Recitals Voting Company Debt Section 3.2(b)

Appears in 1 contract

Sources: Merger Agreement (Marvel Entertainment, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Restraint 6.5(d) Antiboycott Rules Section 4.22(aAntitrust Termination Date 8.1(d) Board Recommendation Section 2.2(bAssets 3.21 Assumed Option 6.11(d)(ii) Assumed RSA 6.11(c) Assumed RSU 6.11(b) Assumed Stock Appreciation Right 6.11(a)(ii) Cancelled Company Shares Section 3.7(a)(iiOption 6.11(d)(i) Cancelled SAR 6.11(a)(i) Cancelled RSU 6.11(b) Capitalization Representation 7.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.7(a)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Common Stock Recitals Company Disclosure Letter Article IV III Preamble Company LicenseForm 10-In K Article III Preamble Company IP Agreements Section 4.16(g3.22(e) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRegistered IP 3.22(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.2 Exchange Fund 2.8(b) Export Controls 3.23(a) Import Restrictions 3.23(a) Incentive Plan 6.12(d) Indemnified Parties 6.13(a) Term Section 3.8(bReference Intervening Event 6.2(c)(ii) Expiration Time Section 2.1(d)(iLabor Organization 3.19(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bLeases 3.20(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Preamble Normal Closing Due Date 2.3 Notice Period 6.2(c)(i) Minimum Condition Section 2.1(a)(iOption Consideration 6.11(d)(i) Multiemployer Plan Section 4.11(c)Parent Preamble Parent Specified Representations 7.3(a) Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Stockholder Approval 3.3(c) SEC Reports 3.6(a) Significant Customer 3.15(a) Significant Supplier 3.15(b) Specified Representations 7.2(a) Stock Appreciation Right Consideration 6.11(a)(i) Stub Bonus 6.12(d) Subsidiary Securities 3.2(d) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Law 3.29(a) Tax Incentive 3.16(k) Termination Date 8.1(d) Termination Fee Amount 8.3(b)(i) Triggering Event 8.1(f)(ii) Uncertificated Shares 2.7(a)(i) Voting Agreement Recitals

Appears in 1 contract

Sources: Merger Agreement (Microchip Technology Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto are defined in the respective sections of this Agreement set forth opposite each of across from such term in the capitalized terms belowfollowing table: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAllocation Schedule 3.5 Assumed Liabilities 2.4 Balance Sheet Date 5.5 Business Employee 5.16(a) Antiboycott Rules Section 4.22(aBuyer Preamble Buyer Applications 7.12(a) Board Recommendation Section 2.2(bCall Referral Arrangement 7.8 Claim Notice 8.4(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dPayment 3.2(a)(ii) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gCurrent Volume 5.11 Customer 7.2(b) Company License-Out Agreements Section 4.16(hData Converter 7.3(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 5.16(b) Exchange Fund Section 3.8(bAct 5.8 Excluded Assets 2.3 Excluded Contracts 2.3(b) Expiration Time Section 2.1(d)(iExcluded Inventory Exhibit C Excluded Liabilities 2.5 Fairness Opinion 5.21 File-Transfer Assets 2.1 File-Transfer Inventory 2.1(b) File-Transfer Locations Recitals File-Transfer Records 2.2(a) Final Conversion 7.3(a) Financial Statements Incipio Incipio Merger 5.5 First Purchased File-Transfer Assets 4.2(c) Fundamental Reps 8.8 GPA Amount 3.1(d) Indemnified Event 8.6 Indemnified Person 8.4(a) Indemnitor 8.4(a) Indemnity Agent 3.4 Indemnity Escrow Account 3.2(a)(i) Indemnity Fund 3.4 Independent Valuator 3.3(a) Information Statement 7.20 Initial Conversion 7.3(a) Inventory 2.2(c) Inventory Amount 3.3(a) Inventory Audit 3.3(a) IOU Prescriptions 7.5 Leased Real Property 5.12(f) Long-Term Care Business 7.22 Notes Amount 3.1(e) Operate Location Pharmacies Recitals Parent Preamble Agreement Section 4.7(bPreamble Parent SEC Reports 5.8 Parent Shareholder Approval 5.1(b) Recitals Recitals Indemnified Persons Section 7.8(aParent Shareholder Approval Evidence 7.18 Payment Program 5.19(c)(i) Inventions Section 1.1 Material Contract Section 4.18(aPermits 5.19(c)(i) Maximum Annual Premium Section 7.8(cPersonal Property 2.2(a) Merger Recitals Merger Consideration Section 3.7(a)(iPharmacy Business 7.2(a) Minimum Condition Section 2.1(a)(iPHI 7.3(b) Multiemployer Plan Section 4.11(cPower of Attorney 7.12(c) Purchase Price 3.1 Purchased Assets 2.2 Real Property Laws 5.12(g) Record Data 7.3(a) Records 2.2(b) Required Licenses 9.2(f) Seller Preamble Seller Group 7.2(a) Seller Receivables 7.14(a) Subsequently Purchased Assets 4.4(c) Tax Survival Period 11.1 Termination Date 10.1(a)(iv) Third Party Distributor 7.4 Third Person Claim 8.4(a) Transfer Taxes 7.9(a) Transferable Permits 7.12(a) Transferred Employee 7.1(b) Transition Services Agreement 4.2(e)

Appears in 1 contract

Sources: Asset Purchase Agreement (Graymark Healthcare, Inc.)

Additional Definitions. The Unless the context clearly indicates otherwise, the following capitalized terms shall used in this Agreement will have the respective meanings ascribed thereto set forth in the respective sections of this corresponding sections. Additional Indication Section 3.4 Alliance Manager Section 2.6 Anti-Corruption Laws Section 14.11 ARScience Licensed Patent Rights Section 1.1.59 Audited Site Section 5.4 Benefit Section 14.11 Biosimilar Application Section 9.3.1 Breaching Party Section 10.2.2 CAPA Section 5.4 Chairperson Section 2.3 Claims Section 13.1.1 CMO Section 6.2.3 Coya Development Activities Section 4.2.2 Coya Fault Event Section 10.3.2 Coya Manufacturing Site Section 6.2.3 Coya Responsible Country Section 10.2.5a Coya Royalty Obligations Section 8.5.2d Coya Sole Know-How Section 9.1.1 Coya Sole Patent Rights Section 9.1.1 Cure Period Section 10.2.2 Biosimilar Application Section 9.3.1 Breaching Party Section 10.2.2 CAPA Section 5.4 Defense Action Section 9.3.3 Development Funding Section 8.2.4 Development Milestone Event Section 8.3 Development Milestone Payment Section 8.3 Development Plan Section 4.3 Development Report Section 4.4 DRL Responsibilities Section 4.2.1 DRL Sole Know-How Section 9.1.2 DRL Sole Patent Rights Section 9.1.2 Enforceability Action Section 9.4 Final Product Trademark Section 9.6 Force Majeure Event Section 14.1 Infringement Section 9.3.1 Infringement Action Section 9.3.3 Infringement Claim Section 9.4 Insolvency Event Section 10.2.3 Joint Know-How Section 9.1.3 Joint Patent Rights Section 9.1.3 JSC Section 2.1 JSC Matters Section 2.2 Methodist Licensed Patent Rights Section 1.1.59 Product Action Section 7.5.1 Payee Section 8.7.1 Payor Section 8.7.1 Pharmacovigilance Agreement set forth opposite each of the capitalized terms below: Section 5.5 Privacy Laws Section 14.12 Recall Section 7.5.1 Recall Costs Section 7.5.2 Remedy Country Section 10.3 ROFN Country Section 3.5.1 ROFN Country Exercise Notice Section 3.5.1 Biosimilar Application Section 9.3.1 Breaching Party Section 10.2.2 CAPA Section 5.4 ROFN County Exercise Period Section 3.5.1 ROFN Country Negotiation Period Section 3.5.1 ROFN Country Notice Section 3.5.1 ROFN Country ROFR Exercise Period Section 3.5.3 ROFN Country ROFR Negotiation Period Section 3.5.3 ROFN Country ROFR Notice Section 3.5.3 ROFR Country Section 3.4 ROFR Exercise Period Section 3.4 ROFR Notice Section 3.4 Royalty Payments Section 8.5.1 Rules Section 14.10 Sales Milestone Event Section 8.4 Sales Milestone Payment Section 8.4 Second Development Funding Payment Section 8.2.1 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement 10.1 Terminated Country Section 10.4 Current Company D&O Insurance Third Development Funding Payment Section 7.8(c) Customs Laws 8.2.2 Upfront Payment Section 4.22(a) Debt Financing Dispute 8.1 USD Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)8.5

Appears in 1 contract

Sources: Development and License Agreement (Coya Therapeutics, Inc.)

Additional Definitions. The following capitalized terms used in this Agreement shall have the respective meanings ascribed thereto assigned in the respective sections of this Agreement set forth opposite each of the capitalized terms belowAgreement: Term Acquiring Party Section Reference Acceptable Confidentiality 8.1(d) Alternative Use Section 6.5(c)(i) Amendment No. 4 to Patent Cross License Agreement Section 6.2(e)(iii2.1(c)(iii) Acquisition Proposal Appointing Party Section 6.2(e)(i6.9(b)(i) Acquisition Sub Preamble Adverse Recommendation Change [*] Section 6.2(c)(i6.5(c)(ii)(B) Agreement Preamble Alternative Acquisition Closing Section 2.1(a) Committee Representatives Section 6.9(b)(i) Common R&D Agreement Section 6.2(c)(ii2.1(c)(i) Antiboycott Rules Common R&D Development Expenses Section 4.22(a6.8(a)(i) Board Recommendation Costs Section 2.2(b6.5(c)(i) Cancelled Company Shares Cross License Agreement Section 3.7(a)(ii2.1(c)(iii) Certificate of Merger Defaulting Party Section 3.2 Certificates 6.12(d) EC Party/Excess Capacity Party Section 3.8(c6.7(b)(i) Changes Embedded NAND Product Section 1.1 Closing 6.7(c)(ii) Employer Section 3.3 Closing 6.10(b)(vii) Engineers Section 6.10 Environmental Indemnification Agreement Section 2.1(b)(vii) Equipment Section 6.5(c)(i) Evaluation Wafers Section 6.8(a)(iii) Financing Section 6.12(b)(iii) Flash Alliance Section 2.1(b) FA Foundry Agreement Section 2.1(b)(iv) FA Operating Agreement Section 2.1(b)(ii) FA Operative Documents Section 2.1(b) FA Patent Indemnification Agreement Section 2.1(b)(vi) FA Termination Date Section 3.3 COBRA Section 4.11(d8.1(b) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities FA Shares Section 4.2(a) Company Shares FP Master Agreement Recitals Confidentiality FP NAND Flash Memory Products Section 3.3(a) FVC Japan Master Agreement Recitals FVC Japan NAND Flash Memory Products Section 3.3(a) Headcount Plan Section 6.10 * Indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. ICs Section 3.2 Intellectual Property Section 4.7 Investing Party Section 6.5(c)(i) Joint Operative Documents Section 2.1(c) Lease Agreement Section 10.4 Current Company D&O Insurance 2.1(b)(viii) Management Committee Section 7.8(c6.9 Minimum RUP Commitment Section 6.5(c)(i) Customs Laws Master Operative Documents Section 4.22(a) Debt Financing Dispute 2.2 NAND Flash Memory Integrated Circuits Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time 6.13 NAND Flash Memory Products Section 3.2 Enforceability Exceptions NAND Process Technology Section 4.4 Environmental Permits 6.3(a) Non-Defaulting Party Section 4.15(b6.12(d) Exchange Fund Non-Investing Party Section 3.8(b6.5(c)(i) Expiration Time Non-Originating Party Section 2.1(d)(i6.7(e) Financial Statements Incipio Incipio Merger Originating Party Section 6.7(e) Parties Heading Product Development Agreement Section 4.7(b2.1(c)(ii) Recitals Recitals Indemnified Persons Proprietary NAND Flash Memory Products Section 7.8(a6.7(d) Inventions Purchase and Supply Agreements Section 1.1 Material Contract 2.1(b)(v) Qualification Wafers Section 4.18(a6.8(a)(iv) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Ramp-Up Plan Section 4.11(c6.5(b) Remaining Y4 Personnel Section 8.1(j) Requesting Party Section 8.1(d)(i) [*] Section 6.5(c)(ii) [*] Section __ SanDisk Heading SanDisk Corporation Heading SanDisk Financing Section 6.12(b)(iii) SanDisk Ireland Heading SanDisk Purchase and Supply Agreement Section 2.1(b)(v) SanDisk Team Section__ SanDisk Termination Capacity Section 8.1(e)(i) Selling Party Section 8.1(d) * Indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Share Purchase Agreement Section 2.1(b)(i)

Appears in 1 contract

Sources: Master Agreement (Sandisk Corp)

Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Antitrust Laws Section 6.2(c)(ii5.5(a) Antiboycott Rules Antitrust Matters Section 4.22(a5.5(b) Board Recommendation Assets Section 2.2(b3.18 Assumed RSU Section 2.11(d) Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Cash Consideration Section 2.9(a) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consent Solicitation Section 5.16(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Current Restricted Share Section 2.11(c) Current RSU Section 2.11(d) Debt Financing Dispute Offer Section 10.9(a5.16(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) ERISA Affiliate Section 4.15(b3.15(a) ESPP Section 2.11(h) Exchange Agent Section 2.10(a) Exchange Fund Section 3.8(b2.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b). Leases Section 3.17(b) Lenders Section 8.9(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c)5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Parent Form 10-K Article IV Parent SEC Reports Section 4.6 Parent Securities Section 4.4(c) Parent Subsidiary Securities Section 4.2(c) Permits Section 3.11(a) Potential Financing Section 5.16(b) Potential Financing Sources Section 5.16(b) Proxy Statement/Prospectus Section 5.2(a) Qualifying Amendment Section 5.2(c) Registration Statement Section 5.2(a) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22

Appears in 1 contract

Sources: Agreement and Plan of Merger (Conexant Systems Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 401(k) Termination Date Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.12(a) Agreement Preamble Alternative Acquisition Agreement Alternate Debt Financing Section 6.2(c)(ii6.16(c) Antiboycott Rules Anti-Bribery Laws Section 4.22(a3.25 Antitrust Termination Date Section 8.1(d) Board Recommendation Assets Section 2.2(b3.21 Assumed Option Section 6.11(c)(i) Assumed RSU Section 6.11(a) Cancelled Company Shares Option Section 3.7(a)(ii6.11(c)(ii) Capitalization Reference Date Section 3.4(a) Cash Consideration Section 2.7(a)(i) Certificate of Merger Section 3.2 2.2(a) Certificates Section 3.8(c2.8(a) Changes Clarification Request Section 1.1 6.1(b) Closing Section 3.3 2.3(a) Closing Date Section 3.3 COBRA 2.3(a) Collective Bargaining Agreements Section 4.11(d3.19(a) Company Preamble Company Board Recitals Company Board Recommendation Section 6.2(a) Company Board Recommendation Change Section 6.2(b) Company Capitalization Representation Section 7.2(a)(iii) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Inbound License Section 3.22(e) Company IP Agreements Section 4.16(g3.22(e) Company License-Out Agreements Leased Real Property Section 4.16(h3.20(b) Company Financial Advisor Outbound License Section 4.10 3.22(e) Company Real Property Leases Section 3.20(b) Company Registered IP Section 3.22(a) Company Related Party Section 9.5 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting Section 6.3 Company Specified Representations Section 7.2(a)(ii) Company Termination Fee Amount Section 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent Section 3.5(b) Copyrights Section 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Debt Commitment Letters Section 4.22(a4.16(a) Debt Financing Dispute Section 10.9(a4.16(a) DGCL Recitals Delaware Secretary of State Section 2.2(a) Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Dollars or $ Section 4.22(a1.3(d) Domain Names Section 1.1 Effect Section 1.1 Effective Time Section 3.2 2.2(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.3(a) EU Section 4.15(b1.1 Exchange Agent Section 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Export and Import Approvals Section 2.1(d)(i3.23 Export Controls Section 3.23 First Step Merger Recitals Form S-4 Section 6.4(a) Financial Statements Incipio Incipio Merger Agreement Fractional Share Cash Amount Section 4.7(b2.7(c) Recitals Recitals Import Restrictions Section 3.23 Indemnified Persons Parties Section 7.8(a6.13(a) Inventions Interim Surviving Corporation Section 1.1 2.1(a) ▇▇▇▇▇ Day Section 6.4(e) Labor Organization Section 3.19(a) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Sub Preamble Merger Sub LLC Preamble New Debt Commitment Letters Section 2.1(a)(i6.16(c) Multiemployer Plan Notice Period Section 4.11(c6.2(c)(i) Option Consideration Section 6.11(c)(ii) Parent Preamble Parent Board Recitals Parent Capitalization Date Section 4.7(a) Parent Capitalization Representation Section 7.3(a)(iii) Parent Disclosure Letter Article IV Parent SEC Reports Section 4.8(a) Parent Securities Section 4.7(c) Parent Specified Representations Section 7.3(a)(ii) Parent Subsidiary Preferred Stock Section 5.4(b) Parent Subsidiary Securities Section 4.2(c) Parent Termination Fee Section 8.3(c) Patents Section 1.1 Proxy Statement/Prospectus Section 6.4(a) Regulation M-A Filing Section 6.4(d) Required Financial Information Section 6.17(a)(iv) Requisite Shareholder Approval Section 3.3(c) Revenue Cap Section 6.5(e) SAR Consideration Section 6.11(d) Second Step Merger Recitals Significant Customer Section 3.15(a) Significant Supplier Section 3.15(b) Specified Jurisdictions Section 7.1(b) Stock Consideration Section 2.7(a)(i) Subsidiary Securities Section 3.2(d) Surviving Company Section 2.1(b) Tail Policy Section 6.13(b) Takeover Law Section 3.29(b) Tax Incentive Section 3.16(l) Termination Date Section 8.1(d) Trademarks Section 1.1 Trade Secrets Section 1.1 Transition Period Section 6.12(b) Triggering Event Section 8.1(f)(ii) Uncertificated Shares Section 2.8(a) WSGR Section 6.4(e)

Appears in 1 contract

Sources: Merger Agreement (Oclaro, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAccounts Receivable 3.26 Acquisition Transaction 1.1(c) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAmended Tax Returns 6.16 Bylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCash Transfer Plan 6.17(c) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.20(a) Company Preamble Company Board Recitals Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Common Stock Recitals Company Directors Plan Consideration 2.8(f) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gIntellectual Property 3.17(b) Company License-Out Agreements Section 4.16(hPBU Consideration 2.8(c) Company Financial Advisor Section 4.10 Related Parties 8.3(g)(ii) Company Restricted Stock Consideration 2.8(e) Company RSU Consideration 2.8(a) Company SAR Consideration 2.8(b) Company SEC Reports Section 4.7(a) 3.9 Company Securities Section 4.2(a3.7(c) Company Shares Recitals Company Systems 3.17(f) Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuation Period 6.11(b) Converted Company D&O Insurance Section 7.8(cShares 2.7(a)(iv) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) DGCL Recitals Deferral Accounts 2.8(f) Deferred Compensation Stock Unit 2.8(f) Directors Plan 2.8(f) Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aDTC 2.9(d) D&O Insurance 6.10(c) Effect 1.1(k) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Employee Plans 3.19(a) Exchange Fund Section 3.8(bEquity Commitment Letter 4.11(a) Expiration Time Section 2.1(d)(iEquity Financing 4.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExpense Reimbursement 8.3(b)(iv) FCPA 3.30 Fee Letter 4.11(a) Financing 4.11(a) Financing Letters 4.11(a) Foreign Employee Plans 3.19(a) GBCC Recitals Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aLegal Restraint 7.1(c) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(d) Notice Period 5.3(d)(i)(3) Option Consideration Section 3.7(a)(i2.8(d) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Related Parties 8.3(g)(i) Parent Termination Fee 8.3(d) Party Preamble Paying Agent 2.9(a) Payment Fund 2.9(b) Permits 3.21 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Privacy Agreements 3.17(h) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Amount 4.11(c) Required Financial Information 6.6(a)(iii) Requisite Shareholder Approval 3.4 Significant Customer 3.14(a) Significant Vendor 3.14(b) Surviving Corporation Article II Uncertificated Shares 2.9(c) WARN 3.20(g)

Appears in 1 contract

Sources: Merger Agreement (PRGX Global, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2019 Bonuses 6.11(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Corruption Laws 3.25(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(iii) Company License-Out Agreements Section 4.16(hOption Consideration 2.8(a) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(iii) Company PSU Consideration 2.8(f) Company RSU Consideration 2.8(d) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(oo) Covered Severance Plan Employees 6.11(b) Commitment Letters 4.11(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(aCommitment Letter 4.11(a) Debt Payoff Letter 6.6(vii) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) Effect 1.1(p) Effective Time Section 2.2 Electronic Delivery 9.13 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFCPA 3.25(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Enforcement Expenses 8.3(e) Recitals Fee Letter 4.11(a) Financing 4.11(a) Go-Shop Period 5.3(a) Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(j) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Lease 3.14(b) Leased Real Property 3.14(b) Limited Guarantee Recitals Marks 1.1(oo) Material Contract Section 4.18(aCustomer 1.1(ss)(iii) Material Vendor 1.1(xx)(iv) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(oo) Payment Agent 2.10(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Amounts 4.11(c) Requisite Stockholder Approval 3.4 Sanctioned Country 3.25(a) Substitute Financing 4.11(e) Substituted Options 2.8(b) Substituted Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iSubstituted RSAs 2.8(c) Multiemployer Plan Section 4.11(cSubstituted RSA Consideration 2.8(c) Substituted RSUs 2.8(e) Substituted RSU Consideration 2.8(e) Surviving Corporation Article II Termination Date 8.1(c) Top Font Families 3.16(n) Trade Control Laws 3.25(a) Uncertificated Shares 2.10(c)

Appears in 1 contract

Sources: Merger Agreement (Monotype Imaging Holdings Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.13(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.21 Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Closing 2.3 Closing Average 1.1(bb) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Common Affiliate 6.20 Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Intellectual Property 3.22(a) Company Product 3.22(a) Company Registered Intellectual Property 3.22(b) Company Restricted Stock 2.7(d) Company Rights Plan Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gSecurities 3.4(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement 6.10 Consent 3.5(b) Term Section 10.4 Current Company Reference D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Delaware Secretary of State 2.2 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExtended Termination Date 8.1(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 3.18(m) Recitals Recitals Funded International Employee Plan 3.18(c) In-Licenses 3.22(n) Incentives 3.16(p) Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 Initial Termination Date 8.1(b) Intellectual Property Rights 3.22(a) International Employee Plans 3.18(a) IP Licenses 3.22(o) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger 2.1 Merger Sub Preamble Object Code 3.22(a) Open Source Materials 3.22(a) Out-Licenses 3.22(o) Parent Preamble Parent Restricted Stock 4.3(b) Parent SEC Reports 4.5 Proxy Statement 3.8 Registered Intellectual Property 3.22(a) Requisite Stockholder Approval 3.3(b) Rights Plan Amendment Recitals Merger Consideration Section 3.7(a)(iRoHS Directive 1.1(y) Minimum Condition Section 2.1(a)(iSEC Reports 3.6 Source Code 3.22(a) Multiemployer Plan Section 4.11(cSpecial Representations 7.3(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Technology 3.22(a) Termination Fee Amount 8.3(b)(i) Triggering Event 8.1(f)(iii) Voting Agreement Recitals WEEE Directive 1.1(y)

Appears in 1 contract

Sources: Merger Agreement (Micro Linear Corp /Ca/)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEffect on Financing 7.18 Advisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a)(i) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8 Effect 1.1(t) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c)6.3(e)(i) Event Notice Period 6.3(e)(i) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Go-Shop Period 6.3(a) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) (a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) No-Shop Period Start Date 6.3(a) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)

Appears in 1 contract

Sources: Agreement and Plan of Merger (H&E Equipment Services, Inc.)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable “Accountant” Section 3.04(b) “Adjustment Escrow Account” Section 3.03(c)(iv) “Adjustment Escrow Deposit” Section 3.03(c)(iv) “Bank” Preamble “Bank Audited Financial Statements” Section 5.03(k) “Bank Benefit Plan” Section 5.03(w)(i) “Bank Disclosure Schedule” Section 5.01 “Bank Financial Statements” Section 5.03(k) “Bank Interim Financial Statements” Section 5.03(k) “Bank Material Contracts” Section 5.03(y) “Bank Releasee” Section 6.12 “Benefit Plans” Section 5.03(w) “Burdensome Conditions” Section 7.01(b) “Closing” Section 2.02 “Closing Date” Section 2.02 “Closing Payment” Section 3.02(a) “Common Stock” Recitals “Confidentiality Agreement Agreement” Section 6.2(e)(iii6.05(a) Acquisition Proposal “Confidential Information” Section 6.2(e)(i6.05(a) Acquisition Sub “Cross-Receipt” Section 3.03(a)(iv) “Director Resignation Agreements” Recitals “Environmental Law” Section 5.03(u)(i) “Escrow Agent” Section 3.03(c)(iii) “Escrow Agreement” Section 3.05(a) “Escrow Deposits” Section 3.03(c)(iv) “Execution Date” Preamble Adverse Recommendation Change “Expiration Date” Section 6.2(c)(i9.05 “Extensions of Credit” Section 5.03(l)(iv) Agreement Preamble Alternative Acquisition Agreement “FHLBNY” Section 6.2(c)(ii7.02(j) Antiboycott Rules “Final Determination” Section 4.22(a3.02(c) Board Recommendation “Final Tangible Common Equity Value” Section 2.2(b3.04(c) Cancelled Company Shares “Funds Flow Memorandum” Section 3.7(a)(ii3.02(b) Certificate “Indemnified Party” Section 9.03(a) “Indemnifying Party” Section 9.03(a) “Indemnity Escrow Account” Section 3.03(c)(iii) “Indemnity Escrow Deposit” Section 3.03(c)(iii) “Lease” Section 4.04 “Losses” Section 9.01(a) “Minority Director Shareholders” Recitals “Net Recovery” Section 3.02(c) “Notice” Section 11.06 “Notice of Merger Objection” Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c3.04(a)

Appears in 1 contract

Sources: Stock Purchase Agreement (Newtek Business Services Corp.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.8(d)(i) Agreement Preamble Alternative Acquisition Agreement Approval Section 6.2(c)(ii3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Antiboycott Rules CERCLA Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii3.20(c) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.8 Company Securities Section 4.2(a3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Compensation Schedule Section 5.1(b)(vii) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 7.8 Certificates Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.8(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.2 Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.8(b) Recitals ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) IPL Section 3.14(g) ITA Section 2.8(f) Inventions Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.12(b) Leases Section 3.12(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.11(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Proposal Section 2.1(a)(i7.4(a) Multiemployer Plan Merger Sub Preamble OECD Convention Section 4.11(c3.19(b) Option Consideration Section 2.7(c) Options Tax Ruling Section 7.9(a) Ordinary Share Section 2.7(a)(iii) Outside Date Section 9.1(c) Ordinary Shares Section 2.7(a)(i) Parent Preamble Patent Rights Section 1.1 Paying Agent Section 2.8(a) Payor Section 2.8(f) Permits Section 3.18 Primary Company Executives Section 3.16(h) Prohibited Payment Section 3.19(b) R&D Sponsor Section 3.14(i) Record ADS Holders Section 7.3(a) Registered Intellectual Property Section 3.14(a) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(b) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Trademark Rights Section 1.1 Trademarks Section 1.1 VAT Section 3.15(s) WARN Section 3.17(c) Works of Authorship Section 1.1 Withholding Tax Ruling Section 7.9(b)

Appears in 1 contract

Sources: Merger Agreement (Ultra Clean Holdings, Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(e)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.14 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letter 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gIntellectual Property 3.16(d) Company License-Out Intellectual Property Agreements Section 4.16(h3.16(c) Company Financial Advisor Section 4.10 Products 3.16(b) Company Registered Intellectual Property 3.16(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStock-Based Award Consideration 2.7(d) Company Shares Recitals Stockholder Meeting 6.4 Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuing Discussion Period 5.3(c) Copyrights 1.1(nn) Dissenting Company Shares 2.7(c)(i) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a) 6.6 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aEffect 1.1(n) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) ESPP 2.7(g) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 In-Licenses 3.16(c) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Lease 3.15(b) Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Newco Preamble Newco Expenses 8.3 Newco Representatives 5.3(f) No-Shop Period Start Date 5.3(a) Notice Period 5.3(f) Option Consideration Section 3.7(a)(i2.7(e) Minimum Condition Section 2.1(a)(iOther Required Company Filing or Other Required Company Filings 3.27(a) Multiemployer Plan Section 4.11(c)Other Required Newco Filing or Other Required Newco Filings 4.6(b) Out-Licenses 3.16(c) Owned Company Shares 2.7(a)(iii) Patents 1.1(nn) Payment Agent 2.8(a) Per Share Price 2.7(a)(ii) Proxy Statement 3.27(a) PTO 3.16(a) Recent SEC Reports Article III Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.15(c) Subsidiary Securities 3.8(c) Surviving Corporation 2.1 (a) Termination Date 8.1

Appears in 1 contract

Sources: Merger Agreement (Sumtotal Systems Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.18(f) Commitment Letters 4.11(a)(ii) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gPlans 6.11(c) Company License-Out Agreements Section 4.16(hRestricted Stock Unit Consideration 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Systems 3.16(l) Company Termination Fee 8.3(b) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c9.4 Consent 3.6 Copyrights 1.1 Cut-Off Date 5.3(a) Customs Laws Section 4.22(aFinancing 4.11(a)(ii) Debt Commitment Letter 4.11(a)(i) Debt Financing Dispute Section 10.9(a4.11(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Effect 1.1 Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a)(ii) Equity Financing 4.11(a)(ii) ERISA Affiliate 3.18(a) ESPP 2.8(e) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExpense Reimbursement 8.3(b)(iv) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFair Value 4.13(e)(i) Go-Shop Period End Date 5.3(a) Guarantor Recitals Limited Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section International Employee Plans 3.18(a) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1 Material Contract Section 4.18(a) Suppliers 1.1 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Maximum Liability Amount 8.3(f)(i) Party Preamble Patents 1.1 Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Present Fair Salable Value 4.13(e) Proxy Statement 6.3(a) Recent SEC Reports Article III Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tax Incentive 3.17(i) Tax Returns 3.17(a) (a) Outside Date 8.1(c)

Appears in 1 contract

Sources: Merger Agreement (Blue Nile Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approvals Annex A Appointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.14 Assumed Option 3.7(e) Board Recommendation Section 2.2(bAssumed RSU 3.7(d) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.18(k) Company Disclosure Letter Article Art. IV Preamble Term Section Reference Company License-In Intellectual Property Agreements Section 4.16(g4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.2(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 7.2(c) Competing Acquisition Transaction 10.4(b) Confidentiality Agreement Section 10.4 Current Company 8.8 Consent 4.5 Continuing Directors 2.3(a) Conversion RSUs 3.7(d)(ii) Covered Securityholders 4.18(k) D&O Insurance Section 7.8(c7.1(c) Customs Laws Section 4.22(aDeemed Cashout Value 3.7(e)(ii) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) Employment Compensation Arrangements 4.18(k) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.1(a) Inventions Section 1.1 Material Contract Section International Employee Plans 4.18(a) Leased Real Property 4.13(b) Leases 4.13(b) (a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Minimum Condition 2.1(a) New Plans 7.2(d) Offer Recitals Offer Price Recitals Offer to Purchase 2.1(a) Offer Documents 2.1(g) Old Plans 7.2(d) Option Consideration 3.7(e) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Proxy Statement 4.28(c) Recommendation Change Notice 6.3(b) Representatives 6.2(b) Term Section 2.1(a)(iReference Requisite Stockholder Approval 4.3 Schedule TO 2.1(g) Multiemployer Plan Section 4.11(cSchedule 14D-9 2.2(b) Stockholders Recitals Subsidiary Securities 4.7(c) Superior Proposal Notice 10.1(e) Surviving Corporation 3.1 (a) Tax Returns 4.16 (a) Tender and Voting Agreement Recitals Termination Date 10.1(b) Termination Fee 10.4(b) Top-Up Notice 2.4(a) Top-Up Option 2.4(a) Top-Up Option Shares 2.4(a) Uncertificated Shares 3.8(c)

Appears in 1 contract

Sources: Agreement and Plan of Merger (3PAR Inc.)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iPlan 6.11(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdjusted Restricted Stock 2.8(a) Agreement Preamble Alternative Acquisition Agreement Term Section 6.2(c)(iiReference Antitrust Approval 7.1 Assumed Option 2.8(e) Antiboycott Rules Section 4.22(aAssumed Restricted Stock Unit 2.8(f) Board Recommendation Section 2.2(bBook-Entry Shares 2.9(b) Cancelled Company Shares Section 3.7(a)(ii2.7(b) Capitalization Date 3.4(a) Cash Consideration 2.7(b) Certificate 2.9(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreements 3.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.7(a) Company Board Recommendation Change 6.7(a) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gInsiders 6.14 Company Registered Intellectual Property 3.20(a) Company License-Out Agreements Section 4.16(hRestricted Stock 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholder Meeting 6.6(a) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.3(b) Continuing Employees 6.11(d) D&O Insurance Section 7.8(c6.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3(a) Employee Plans 3.15(a) ERISA Affiliate 3.15(a) Exchange Fund Agent 2.9(a) (a) Final Surviving Corporation 2.1(b) First Step Merger Recitals Foreign Employees 3.15(j) In-Licenses 3.20(g) Incentives 3.14(o) (a) Integrated Merger Recitals Interim Surviving Corporation 2.1(a) International Employee Plans 3.15(a) Term Section 3.8(bReference Intervening Event 6.7(b) Expiration Time Section 2.1(d)(iInvestment Company Act 3.11(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIP Licenses 3.20(h) Recitals Recitals Indemnified Persons Section 7.8(aLeased Real Property 3.17 Leases 3.17 Legal Proceeding Matters 6.8(d) Inventions Section 1.1 Material Contract Section 4.18(a3.13(a) Maximum Annual Premium Section 7.8(c6.12(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(b) Minimum Condition Section 2.1(a)(iMerger Proposal 6.6(a) Multiemployer Plan Section 4.11(cMerger Sub One Preamble Merger Sub Two Preamble Option Exchange Program 2.8(b) Option Exchange Proposal 2.8(c) Out-Licenses 3.20(h) Paragon 3.24 Parent Preamble Parent Disclosure Schedule Article IV Parent SEC Reports 4.5(a) Permits 3.11(a) Proxy Statement/Prospectus 6.5(a) Qualifying Amendment 6.5(c) Registration Statement 6.5(a) Regulation M-A Filing 6.5(d) Regulatory Filings 3.11(c) Requisite Merger Approval 3.2(c) Requisite Option Exchange Approval 3.2(c) Restricted Stock Units 2.8(b) Reviewable Transaction 8.1(b) RoHS Directive 1.1(y) Second Step Merger Recitals Specified Company Representations 7.2(a) Specified Parent Representations 7.3(a) Stock Consideration 2.7(b) Subsidiary Securities 3.5(d) Tax Opinions 6.18 Termination Date 8.1(b) Termination Fee Amount 8.3(b) Trade Secrets 1.1(hh) Trademarks 1.1(hh)

Appears in 1 contract

Sources: Merger Agreement (Td Ameritrade Holding Corp)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto meaning defined in the respective corresponding sections of this Agreement indicated below: Agreement Preamble Effective Date Preamble BGI Preamble Bunge Netherlands Preamble Bunge Brazil Preamble Bunge Group Preamble Solazyme, Inc. Preamble Solazyme Brazil Preamble Solazyme Group Preamble Company Preamble SB Oils Preamble JV Companies Preamble SBO Holdco Preamble Initial Plant Recitals Joint Venture Recitals Party 1.2 Dollar 1.2 Reais 1.2 * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Business 2.2(a) Percentage Interest 3.2 Capital Contributions 4.1 Initial Solazyme Equity Commitment 4.1(a)(i) Additional Solazyme Equity Commitment 4.1(a)(ii) Initial Bunge Equity Commitment 4.1(b)(i) Initial Equity Commitments 4.1(b)(i) Additional Bunge Equity Commitment 4.1(b)(ii) Additional Equity Commitments 4.1(b)(ii) Capital Call 4.5 Estimated Tax Distributions 4.8(e) Annual Tax Distribution 4.8(e) Tax Distributions 4.8(e) U.S. GAAP 4.9 Regulatory Allocations 5.4(d) SB Oils Officers 6.1 Board 6.1 Key Managers 6.11 Secondees 6.11 Administrative Services 7.1(b) R&D 7.2 Land Commitment for Purchase and Sale In Rem Right 7.6(a) 7.6(a) 7.6(b) Initial Business Plan 7.9(b) Initial Annual Budget 7.9(b) Section 8.3(a) Notice 8.3(a) Section 8.3(a)(ii) Notice 8.3(a) Section 8.3(b) Notice 8.3(b) Section 8.3(c) Notice 8.3(c) Section 8.3(d) Notice 8.3(d) Expansion Notice 8.5(a) Election Period 8.5(b) Commence Construction 8.5(f) * Notice 9.1(a) Section 9.1(a) Notice 9.1(a) Section 9.1(a) Response 9.1(a) HSR Act 10.1 SBDC Approval 10.2 SOX Compliance 10.6(f)(ii) Form 1065 10.7 Tax Matters Partner 10.9 Fiscal Year 10.11 Tax Year 10.11 Lock-Out Period 12.1 * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Remaining Party 12.2(a)(i) Section 12.2(a) Transfer Notice 12.2(a)(i) Qualifying Offer 12.2(a)(ii) Competitor Transfer Offer 12.2(b)(i) Offered Interest 12.2(b)(i) Section 12.2(b) Transfer Notice 12.2(b)(i) Election Notice 12.2(b)(ii) Target Party 12.3 Section 12.3(a) Notice 12.3(a) Section 12.3(b) Response Date 12.3(b) Confidential Information 14.1 Indemnifying Party 15.1 Indemnified Party 15.1 Term 16.1 Control Definition of Affiliate Acquired Party Definition of Change in Control Primary Field Definition of Field Secondary Field Definition of Field Solazyme Development Agreement Definition of JV Agreements Bunge Development Agreement Definition of JV Agreements Development Agreements Definition of JV Agreements Cross-License Agreement Definition of JV Agreements Feedstock Supply Agreement Definition of JV Agreements Brazilian Administrative Services Agreement Definition of JV Agreements Dutch Administrative Services Agreement Definition of JV Agreements Administrative Services Agreements Definition of JV Agreements Utility Supply Agreement Definition of JV Agreements Working Capital Agreement Definition of JV Agreements Lease Definition of JV Agreements Additional Definitions in the Solazyme Development Agreement. Capitalized terms used in this Agreement but not defined anywhere herein (including the Exhibits) shall have the meaning ascribed to them in the Solazyme Development Agreement. Such terms include the following: Background Technology 10.3 Solazyme Project Technology 10.3 Solazyme Technical Services Technology 10.3 Solazyme Platform Technology 10.3 * * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Aggregate Capital Funded – Party A 60 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 100 million Initial Percentage Interest – Party A 60%(60/100) Initial Percentage Interest – Party B 40%(40/100) Capital Call (each) 10 million Party A Funds 20 million Party B Funds -0- Aggregate Capital Funded – Party A 80 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 120 million Initial Percentage Interest – Party A 66.7%(80/120) Initial Percentage Interest – Party B 33.3%(40/120) Aggregate Capital Funded – Party A 60 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 100 million Initial Percentage Interest – Party A 60%(60/100) Initial Percentage Interest – Party B 40%(40/100) Capital Call (each) 10 million Party A Funds 10 million Party B Funds -0- Aggregate Capital Funded – Party A 70 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 110 million Initial Percentage Interest – Party A 63.6%(70/110) Initial Percentage Interest – Party B 36.4%(40/110) If the Percentage Interests of the Parties at the time of actual cash distributions has changed from the Percentage Interests of the Parties on the Effective Date, the * splt provided in Section 4.8(b) shall be adjusted proportionately to the change in Percentage Interests as set forth opposite each of in the capitalized terms belowfollowing tables: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company * For Percentage Interests different than those set forth in the above table a comparable adjustment shall be made (assuming a straight line between the relevant numbers). * Certain information on this page has been omitted and filed separately with the Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) and Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Commission. Confidential treatment has been requested with respect to the omitted portions.

Appears in 1 contract

Sources: Joint Venture Agreement (Solazyme Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAssumed Company Option 2.8(c)(i) Board Recommendation Section 2.2(bAssumed Company Stock-Based Award 2.8(c)(ii) Base Indenture 1.1(ppp) Book-Entry Shares 2.9(b) Burdensome Condition 6.2(b) Bylaws 3.1 Cancelled Owned Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(b) Changes Section 1.1 Charter 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.4(a) Company License-Out Agreements Section 4.16(hEmployee 3.18(i) Company Financial Advisor Section 4.10 Plans 6.9(b) Company Recent SEC Reports Article III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.9(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.7(b)(i)1.1(o)2.2 Electronic Delivery Employee Plans ERISA Affiliate Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FinCEN First Supplemental Indenture Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Indenture Initial Termination Date Injunction International Employee Plan Lease Leased Real Property Maximum Annual Premium Section 7.8(cMerger Merger Sub New Plans Notice Period OFAC Old PlansOwned Real Property Parent Parent Disclosure Letter Parent Qualified Plan Parent Recent SEC Reports Parent Termination Fee Party Paying Agent Payoff Letter Permits Proxy Statement Representatives Repurchase Transaction Repurchase Transaction Notice Requisite Stockholder Approval Revolving Credit Facility Termination Sanctioned Countries Sanctioned Person Sanctions Second Supplemental Indenture 9.123.18(a)3.18(a)2.9(a)3.21(d)1.1(ooo)6.8(a)1.1(ppp)8.1(c)8.1(b)3.18(a)3.14(b)3.14(b)6.8(c)Recitals Preamble 6.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i5.3(d)(ii)(3)3.21(c)6.9(c)3.14(a)Preamble 1.4(b) Minimum Condition Section 2.1(a)(i6.9(d)Article IV 8.3(c)(i) Multiemployer Plan Section 4.11(cPreamble 2.9(a) 6.16(d)3.206.3(a)5.3(a)6.16(c)6.16(c)3.46.16(d)3.21(c)3.21(c)3.21(c)1.1(ppp) -17- Sublease 3.14(c) Surrendered Company Stock-Based Award 2.8(a) Surviving Corporation 2.1 Tax Returns 3.17(a)(i)

Appears in 1 contract

Sources: Agreement and Plan of Merger

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aBylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(bCash Replacement Company RSU/RSA Award Amounts 2.8(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCash Replacement Option Amounts 2.8(b)(ii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c9.4 Consent 3.6 Copyrights 1.1(pp) Customs Laws Section 4.22(aDebt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Effect 1.1(o) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) ESPP 2.8(e) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iGo-Shop Period 5.3(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(e)(i) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(pp) Material Contract Section 4.18(aCustomers 1.1(tt)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(d) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(mm) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Trade Control Laws 3.26(a)(i) Termination Date 8.1(c) Uncertificated Shares 2.9(c) Unvested Company Options 2.8(b)(ii) Unvested Company RSU/RSA Award 2.8(a)(i) Vested Option Consideration Section 3.7(a)(i2.8(b)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cVested RSU/RSA Consideration 2.8(a)(i)

Appears in 1 contract

Sources: Merger Agreement (Ellie Mae Inc)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAnti-Bribery Laws 3.22(a) Acquisition Proposal Section 6.2(e)(iBurdensome Condition 6.2(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Company Board Recommendation 5.3(a) Company Preamble Company Common Stock Recitals Board Recommendation Change 5.2(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.2(b) Company Financial Advisor Section 4.10 3.11 Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Stockholder Approval 3.5 Company Stockholders’ Meeting 6.12(b) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(cIndemnified Party 6.7(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.3 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b3.16 ESPP Purchase Date 2.7(h) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExcluded Shares 2.7(a)(ii) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExisting Offer Period 2.7(h) Recitals Recitals Indemnified Persons Section 7.8(aFDCA 3.20(a) Inventions Section 1.1 Foreign Antitrust Laws 3.6 Leased Real Property 3.18(b) Material Contract Section 4.18(a3.19(a) Maximum Annual Premium Section 7.8(cMedical Device 3.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMoney Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(cNew Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Owned Real Property 3.18(a) Parent Disclosure Letter 1.1 Paying Agent 2.8(a) Proxy Statement 3.6 Real Property 3.18(a) Real Property Leases 3.18(b) Regulatory Permits 3.20(h) Remedy Actions 6.2(a) Social Security Act 3.20(e) Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Termination Fee 8.3(b) Trustee 6.14(c) Uncertificated Shares 2.8(c)(ii)

Appears in 1 contract

Sources: Merger Agreement (Shockwave Medical, Inc.)